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Abstract 
Translation is a multi-stage process comprising initiation, elongation and termination. It has 
been suggested that the initiation phase is the rate limiting step of this process.   In this 
thesis the contributions of how changes in initiation and elongation rates lead to overall 
alterations in gene expression pathways were investigated in a number of different systems.  
It has been shown previously that increased expression of tRNAi
Met
 is associated with 
tumourigenesis however the precise role of tRNAi
Met
 in this process was unclear.  Data 
obtained from cells with increased tRNAi
Met 
copy number show that the associated increase 
in proliferation is transient and unlikely to play a major role in cancer. 
/ŶĐŽůůĂďŽƌĂƚŝŽŶǁŝƚŚƌKǁĞŶ^ĂŵƐŽŶ ?ƐŐƌŽƵƉ ?ŝƚǁĂƐƐŚŽǁn that early dysplastic changes in 
intestinal tumourigenesis are driven by increased translation elongation via mammalian 
target of rapamycin 1 (mTORC1). It was found that constitutively active mutant K-Ras confers 
resistance to mTORC1 inhibition, and combined mTORC1/2 inhibition but that these tumours 
are acutely sensitivity to loss of the mTORC2 component, Rictor.    
Interestingly, changes in translation elongation rate were also identified in cells cooled to 
32
o
C and this was associated with the reprogramming of gene expression under these 
conditions.  
Finally, the use of the next-generation sequencing technique ribosome profiling illustrated 
some potential challenges of using this approach to infer biologically relevant conclusions. 
These include: biases in fragment and library generation, limited read depth and statistical 
inference from low-count data.  An alternate library generation method reduced bias, but 
reads predicted to be highly structured were still over-represented.  The use of a newly 
developed thermostable ligase did not remedy this problem, but this may be due to 
additional biases associated with the particular ligase used.
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Chapter 1. Introduction 
The regulation of the abundance and activity of cellular proteins is essential to the response 
to intracellular and extracellular conditions. Unsurprisingly, the control of the expression of 
protein coding genes is central to this. Gene expression is a multi-stage process involving the 
nuclear transcription of a pre-mRNA, splicing of this to form a mature mRNA, export to (and 
localisation within) the cytoplasm, translation of the coding sequence of the mRNA to yield 
the protein product, which may be subject to post translational modifications that affect its 
activity and/or degradation. Regulation can occur at any of these stages but, at least in 
cultured cells, the single biggest determinant of gene expression is the rate of translation of 
the mRNA message (Schwanhausser et al., 2011). 
A complete round of translation in a cell culture system typically takes 2 minutes (Ruvinsky et 
al., 2005), and thus regulation at the level of translation allows for a rapid response to 
stimuli. Where components common to the translation of all mRNAs are regulated the 
response is global. Specific /differential regulation is determined by sequences and 
structures within the mRNA in addition to the role of RNA-binding proteins. Furthermore, 
these two forms of regulation are not mutually exclusive, for example allowing the global 
downregulation of translation rates but specific upregulation of the translation of mRNAs 
required to respond to a particular stimulus. 
Translation can be divided into three primary stages: initiation, elongation and termination 
and ribosome recycling. Initiation is typically reported as being the rate limiting step in 
translation (Mathews et al., 2007) and modulation of initiation factors is observed in 
response to a range of stimuli. However, systematic modulation of different components of 
the translational machinery in exponentially growth yeast suggest that elongation may be 
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rate limiting under those conditions (Firczuk et al., 2013). Furthermore, this thesis will 
present evidence that modulation of elongation rate is central in other contexts. 
This Introduction will outline the required molecular components of all three stages of 
translation, interweaving the effects of their regulation.  
1.1 Mechanism and regulation of translation initiation 
Translation initiation is the process by which a translation competent ribosome is recruited 
to the start codon of an mRNA with the aid of initiation factors (eIFs: eukaryotic initiation 
factors). The current model for this involves the scanning of a 43S pre-initiation complex 
(PIC)  W minimally consisting of the 40S ribosomal subunit, eIF1, eIF1A, eIF2-GTP, eIF3, eIF5 
and complex of initiator tRNA methionine (Met-tRNAi
Met
)  W ĂůŽŶŐƚŚĞ ? ?ƵŶƚƌĂŶƐůĂƚĞĚƌĞŐŝŽŶ
(UTR) of a message until a start site is recognised, upon which a 60S subunit is recruited and 
translation elongation begins (reviewed in (Aitken and Lorsch, 2012) and represented Figure 
1.1).  
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Figure 1-1 Schematic of the mechanism of translation initiation 
Translation initiation is mediated by the numbered eukaryotic initiation factors (eIFs) 
depicted and described within the text.  Global initiation rates are governed by the 
availability of either eIF4F complex or Met-tRNAi
Met
-eIF2-GTP. 
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1.1.a Recruitment of tRNAi
Met 
to the 40S ribosomal subunit  
Typically, start codons are decoded by tRNAi
Met
 (methionine codons in the body of a reading 
frame are decoded by elongator tRNA methionine, tRNAe
Met
) and thus delivery of 
Met-tRNAi
Met
 may be a limiting factor for translation initiation.  Met-tRNAi
Met
 is found in the 
PIC bound to eIF2-GTP. Human cell lysates contain eIF2 in a free form and as part of 
multifactor complex with eIF1, eIF2, eIF3 and eIF5, with recruitment of Met-tRNAi
Met
 possible 
in both forms (Sokabe et al., 2012). During initiation, eIF2 bound GTP is hydrolysed yielding 
eIF2-GDP. Met-tRNAi
Met
 binds eIF2-GTP with greater affinity than eIF2-GDP, therefore 
efficient recycling of GDP to GTP following a single round of initiation is required to recruit a 
new tRNA molecule (forming an active ternary complex of Met-tRNAi
Met
-eIF2-GTP). eIF2B, a 
guanine nucleotide exchange factor (GEF) that facilitates the release of GDP from eIF2 
(Williams et al., 2001) ?ŝƐƐĞƋƵĞƐƚĞƌĞĚďǇĞ/& ?ƉŚŽƐƉŚŽƌǇůĂƚĞĚŽŶƚŚĞɲ-ƐƵďƵŶŝƚ ?Ğ/& ?ɲ-P). 
Because eIF2 is vastly more abundant than eIF2B, ŵŽĚĞƐƚĐŚĂŶŐĞƐŝŶĞ/& ?ɲ-P and/or eIF2B 
abundance can dramatically affect ternary complex availability. There are four Ğ/& ?ɲŬŝŶĂƐĞƐ
in mammals, each of which respond to different stresses including, but not limited to, amino 
acid starvation and DNA damage (reviewed in (Proud, 2005)). Equally there are eIF2ɲ 
phosphatases, most notably protein phosphatase 1, which is activated by GADD34, a protein 
induced when ternary complex availability is low forming a negative-feedback loop to allow 
recovery from translation inhibition following these stress responses (Novoa et al., 2001). 
Importantly, whereas Ğ/& ?ɲƉŚŽƐƉŚŽƌǇůĂƚŝŽŶŵĂǇďĞĂƐƐŽĐŝĂƚĞĚǁŝƚŚĂƌĞĚƵĐƚŝŽŶin global 
translation levels, the translation of some transcripts is upregulated.  A mechanism 
underlying this is the presence of multiple upstream open reading frames (uORFs) within 
such transcripts.  A paradigmatic example is the mammalian ATF4 mRNA which contains two 
uORFs, the second overlapping the coding region thus precluding translation of both the ATF 
protein and uORF-2 by the same ribosome (Figure 1-2). Following termination at the first 
uORF, the 40S subunit continues to scan and if active ternary complex is acquired, will 
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reinitiate at uORF-2. When ternary complex availability is reduced it becomes more likely 
that ribosomes acquire ternary complex after scanning past the start site of uORF-2 and thus 
re-initiate at the coding sequence (Vattem and Wek, 2004). ATF4 is a transcription factor that 
targets genes involved in amino acid synthesis and import, creating a closed-loop whereby 
ƉŚŽƐƉŚŽƌǇůĂƚŝŽŶŽĨĞ/& ?ɲďǇ'E2 in response to amino acid depletion increases translation 
of ATF4 until amino acid levels are raised ĂŶĚĞ/& ?ɲ-P levels fall (Harding et al., 2003). Up to 
35 % of mRNAs are predicted to have uORFs (Iacono et al., 2005), however this does not 
mean all will be capable of supporting re-initiation, for example long uORFs do not result in 
reinitiation (Kozak, 2001, Luukkonen et al., 1995).  Even where reinitiation does occur not all 
ribosomes do so and thus uORFs are generally inhibitory to translation. 
23 
 
 
Figure 1-2 uORFs and translation 
Schematic showing the translation of an mRNA, such as ATF4, with two upstream open reading frames (uORFs), one overlapping the main ORF. Decreased 
ternary complex availability increases scanning past the second uORF increasing translation of the coding sequence. This is also the case even where the 
uORF does not overlap the main ORF as not all terminated ribosomes reinitiate.   
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1.1.b Start site recognition 
The scanning model requires a mechanism by which the PIC recognises a start codon and 
recruits a 60S subunit. The sequence of the nucleotides surrounding the start site - the Kozak 
consensus sequence, GCC(A/G)CCAUGG, (Kozak, 1987)  W and the presence of eIF1A and eIF1 
contribute to this. Initiation does occur from non-AUG codons, most commonly CUG, and 
from AUG codons in weaker context. However experiments performed in vitro show that 
mutation of transcripts away from the Kozak consensus reduces initiation and increases 
 “leaky ? scanning, whereby the PIC scans past an AUG and initiates at a downstream start 
codon (Kozak, 1991). Initiation does not occur in the absence of eIF1, and although eIF1A is 
somewhat dispensable in vitro, leaking scanning and recognition of codons in weak context is 
reduced when both factors are present (Pestova and Kolupaeva, 2002). Cryo-electron 
microsocopy has shown that eIF1 and eIF1A bind to the yeast 40S subunit and collectively 
maintain a structure that is more permissive to scanning  W an open conformation (Passmore 
et al., 2007). The binding sites of eIF1 and eIF1A on the yeast ribosome are analogous to 
those reported on the mammalian ribosome (Lomakin et al., 2003) and thus it is assumed 
the same conformation is found in all eukaryotes.  Upon recognition of a start site, eIF2 
bound GTP is hydrolysed by eIF5 and eIF1 is ejected resulting in a closed structure that can 
no longer scan (Passmore et al., 2007). 
1.1.c Recruitment of the pre-initiation complex to mRNA 
Whilst the PIC can independently scan and initiate translation from the start site of mRNAs 
ĐŽŶƚĂŝŶŝŶŐƵŶƐƚƌƵĐƚƵƌĞĚ ? ?hdZƐƐƵĐŚĂƐɴ-globin (Pestova and Kolupaeva, 2002), it is typically 
recruited to mRNAs by additional factors and requires further factors to remove secondary 
structures inhibitory to scanning.  
ƵŬĂƌǇŽƚŝĐŵZEƐĐŽŶƚĂŝŶĂ ? ?ĐĂƉƐƚƌƵĐƚƵƌĞƚŚĂƚŝƐĂĚĚĞĚĐŽŶĐƵƌƌĞŶƚǁŝƚŚthe transcription 
of the pre-mRNA (Shatkin, 1976). eIF4E binds to this cap complex and can recruit either of 
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two eIF4G isoforms (Gradi et al., 1998), both large (~220kDa) scaffold proteins. Mammalian 
eIF4G binds to eIF3 via a site in the central region of the protein (Korneeva et al., 2000), thus 
facilitating recruitment of the PIC to capped mRNA. eIF4G also contains two binding sites for 
the RNA helicase eIF4A (Imataka and Sonenberg, 1997) and PolyA-binding protein (PABP) 
(Imataka et al., 1998). The helicase activity of eIF4A is dramatically stimulated by the 
presence of eIF4G and eIF4B or eIF4H, with the eIF4B more potent than eIF4H in vitro (Ozes 
et al., 2011). However even these proteins are insufficient to permit scanning through highly 
structured mRNA and other helicases such as DHX29 are required in these cases (Pisareva et 
al., 2008). Programmed cell death 4 (PDCD4) inhibits eIF4A helicase activity and can be 
regulated at the transcriptional level or by phosphorylation which targets the protein for 
degradation (Lankat-Buttgereit and Goke, 2009). Two of the three isoforms of eIF4A are 
thought to be functionally interchangeable as helicases (Li et al., 1999), however recent work 
has shown that eIF4AII is specifically required for microRNA mediated repression of 
translation by a meĐŚĂŶŝƐŵĞŶŚĂŶĐĞĚďǇƐƚƌƵĐƚƵƌĞǁŝƚŚŝŶƚŚĞ ? ?hdZ(Meijer H, Lu W.T., 
Kong Y.W.,Wilczynska A and Bushell M, in press). As its name suggests, PABP binds to the 
PolyA tail, and so the interaction between eIF4G and PABP results in the circularisation of 
mRNA. Circularisation increases translational efficiency (Niepel et al., 1999) and this is 
probably due to reducing the distance required for terminated ribosomes to travel before 
reinitiating rather than  permitting scanning along the  ? ?hdZ(Rajkowitsch et al., 2004).  
eIF4E, eIF4G and eIF4A are collectively known as the eIF4F complex and the availability of 
this complex may affect the rate of initiation by reducing recruitment of the PIC to capped 
mRNAs. The binding of 4E-binding proteins (4E-BPs) to eIF4E prevents association with eIF4G 
and therefore are central to regulation of eIF4F availability. There are at least six 
phosphorylation sites on the 4E-BPs and a increase in phosphorylation decreases affinity for 
eIF4E. This process forms part of the mTORC1 signalling pathway which shall be introduced 
in greater detail in a later section. In addition, an increase in eIF4E levels will counter the 
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negative regulation by 4E-BPs. This will also be discussed later as it is frequently observed in 
tumourigenesis.  
Whilst recruitment of the PIC is typically cap-dependent, this is impaired in a number of 
stress conditions, for example during picornavirus infection and apoptosis. Under both of 
these conditions 4E-BP1 phosphorylation is reduced (Bushell et al., 2006, Gingras et al., 
1996) and eIF4G is cleaved between the eIF4E binding site and the eIF3 binding site (Clemens 
et al., 1998, Lamphear et al., 1995). The ability of the C-terminal (eIF3 binding) fragment of 
eIF4G to facilitate translation of a capped mRNA in vitro is drastically reduced, but not 
abolished (Ali et al., 2001). Nonetheless the drastic reduction of eIF4F availability caused by 
the above changes favours the translation of mRNAs that can initiate in a cap independent 
manner, allowing a global downregulation of protein synthesis but a relative upregulation of 
such transcripts. Many viral transcripts, including picornaviral ones, contain internal 
ribosome entry sites (IRESs) upstream of their coding sequences, able to initiate translation 
in the absence of a cap (the proof of this is rather elegantly demonstrated in (Chen and 
Sarnow, 1995)). Most IRESs are highly structured, but there is little commonality in these 
structures and the factor requirements of different viral IRESs varies greatly (Kieft, 2009). 
Whilst the identification of some putative IRES containing cellular transcripts may have been 
an artefact of the reporter system used (Kozak, 2008, Lemp et al., 2012), these concerns do 
not account for all IRES containing transcripts (Komar and Hatzoglou, 2011). Furthermore, 
despite a global decrease in ribosomal association and protein synthesis during apoptosis, 
the translation of a subset of mRNAs is either unchanged or upregulated (Bushell et al., 
2006). Notably, 70 % ŽĨƚŚĞ ? ?hdZƐƚĞƐƚĞĚĨƌŽŵƚŚŝƐƐƵďƐĞƚƐƵƉƉŽƌƚĞĚƚƌĂŶƐůĂƚŝŽŶin classical 
bicistronic pRF construct without evidence of cryptic promoter/splicing activity suggesting 
they contain an IRES. 
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1.1.d Large ribosomal subunit joining 
Following recognition of a start site, eIF5 and eIF2 are displaced from the 48S complex by the 
GTPase eIF5B, with complete dissociation occurring upon 60S subunit joining (Pisareva et al., 
2006). eIF5 can remain associated with eIF2-GDP and inhibit GTP exchange. This association 
is increased during amino acid starvation further antagonising ternary complex recycling 
(Jennings and Pavitt, 2010).  
1.2 Mechanism and regulation of translation elongation 
The process of translation elongation involves three sequential steps: recruitment of an 
aminoacyl-tRNA (aa-tRNA) complementary to the mRNA codon in the ribosomal A-site, 
peptide bond formation and ribosomal translocation to position the next (downstream) 
codon into the A-site. In eukaryotes the first of these steps is performed by eEF1, the second 
by the 60S ribosomal subunit, the third by eEF2 (Figure 1-3).  
The comparative difficulty in generating crystal structures for eukaryotic, rather than 
prokaryotic, ribosomes means that much of the work on biophysical investigation of 
elongation has been performed with prokaryotic ribosomes and factors. However, the core 
of the ribosome is essentially conserved between all domains of life (Melnikov et al., 2012) 
as are elongation factors (Taylor et al., 2007a), making extrapolation from findings in 
prokaryotes appropriate.   
1.2.a Recruitment of aminoacyl-tRNAs 
To ensure the fidelity of translation it is crucial that aa-tRNAs with non-complementary anti-
codons do not take part in peptide bond formation. A degree of mismatch in the 3
rd
 
nucleotide (nt) of the codon can occur, wobble base-pairing, but the degree of fidelity, nor 
wobble-base pairing, can be accounted for by base-pairing energies alone. The ribosome 
itself and elongation factors therefore play a crucial role in accurate decoding (reviewed in 
(Ogle et al., 2003)) 
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eEF1 consists of eIF1A and eIF1B, with the latter consisting of three subunits  W ɲ ?ɴ ?ɶ ?dŚĞ
GTP-bound form of eEF1A can bind to aa-tRNA. Base-pairing can occur between the tRNA 
anticodon and A-site mRNA codon, but the amino acid end of the tRNA can only fully enter 
the A-site, and thus take part in peptide bond formation, upon release from eEF1. The 
hydrolysis of eEF1A-GTP to eEF1A-GDP drastically reduces the affinity for aa-tRNA. This 
process is mediated by the ribosome in a manner that recognises stem loop structures of 
cognate tRNAs but not mispaired ones (Connell et al., 2007, Pape et al., 1998). Antibiotics 
and/or rRNA mutations that affect the structure of the ribosome can therefore dramatically 
affect the fidelity of translation (Ogle et al., 2003). Much like the tRNAi
Met
 ternary complex, 
GTP exchange must occur rapidly on eEF1A to allow recruitment of a new aa-tRNA. eEF1B 
acts as a GEF, with both the ɲĂŶĚɴƐƵďƵŶŝƚƐŽĨĞ& ?ĐŽŶƚĂŝŶŝŶŐGEF domains (reviewed in 
(Browne and Proud, 2002)). 
1.2.b Peptide bond formation 
Following accommodation of the aminoacyl stem of the tRNA into the A site, peptide bond 
formation is catalysed by the 60S subunit. The catalytic region, the peptidyl transferase 
center (PTC), is within the ribosomal core, conserved in all domains, and is exclusively rRNA  W 
the ribosome is a ribozyme (Cech, 2000). 
1.2.c Ribosomal translocation 
The final step of elongation is the translocation of the ribosome to allow recognition of the 
next codon. Ribosomal translocation occurs via a rachet like mechanism of the ribosomal 
subunits triggered by the binding and hydrolysis of eEF2-GTP (Spahn et al., 2004, Taylor et 
al., 2007b). eEF2 leaves the ribosome as eEF2-GDP, but guanosine exchange is sufficiently 
rapid as to not require an additional factor (unlike eEF1A).  The eEF2 protein has two key 
residues that are sites of regulation. The first, H714 in human eEF2, is modified to 
diphthamide forming a unique site for ADP-ribosylation, and thus translational inhibition, by 
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diphtheria toxin (DT). Whilst mutation of this site to prevent diphthamide modification 
confers resistance to DT without affecting protein synthesis rates in cultured mammalian 
cells (Ivankovic et al., 2006), this is associated with developmental defects in mice (Liu et al., 
2012). Interestingly, expression of eEF2 that does not contain diphthamide is associated with 
an increase in -1 frameshifting in yeast (Ortiz et al., 2006) and human cells (Liu et al., 2012) 
suggesting this modification is required for ribosomal translocation across all 3 nucleotides of 
a codon. The second site of modification is within the GTP-binding domain (T56 in human 
eEF2). Phosphorylation of this site, by eEF2 kinase (eEF2k) prevents binding of eEF2 to the 
ribosome (Carlberg et al., 1990). eEF2k can be phosphorylated on a number of serine and 
threonine residues, resulting in either the inhibition or activation of kinase activity. Under 
basal Ca
2+
 conditions (and contingent on the activity of phosphoinositide dependent protein 
kinase-1 (PDK1)) eEF2k is inhibited by phosphorylation on serine 366 by p70 ribosomal 
protein S6 kinase (S6K) or p90RSK1 downstream of mTORC1 and Ras-MEK-ERK pathways 
respectively (Wang et al., 2001). However, autophosphorylation of additional residues occurs 
in a calmodulin mediated response to elevated Ca
2+ 
(Redpath and Proud, 1993) which can 
overcome S6K/p90RSK mediated inhibition (Wang et al., 2001). The relative importance of 
these two opposing regulatory pressures in vivo is not yet clear.      
There are up to 9 residues of eEF2k that can be phosphorylated (Pyr Dit Ruys et al., 2012). 
Intriguingly a mutation that abolishes phosphorylation at serine 366 reduces the kinase 
activity of autophosphorylated eEF2k towards the synthetic substrate MH-1 peptide. This 
suggests there are important differences between the action of eEF2k on this peptide and 
the endogenous target eEF2 meaning interpretation of existing literature based on MH-1 as a 
read out should be done with caution.
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Figure 1-3 Schematic of the mechanism of translation elongation 
Aminoacyl tRNAs are recruited to the ribosome by elongation factor 1 (eEF1)-GTP. Hydrolysis 
of GTP upon recognition of cognate tRNA allows full entry into the A site. Peptide bond 
hydrolysis is catalysed by the peptidyl transferase centre within the 60S subunit. Elongation 
factor 2 is required for the translocation of the ribosome but can be inhibited by 
phosphorylation by elongation factor 2-kinase via mTORC1 or Erk mediated phosphorylation 
of PDK1 targets: ribosomal S6 kinases p70 and p90, under normocalaemic conditions
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1.3    Mechanism of translation termination and ribosomal recycling 
In all domains, termination of translation requires the recognition of a stop codon in the A 
site by a class I release factor (RF) that mimics a tRNA and catalyses the hydrolysis of the 
tRNA in the P site releasing the peptide chain. This process also involves a class II RF, but 
there are significant differences in the actions of class II RFs between domains. Furthermore, 
whilst prokaryotes that have two class I RFs (RF1 and RF2) that each recognise two of the 
three stop codons, eRF1 is capable of recognising all 3 stop codons, thus explaining the 
slightly innumerate nomenclature of the eukaryotic class II RF, eRF3! 
Monomeric eRF1 does not have a tRNA-like conformation, but binding to eRF3 induces a 
conformational change that permits mimicry of a tRNA. This additionally increases the 
affinity of eRF3 for GTP, meaning that termination is achieved by an eRF1-eRF3-GTP complex 
somewhat analogous to tRNA-eEF1-GTP (Cheng et al., 2009). A conformation change in the 
pre-termination ribosomal complex (pre-TC) occurs upon binding of eRF1, as part the eRF1-
eRF3-GTP. Following ribosome-mediated GTP hydrolysis of eRF3, it is proposed the eRF1 is 
positioned closer to PTC resulting in rapid peptide release (Alkalaeva et al., 2006, Cheng et 
al., 2009).  
Peptide release does not result in spontaneous ribosome dissociation, and eRF1 remains 
associated with the post-termination complex. Dissociation of the post-TC is required for 
ribosomes to participate in translation initiation (ribosome recycling) and is thus essential for 
the maintenance of translation. The full dissociation of both the 40S and the 60S subunits 
requires eIF3, eIF1 and eIF1A, however this will only occurs in vitro under low, likely sub-
physiological, Mg
2+
 concentrations (Pisarev et al., 2010). Where Mg
2+
 concentration is not 
permissive, ABCE1 is required for ribosomal dissociation, coupling termination to ribosome 
recycling (Pisarev et al., 2010). ABCE1 is an ATPase highly conserved in eukaryotes that binds 
to both ribosomal subunits and eRF1 and following ATP hydrolysis has been modelled to 
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prise open the ribosome (Becker et al., 2012).  
The importance of ABCE1, and ribosome recycling more generally, is not limited to 
ribosomes arrested on stop codons. Numerous surveillance mechanism operate during the 
pioneer round of translation on a transcript, targeting it for degradation if there have been 
errors in transcription or processing (Maquat et al., 2010). In two of these mechanisms (the 
no-go and non-stop decay pathways), ribosomes are stalled on transcripts and translation 
termination and ribosome recycling must occur. This process involves a complex analogous 
to that required in termination on stop codons - a eRF1 homolog (Dom34 in yeast, Pelota in 
mammals) associated with GTP-bound-Hbs1 (a eRF3 homolog). Whilst ABCE1 is not strictly 
required for dissociation of post-TCs in yeast (Shoemaker et al., 2010), it is essential for this 
process in mammals (Pisareva et al., 2011). 
1.4 mTOR signalling 
Target of rapamycin (TOR) proteins are serine/threonine kinases that are present in two 
complexes, TOR complex 1 (TORC1) and TOR complex 2 (TORC2), conserved from yeast to 
human. In yeast the two TOR proteins are functionally redundant, whilst only one TOR 
protein is found in higher eukaryotes. TORCs form part of interconnected signalling networks 
that mediate both transcriptional and translation response to intracellular and extracellular 
growth signals. Aberrant TOR signalling has been reported to play a causal role in cancer, 
ageing and metabolic diseases such as type-II diabetes (Laplante and Sabatini, 2012).  
That TOR proteins are inhibited by rapamycin was first identified in budding yeast (Heitman 
et al., 1991), however it took a further 11 years to recognise that they exist in both the 
rapamycin-sensitive TORC1 and the largely rapamycin insensitive TORC2 (Loewith et al., 
2002). This goes some way to explaining why the details of TORC1 signalling are somewhat 
more elucidated than for TORC2. Whilst TOR signalling is broadly conserved, there are some 
differences between kingdoms which fall outside the scope of this thesis, which focuses 
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predominantly on mammalian systems. Both mammalian target of rapamycin complexes 
(mTORCs) are comprised of mTOR, mLST8, DEPTOR, Tti1 and Tel2 with mTORC1 additionally 
containing Raptor and PRAS 40, and mTORC2 containing Rictor, mSim1 and protor1/2 
(Laplante and Sabatini, 2012). A complex of rapamycin and the intracellular FK506-binding 
protein (FKBP12) can allosterically inhibit some of the kinase activity of mTORC1 (Brown et 
al., 1995). mTOR signalling  constitutes a complex and inter-connected network, depicted in 
Figure 1-4 and described below. 
1.4.a mTORC1 signalling 
The targets of mTORC1 are involved multiple different processes including, but not limited 
to, protein synthesis, lipid metabolism and autophagy (reviewed in (Laplante and Sabatini, 
2012)). In the context of translational control, mTORC1 signalling increases protein synthesis 
via two primary targets: 4E-BPs and S6Ks, the latter of which must also be subsequently 
phosphorylated by PDK1 (Pullen et al., 1998). mTORC1 also inhibits Maf1, a negative 
regulator of RNA Polymerase III, such that increased mTORC1 activity is associated with 
increased transcription of Pol III genes such as tRNAs (Kantidakis et al., 2010). As described 
previously, phosphorylation of 4E-BPs reduces their affinity for eIF4E thereby increasing cap 
dependent translation. Of the S6K targets identified, eEF2k, PDCD4 and eIF4B may all play a 
role in the regulation of translation as described in earlier sections. Significantly, many 
transcripts encoding pro-ƉƌŽůŝĨĞƌĂƚŝǀĞƉƌŽƚĞŝŶƐĐŽŶƚĂŝŶŚŝŐŚůǇƐƚƌƵĐƚƵƌĞĚ ? ?hdZƐŵĞĂŶŝŶŐ 
mTORC1 mediated increases in helicase activity of eIF4F is a mechanism by which the 
expression of such proteins is specifically up-regulated in response to growth signals 
(Ruggero, 2012). 
The contribution of ribosomal protein S6 (RPS6) to translation is somewhat less well 
understood. A reduction in the phosphorylation of RPS6 correlates with a reduction in 
protein synthesis in response to rapamycin, but MEFs expressing a mutant RPS6 that cannot 
be phosphorylated at any of the 5 reported serine residues (RPS6
P-/-
) show an increase in 
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global protein synthesis rate relative to WT cells with phosphorylated RPS6 (Ruvinsky et al., 
2005). An explanation for this is that despite the above correlation, phosphorylation of RPS6 
does not increase protein synthesis but does compete with eEF2k phosphorylation for S6K 
such that when RPS6 cannot be phosphorylated there is increased phosphorylation of eEF2k. 
Consistent with this an increase in elongation rate was observed in RPS6
P-/- 
MEFs but this was 
not dramatic enough to fully account for the increase in translation rate (Ruvinsky et al., 
2005). 
Inhibition of mTORC1 by rapamycin decreases the protein synthesis rate, but a subset of 
mRNAs show greater sensitivity to rapamycin inhibition  W ƚŚŽƐĞĐŽŶƚĂŝŶŝŶŐ ? ?-terminal 
oligopyrimidine tracts (TOPs) (Jefferies et al., 1994). Rapamycin does not inhibit the S6K and 
4E-BP arms of the mTORC1 pathways equally (Choo et al., 2008), which has driven the 
development of other active site inhibitors of mTORC1 (asTORi) such at Torin (Thoreen et al., 
2009). These active site inhibitors affect the kinase activity of both mTORCs. mRNAs sensitive 
to both rapamycin and the asTORi pp242, contain a TOP or a stringent pyrimidine rich 
ƚƌĂŶƐůĂƚŝŽŶĞůĞŵĞŶƚ ?WZd ? ?ĂŶĚĂƐŚŽƌƚĞƌ ? ?hdZǁŚŝĐh, surprisingly given that eIF4B is a 
target of mTORC1, are predicted to be less structured (Hsieh et al., 2012). The mechanism(s) 
regulating TOP containing mRNAs remain unclear, as illustrated in the next paragraph.   
Early work suggested that the regulation of TOP mRNAs by mTOR is mediated by S6K 
(Jefferies et al., 1997). However, knockout of both S6K isoforms in mouse embryo fibroblasts 
(MEFs) is not associated with the resistance of a TOP mRNA to rapamycin mediated 
inhibition suggesting TOP mRNAs are not regulated by S6K (Pende et al., 2004). Deletion of 
the two 4E-BPs expressed in MEFs removes the Torin 1 mediated inhibition of protein 
synthesis and significantly reduces, but does not abolish, the reduction in polysomal 
association of TOP/PRTE mRNAs under these conditions (Thoreen et al., 2012). That TOPs are 
still sensitive to Torin in the 4E-BP
DKO
 cells suggests additional non-mTORC1/2 mediated 
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regulation of TOPs. This could explain why rapamycin, despite a limited ability to inhibit 4E-
BP phosphorylation, can still affect TOPs mRNAs in S6K knockout mice. Furthermore, 
knockdown of raptor (and persumably mTORC1 activity) in HEK 293 cells has a minimal effect 
on the polysomal association of a TOP mRNA in response to insulin stimulation, unlike mTOR 
knockdown (Patursky-Polischuk et al., 2009). 
Four molecular mechanisms that regulate the kinase activity of mTORC1 in a physiological 
context have been identified. The activity of mTORC1 is contingent on interaction with GTP-
bound Ras homolog enriched in brain (Rheb), which despite its name is widely expressed, 
and two mechanisms affect this.   
The first involves the down regulation of translation in response to amino-acid starvation via 
a complex of the multi-protein GEF, Ragulator, and Rag-GTPases, bound to the lysosomal 
membrane (Bar-Peled et al., 2012). The Rag proteins exist as obligate heterodimers of either 
RagA or RagB with RagC or RagD. The GTP loading of RagA/B is always the opposite of 
RagC/D such that GDP-bound RagA or RagB will be found in a complex with GTP bound RagC 
or RagD. Upon activation in the presence of amino acids, Ragulator catalyses the GTP 
exchange creating GTP-bound RagA or RagB (Zoncu et al., 2011). This recruits mTORC1 to the 
lysosome allowing interaction with Rheb which is necessary for mTORC1 activity. Consistent 
with this model, expression of mutant forms of RagA or RagB that are constitutively bound 
by GTP results are insensitive to amino acid starvation. The second mechanism of regulation 
is via a dimer of the tuberous sclerosis complex proteins (TSC1/2). TSC1/2 catalyses the 
hydrolysis of Rheb-GTP to Rheb-GDP and thus is inhibitory to mTORC1 (Inoki et al., 2003a). 
Many different signalling pathways converge on TSC1/2. The Ras-MEK-ERK, PI3K and Wnt 
signalling pathways inhibit TSC1/2, thus coupling pro-proliferative signalling with increased 
mTORC1 activity and associated increases in translation. Redd1, a target of the hypoxia 
ŝŶĚƵĐŝďůĞƚƌĂŶƐĐƌŝƉƚŝŽŶĂůĨĂĐƚŽƌ,/& ?ɲ ?ĂĐƚŝǀĂƚĞƐd^ ? ? ? ?ƌĞƐƚƌŝĐƚŝŶŐƉƌŽůŝĨĞƌĂƚŝŽŶǁŚĞŶ
oxygen is limiting (Brugarolas et al., 2004). InteƌĞƐƚŝŶŐůǇ ?ĞǆƉƌĞƐƐŝŽŶŽĨ,/& ?ɲĐĂƵƐĞƐĂŶ
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increase in mTORC1 activity, but this transcription factor is suppressed under apithological 
conditions by von-Hippel Lindau tumour suppressor (VHL) and is typically expressed at much 
ůŽǁĞƌůĞǀĞůƐƚŚĂŶ,/& ?ɲ (Elorza et al., 2012).   AMP-activated protein kinase (AMPK) activates 
TSC1/2, coupling energy deficit with reduced protein synthesis via mTORC1 (Inoki et al., 
2003b).  
The other two mechanisms affect the composition of mTORC1. In addition to activating 
TSC1/2, AMPK also phosphorylates the mTORC1 essential Raptor, targeting the protein for 
degradation (Gwinn et al., 2008). Conversely, Akt1, a downstream effector of mTORC2, 
inhibits TSC1/2 and additionally dissociates PRAS40, an inhibitor of mTORC1, with Raptor, 
increasing mTORC1 activity (Vander Haar et al., 2007). 
Finally, interaction between downstream mTORC1 effectors and upstream signalling 
pathways may occur. For example, S6K inhibits insulin receptor substrate, which is an 
activator of phosphatidylinositide-3-kinases (PI3K). PI3K activates PDK1 which activates Akt1, 
which in turn inhibits TSC1/2 , meaning mTORC1 activation via PI3K sets off a negative 
feedback loop (Manning, 2004). 
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Figure 1-4 An overview of mTOR signalling 
IGF = Insulin-like growth factor, EGF = Epidermal growth factor, FGF = Fibroblast growth factor, PDGF = Platelet-derived growth factor. For full details of 
other abbreviations see accompanying text. 
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1.4.b mTORC2 signalling 
Both the upstream regulation and downstream effectors of mTORC2 are less well 
characterised than for mTORC1. mTORC2 appears to be regulated by growth factor 
signalling, but, unlike mTORC1, the evidence for activation due to nutrient depletion is 
unclear (Oh and Jacinto, 2011). In vitro, the presence of PIP3 increases mTORC2 activity 
suggesting mTORC2 may be regulated by PI3K signalling (Gan et al., 2011). Furthermore, in 
another contrast to mTORC1, stimulation of mTORC2 requires TSC1/2 (Huang et al., 2008). 
The identified targets of mTORC2 kinase activity include Akt1, serum and glucocorticoid 
induced kinase 1 (SGK1), protein kinase C (PKC) and Rho GTPase.  
Akt1 can be phosphorylated by mTORC2 at two residues  W T450 and S473  W that are distinct 
from the T308 site phosphorylated by PDK1. Phosphorylation at T450 occurs in a co-
translational manner on the nascent peptide (Oh et al., 2010) and is believed to be stable, 
whereas S473 is phosphorylated in a temporal manner in response to growth signals (Oh and 
Jacinto, 2011). Knockdown of mTORC2 essential component, Rictor, in a number of human 
cell lines reduces the phosphorylation of not only S473, but also T308 to the same extent 
(Sarbassov et al., 2005). However this is not observed in MEFs derived from embryos with 
homozygous deletion of Rictor (Guertin et al., 2006) suggesting the interactions of PDK1 and 
mTORC2 mediated phosphorylation of Akt1 are context-dependent. Evidence from these 
Rictor
-/-
 MEFs, suggests S473 phosphorylation is required for Akt1 activity against FoxO 
proteins but not TSC1/2 (and thus mTORC1).    
SGK1 has a diverse range of targets involved in such processes as ion transport, cell survival, 
and growth (Lang et al., 2006). To give just one example of the contribution of SGK1 to cell 
survival, the pro-apoptotic transcription factor FoxO3a is targeted for degradation upon 
SGK1 mediated phosphorylation (Brunet et al., 2001). This contribution to the evasion of 
apoptosis and the role of other SGK1 targets in oncogenesis provide a link between mTORC2 
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and cancer that is independent of Akt1 (Bruhn et al., 2010). Furthermore PKC and Rho 
proteins are involved in the regulation of the actin-cytoskeleton and therefore may explain 
the contribution of mTORC2 to cell migration and metastasis (Gulhati et al., 2011).  
1.5 Translational control and cancer 
In the United Kingdom, the estimated lifetime risk of developing a cancer is 1 in 3, with over 
a quarter of all deaths caused by it (ONS, 2009). 
As illustrated in the previous section, translational control is central to the regulation of 
cellular growth in response to internal and external stimuli, for example via mTORC1. It 
should therefore come as little surprise that dysregulated translational control can result in 
persistent growth in the absence of proliferative stimuli  W a neoplasm. The acquisition of 
other characteristic hallmarks of a malignant neoplasm (cancer), such as invasive potential, 
resistance to cell death and angiogenesis (Hanahan and Weinberg 2011) are mediated by 
subsets of proteins that may also be regulated at the level of translation. 
Aberrant translation in cancer has been reported to be mediated by increased ribosome 
abundance, changes in the expression or activity of initiation and elongation factors, altered 
expression of RNA-binding proteins, and microRNA mediated regulation of transcripts 
encoding oncogenes and tumour suppressors (Blagden and Willis, 2011, Kong et al., 2012, 
Ruggero, 2012). This section will focus primarily on the modes by which initiation and 
elongation factors are dysregulated.  
1.5.a The eIF4F complex and cancer 
Where eIF4F is limiting for translation initiation, increasing availability will cause increases in 
global synthesis and differential upregulation of mRNAs with long structured  ? ?hdZƐ 
(Koromilas et al., 1992) such as vascular endothelial growth factor (VEGF) (Scott et al., 1998). 
The latter is an example of the link between translational control and angiogenesis required 
to function in the tumour microenvironment. eIF4E is typically the least abundant of eIF4F 
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factors. Increased expression of eIF4E correlates with worse outcomes in cancers from at 
least 8 different organs (Silvera et al., 2010) and overexpression of eIF4E in a mouse models 
is sufficient to induce transformation (Ruggero et al., 2004). However, eIF4E availability is 
actually governed by ratio of eIF4E to hypophosphorylated 4E-BPs and whilst decreased 
expression and/or increased phosphorylation of 4E-BP has been observed in cancers, 
prognostic value is contingent on the 4E-BP:eIF4E axis (Coleman et al., 2009). Numerous 
different molecular changes have been reported to drive increased 4E-BP phosphorylation 
via mTORC1. Tuberous sclerosis, an autosomal dominant disorder is characterised by loss of 
function mutations in, or deletion of, tsc1 and tsc2 resulting in multi-organ neoplasia. Whilst 
these neoplasms are non-malignant, they still are still associated with severe pathology as 
they compete for space with healthy tissue, such as in the brain. In the context of sporadic 
cancers, components of the multiple signalling pathways upstream of TSC1/2 are frequently 
mutated. The three pathways most pertinent to this thesis are the Wnt signalling, PI3K/Akt1 
and Ras-MEK-ERK pathways. The latter exhibit cross-talk that is positive  W Ras activation 
increases PI3K activity  W and negative  W Akt1 inhibits MEK  W with the balance between them 
affected by upstream growth factor signalling which may be altered in cancers (Aksamitiene 
et al., 2012, Castellano and Downward, 2011). Upregulation of Wnt signalling, observed in 93 
% sporadic colorectal cancers (Cancer Genome Atlas, 2012), drives cell proliferation, at least 
ŝŶƉĂƌƚ ?ďǇŝŶĐƌĞĂƐĞĚĞǆƉƌĞƐƐŝŽŶŽĨ'^< ?ɴ ?ĂŶŝŶŚŝďŝƚŽƌĨd^ ? ? ? ?The tumour-suppressor 
gene pten is deleted or epigenetic silenced in many different cancers (Goel et al., 2004, Kang 
et al., 2002), thus relieving repression of PI3K signalling to both mTORCs. Mutations in the 
Ras and Raf proteins that result in constitutive activation of the ERK pathway have been 
reported in numerous different tumours of epithelial origin (Dhillon et al., 2007). 
Underscoring the importance of this pathway, approximately 90 % of pancreatic cancers 
have oncogenic mutant K-Ras (Thomas et al., 2007).   
Other components of the eIF4F complex may also play a role in oncogenesis. Evidence for 
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the involvement of eIF4A per se (rather than as a consequence increased eIF4F availability) 
are the observations that decreased PDCD4 expression drives proliferation in renal, brain 
and lung cancers cell lines (Jansen et al., 2004) and that increases in eIF4B expression in non-
,ŽĚŐŬŝŶ ?ƐůǇŵƉŚŽŵĂcorrelates with poor clinical outcomes (Dr E. Horvilleur, unpublished 
observations). eIF4G-1 is vastly over-expressed in ~70 % of squamous cell lung cancers 
relative to normal tissue (Bauer et al., 2002) and overexpression of eIF4G is sufficient to 
transform MEFs, independent of eIF4E expression (Fukuchi-Shimogori et al., 1997).    
1.5.b Ternary complex and cancer 
Both decreases and increases in ternary complex availability may play a role in cancer. 
Reduced availability favours the translation of number of proto-oncogenes with multiple 
uORFs, such as bcl-2 (Willis, 1999) and Her2 (Child et al., 1999), but increased availability may 
increase global translation which can drive proliferation.  tŚŝůƐƚŽǀĞƌĞǆƉƌĞƐƐŝŽŶŽĨĞ/& ?ɲŝƐ
sufficient to drive oncogenic transformation in MEFs (Donze et al., 1995) and is associated 
with benign and malignant tumours colonic neoplasms (Rosenwald et al., 2003), inhibition of 
ƚŚĞĞ/& ?ɲŬŝŶĂƐĞWZ<vastly reduced the size of tumours in a Ras-transformed mouse 
xenograph model (Fels and Koumenis, 2006). A potential explanation of these seemingly 
paradoxical findings is that reduced ternary complex availability causes the preferential 
translation of mRNAs necessary for a protective response to cellular stresses such a DNA 
damage (Powley et al., 2009) and hypoxia which are typical of the tumour 
microenvironment. Increased ternary complex availability is therefore disadvantageous for a 
tumour in the early stages of tumourigenesis, but the increased protein synthesis rates may 
be beneficial following the acquisition of mechanisms to evade stress-induced pro-apoptotic 
signalling (Adams and Cory, 2007) and/or increased vascularisation via a PERK mediated 
mechanism (Fels and Koumenis, 2006). Consistent with this increased expression and 
ĚĞĐƌĞĂƐĞĚƉŚŽƐƉŚŽƌǇůĂƚŝŽŶŽĨĞ/& ?ɲŝƐŽďƐĞƌǀĞĚŝŶĂvariety of metastatic cancers (Silvera et 
al., 2010). The corollary of this is that the efficacy of chemotherapeutics that induce cell 
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stress, such as DNA damaging agents etoposide and cisplatin, may be enhanced when Ğ/& ?ɲ
kinases are also inhibited (Pataer et al., 2009), but that this approach may be counter-
productive for more advanced tumours.   
1.5.c Translation elongation and cancer 
Although the majority of work on the contribution of translational dysregulation in cancer 
has focussed on initiation, three strands of evidence implicate translation elongation.  
First, as has already been described, eEF2 is negatively regulated by eEF2k. Inhibition of 
eEF2k under normocalaemic conditions is achieved by mTORC1 dependent (S6K) and 
mTORC1 independent (p90RSK) pathways that are frequently upregulated in cancer (see 
1.2.c and 1.5.a). Second, eEF2 is overexpressed in gastric and colorectal cancers and 
increased expression in a gastric carcinoma cell line increases tumour volumes when injected 
into immunocompromised (nude) mice (Nakamura et al., 2009). The third line of evidence 
relates to the two isoforms of eEF1A (the tRNA binding subunit of eEF1). eEF1A1 is the 
predominant form in normal tissue, but eEF1A2 expression is highly increased in estrogen 
receptor positive breast cancers (Tomlinson et al., 2007) and overexpression in a pancreatic 
cancer cell line increases the growth of nude mice xenographs (Cao et al., 2009). However, 
overexpression of eEF1A2 in NIH 3T3 MEFs is not associated with a statistically significant 
increase in translation rates, suggesting that the oncogenic capacity of eEF1A2 is due to 
moonlighting functions (Janikiewicz, 2011). 
1.6 Project aims 
As described within this chapter, translation is a highly complex process that is regulated 
(and consequently can be dysregulated) at many stages. The work in this thesis focuses on a 
number of these stages in a variety of different contexts. Chapters 3 and 4 explore the role of 
translation and cancer, focussing on the role of tRNAi
Met
 in the transformation of cultured 
cells and mTOR signalling in colorectal cancer respective
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contribution of translation elongation to the multi-faceted cold shock response. Finally, 
drawing on experiences of using the next-generation sequencing techniques within this 
thesis, Chapter 6 attempts to characterise the strengths and limitations of these approaches 
and propose improvements to sequencing protocols. 
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Chapter 2. Materials and methods 
2.1 Solutions common to multiple methods 
1X TBE:  89 mM Tris, 89 mM boric acid, 2.5 mM Na2EDTA, pH 8.3 
1X TAE: 40 mM Tris-HCl, 2 mM Na2EDTA, pH 8.0 
20X SSC: 3 M NaCl, 300 mM sodium citrate, pH 7.4 
 ? ?yĞŶŚĂƌĚƚ ?Ɛ^ŽůƵƚŝŽŶ P ?% (w/v) Ficoll, 1 % (w/v) polyvinyl pyrrolidone, 1 % (w/v) BSA 
Formamide loading dye: 96 % Formamide, 10 mM EDTA, 0.01 % bromophenol blue, 0.01 % 
xylene cyanol) 
LB Broth: 1 % w/v Bactotryptone, 0.5 % w/v bacto yeast extract, 1 % w/v NaCl. 
2.2 Cell culture 
2.2.a Monolayer cultures 
i) Routine cell culture 
NIH 3T3 mouse embryonic fibroblasts (MEFs), described in Marshall et al., 2008, were kindly 
provided by Prof Robert White. HeLa and HEK293 cells were from Willis Laboratory stocks, 
originally purchased from American Type Culture Collection (ATCC). Cells were cultured in 
gamma sterilized plasticware (TPP c/o Helena Biosciences) under a humidified atmosphere 
containing 5 % CO2 at 37
o
C. 
D&ƐǁĞƌĞĐƵůƚƵƌĞĚŝŶƵůďĞĐĐŽ ?ƐŵŽĚŝĨŝĞĚĂŐůĞ ?ƐŵĞĚŝƵŵ ?DD ?ǁŝƚŚŽƵƚƐŽĚŝƵŵ
pyruvate (Invitrogen) supplemented with 10 % v/v fetal calf serum (FCS; Helena Biosciences), 
2mM L-Glutamine (Sigma),  100U/ml Penicillin, 100U/ml Streptomycin and, following 
transfection with pPUR vectors, 2.5 ʅŐ ?ŵůWƵƌŽŵǇĐŝŶ ?HeLa and HEK293 cells were cultured 
in DMEM supplemented with 10 % FCS and 2mM L-glutamine. 
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For routine culture, cells grown to full confluence were washed with phosphate buffered 
saline (PBS) and treated with 1X Trypsin-0.5mM EDTA (PAA) for 5 min at 37
o
C. Once cells had 
detached, fresh medium was added to neutralise the trypsin and 10-40 % seeded into to a 
new flask.  
Where a specific seeding density was required, a haemocytometer was used to count cell 
density from a neutralised sample stained with 0.4 % w/v trypan blue (Gibco) to exclude 
dead cells.   
For plating cells 48 hours prior to assaying 
Cell type 6cm dish 10cm dish 15cm dish 
NIH 3T3 MEFs n/a 5x10
5
 1.2x10
6
 
HeLa 3.2x10
5
 n/a 2x10
6
 
 
ii) DNA/RNA transfection 
The 2D MEF clone was transfected with 2 µg of puromycin resistance plasmid (pPUR) with or 
without the tRNAi
Met
 gene, in a 6-well plate format using Lipofectamine2000, following the 
manufactureƌ ?s instructions.  
For transfection of [
33
P] labelled capped RNA (2.6.l), 4µg RNA was transfected into a ~90 % 
confluent 6cm dish of HeLa cells using Lipofectamine 2000. Cells were re-fed 90 min prior to 
transfection. 1 or 2 hrs after transfection, cells were treated as described in 2.6.hiv).  
2.2.b Matrigel cultures 
Matrigel cultures were derived and maintained by Dr Liam Faller, (Beatson Institute, 
Glasgow).   
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i) WT crypt culture 
Intestines were isolated from mice sacrificed under UK Home Office guidelines. The intestinal 
villi were removed by scraping and intestines chopped into small pieces prior to repeated 
washing with cold PBS (typically around 10 times). Crypts were detached by incubation in 
either 2mM (duodenum) or 25mM (colon) EDTA in PBS at 4
o
C for 30min. The intestine was 
broken by repeated pipetting. This was repeated 3 times giving 4 fractions. The first fraction 
was discarded as it was rarely enriched for crypts. Crypt fractions were combined with 
advanced DMEM/F12 (ADF) and pelleted. Pellets were resuspended in ADF and repeatedly 
passed through a cell strainer to separate crypts. Crypts were resuspended in 10ml ADF and 
the number of crypts in 20 ʅůŽĨƐƵƐƉĞŶƐŝŽŶĚĞƚĞƌŵŝned. As much supernatant as possible 
was removed from the suspension and Matrigel added to give a final concentration of 2000 
ĐƌǇƉƚƐ ?ŵů ? ? ?ʅůŽĨDĂƚƌŝŐĞůŵŝǆǁĂƐĂĚĚĞĚƚŽĞĂĐŚǁĞůůŽĨĂƉƌĞǁĂƌŵĞĚ ? ?-well plate and 
incubated at 37
o
C, 5-10 min to solidify ƚŚĞŐĞů ?ƌǇƉƚƐǁĞƌĞĐƵůƚƵƌĞĚŝŶ ? ? ?ʅů&in the 
presence of 100ng/ml EGF, 500ng/ml R-spondin and 100ng/ml Noggin. Growth factors were 
replenished every two days with media changed twice per week. Organoids were passaged 
by mechanically pipetting the Matrigel, diluted with ADF, and pelleted (600 rpm, 2 min) to 
separate crypts from Matrigel plug. The supernatant (with the Matrigel) was carefully 
removed and the washing process repeated to dilute Matrigel. The number of crypts was 
quantified, fresh Matrigel added and seeded as described above. 
ii) Culture of adenomas 
Adenomas were removed from the small intestine and cut into small pieces. These were 
washed repeatedly then incubated in 5mM EDTA-PBS for 10 min, room temperature. The 
pieces were then washed 2-3 times with PBS and incubated at 37
o
C, 30 min, in 5 ml 10X 
trypsin, 1X DNase buffer and 100-200U DNaseI. Trypsin was neutralised with 5ml ADF and 
the tube vigorously shaken to dissociate cells. This was repeated until 40-45 ml ADF had 
been added. The cells were pelleted and counted and seeded as described in 2.2.bi) but at a 
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density of 100-200 cells per well. Routine culturing is as described in 2.2.bi) but without R-
Spondin and growth factors supplemented once per week. 
2.3  in vivo methods 
All mouse work was performed by Dr Liam Faller (Beatson Institute, Glasgow) under UK 
Home Office guidelines.  
2.3.a Details of Cre Recombinase inducible mice 
Outbred male mice from 6 to 12 weeks of age were used. 
The following mice strains were used: 
S6K1/2 
-/-
: systemic deletion of both ribosomal S6 protein kinases (Pende et al., 2004) 
4EBP DKO 
-/-
: systemic knockout of both 4E-BP1 and 4E-BP2 (Le Bacquer et al., 2007) 
rpS6
p-/-
: systemic mutation of all 5 serine residues that are phosphorylated by S6K (Ruvinsky 
et al., 2005) 
eEF2k
-/-
: systemic deletion of eEF2k (Dorovkov et al., 2002) 
Apc
580S
: Exon 14 of APC flanked by LoxP sites for creation of inducible truncation mutation 
that removes APC function (Shibata et al., 1997) 
Raptor
fl/fl
: Raptor gene flanked by LoxP sites for inducible deletion (Polak et al., 2008) 
Rictor
fl/fl
: Rictor gene flanked by LoxP sites for inducible deletion (Cybulski et al., 2009)  
KRas
G12D/+
: K-Ras G12D mutant allele preceded by transcription termination stop element 
flanked by LoxP sites allowing for inducible expression of the mutant allele (Jackson et al., 
2001) 
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For conditional knockouts, mice were either crossed with a VillinCre
ER
 strain (Andreu et al., 
2005) or an Lgr5Cre strain (Sato et al., 2009). Villin is expressed along the crypt axis, Lgr5 is 
specific to intestinal stem cells and Paneth cells. 
To induce recombination in VillinCre
ER
 mice, animals were given two injections (IP) of 
tamoxifen (80 mg/kg) on consecutive days. For LGR5Cre
ER
 mice, a single IP injection of 3mg 
tamoxifen was given. At the appropriate time point, mice were sacrificed and the small 
intestines were removed and flushed with water (at least three mice were used for each 
experiment), and epithelial cells prepared according to the applicable protocol. 
2.3.b Rapamycin treatment 
Rapamycin was made up as a 50 mg/ml stock solution in ethanol and diluted in PBS + 5 % 
Tween 80, 5 % PEG 400. Mice were IP injected with 10 mg/kg rapamycin daily. 
2.3.c Low dose cycloheximide treatment.  
Mice were treated with 50 mg/kg cycloheximide on days 2, 3, 4, and sacrificed 6 hrs after last 
dosing 
2.3.d Survival studies 
Lgr5Cre strains were used for conditional deletion. Mice were induced and two cohorts 
assembled. The first started rapamycin treatment at day 10, for 30 days, to assess the ability 
of rapamycin to prevent tumour growth. The second began treatment when showing signs of 
illness (pale paws, weight loss, hunching), and were treated for 60 days to assess the ability 
of the drug to regress established tumours. 
2.3.e Intestinal regeneration assay 
VillinCre strains were used for conditional deletion. Mice were exposed to gamma-irradiation 
137Cs sources. This delivered gamma-irradiation at 0.423 Gy/min, to a total of 14 Gy per 
mouse. 72 hr after irradiation, mice were sacrificed, and intestines isolated and scored for 
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crypt regeneration. This scoring was carried out by counting the number of regenerating 
crypts in up to 10 cross-sections of the small intestine and taking an average.  
2.3.f BrdU incorporation in vivo 
 ? ? ?ʅůBrdU was injected (IP) into each mouse 2 hours prior to sacrificing. IHC was used to 
visualise BrdU incorporation and proliferation was scored manually. 
2.3.g Murine intestinal crypt extraction for polysome profiling 
VillinCre strains were used for conditional deletion.  
i) Standard method 
Mice were sacrificed ?ŝŶƚĞƐƚŝŶĞƐƌĞŵŽǀĞĚĂŶĚĨůƵƐŚĞĚǁŝƚŚW^ĐŽŶƚĂŝŶŝŶŐ ? ? ?ʅŐ ?ŵů
cycloheximide (PBS-CHX). Intestines were scraped briefly to remove villi then incubated with 
agitation for 15 min at 37
o
C in HBSS containing 100 µg/ml cycloheximide, 10 mM EDTA to 
dislodge the crypts. Cells were pelleted in 50 ml falcon tubes at 4000 rpm, 4
o
C, for 5 min, 
resuspended in 1 ml ice cold PBS-CHX, transferred to 1.5 ml eppendorf and pelleted again. 
The supernatant was aspirated and pellets snap frozen in liquid nitrogen prior to storage at -
80
o
C. 
ii) Rapid extraction method 
The intestines were extracted as described above, however the time spent in warm media 
was reduced. Specifically: following incubation of intestine in warm media containing 
cycloheximide (100Pg/ml) for 5 min the intestine was placed in ice cold PBS-CHX and 
vigorously shaken to dislodge the crypts. All other steps were as described in 2.3.gi) 
2.4 Functional assays for cultured cells 
2.4.a  Cell proliferation assay 
2x10
4 
cells were seeded in 4 12-well plates, in 1 ml media. After 3 hours, one plate was 
processed as follows. The media was aspirated, cells washed with warm PBS, then fixed with 
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500 Pl 100 % methanol for 30 min. The methanol was aspirated, and the well covered with 
500 Pl 1 % w/v methylene blue in borate buffer (10 mM Na2B4O7, pH 8.5) for 30 min. Excess 
stain was removed by at least 4 washes of borate buffer, until no further blue colour could 
be eluted. Residual buffer was carefully aspirated and the dye eluted with 1 ml acidified 
ethanol (1:1 v/v 0.1M HCl and ethanol) for 1 hr with gentle rocking. The absorbance at 
650nm of 200 Pl of eluate was read using a spectrophotometric plate reader. 
This process was repeated for the other plates at 24, 48 and 72 hr. A growth curve was 
plotted using the mean of readings from 6 wells.  
2.4.b Protein synthesis assay  
i) Adherent cells 
1x10
5
 cells were seeded in a 6-well format in 2 ml media. At roughly 80 % confluency 
 ?ƚǇƉŝĐĂůůǇ ?ĚĂǇƐ ? ?ŵĞĚŝĂǁĂƐƌĞŵŽǀĞĚĂŶĚƌĞƉůĂĐĞĚǁŝƚŚ ? ? ?ʅůŽĨŵĞƚŚŝŽŶŝŶĞ-free DMEM 
supplemented with 10 % dialysed FCS, 2 mM L-'ůƵƚĂŵŝŶĞĂŶĚ ?ʅů ?ŵůŵĞĚŝĂ[35S]-Met label 
(PerkinElmer or Hartmann Analytic), and returned to the incubator. After 30 min the cells 
were placed on ice, washed with ice cold PBS containing 0.3 % (w/v) L-Methionine (PBS-
Met), ĂŶĚůǇƐĞĚǁŝƚŚ ? ? ?ʅů ?yWĂƐƐŝǀĞůǇƐŝƐďƵĨĨĞƌ ?WƌŽŵĞŐĂ ? ? 
Lysates were centrifuged for 2 min at 13,000 rpm, 4
o ? ? ? ?ʅůŽĨƚŚĞƐƵƉĞƌŶĂƚĂŶƚǁĂƐĂĚĚĞĚ
ƚŽ ? ? ?ʅů ? ? % (w/v) TCA and left on ice for 30 min to precipitate. The remaining supernatant 
was transferred to a fresh eppendorf and quantified using Bradford reagent (Bio-Rad) 
ĨŽůůŽǁŝŶŐƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐ ? 
Vacuum filtration was used to apply precipitated protein to glass microfibre filters 
(Whattman), pre-soaked in 25 % TCA. Filters were washed twice with 70 % industrial 
methylated spirits, twice with acetone and left to dry. 
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Radiolabelled protein was liberated using Ecoscint scintillation fluid (National Diagnostics) 
and quantified in a Wallac 1409 scintillation counter (Pegasus Scientific). Counts were 
normalised to protein mass taken from the mean of three Bradford reactions. 
ii) Matrigel cultures 
Matrigel cultures were washed with warm PBS then incubated with 1ml of ADF 
supplemented with 100ng/ml EGF, 500ng/ml R-spondin and 100ng/ml Noggin, ĂŶĚ ?ʅů ?ŵů 
[
35
S]-Met label and returned to the incubator for 30 min. The cultures were placed on ice and 
washed with ice cold PBS-Met. Cultures were scraped into 1 ml of PBS-met and dispersed by 
30 pipette strokes using a P200 tip. Cells were pelleted at 600 rpm and the supernatant and 
MĂƚƌŝŐĞů “ƉůƵŐ ?ĐĂƌĞĨƵůůǇƌĞŵŽǀĞĚ ?dŚŝƐƉƌŽĐĞƐƐǁĂƐƌĞƉĞĂƚĞĚ3 times to obtain a Matrigel-
free cell pellet. Cells were lysed in  150  Pl RIPA buffer (50 mM Tris-HCl pH 7.5, 150mM NaCl, 
0.5 % sodium deoxycholate, 1 % Triton X-100, 0.1 % SDS) and cleared by centrifugation at 
13,000 rpm, 4
o
C, 5 min.  Subsequent steps were essentially as described in 2.4.bi) with 
quantification by BCA Assay (Pierce). 
2.5 DNA methods 
2.5.a Phenol-chloroform extraction 
A equal volume of 1:1 Phenol:chloroform was added to DNA-containing solution and shaken 
vigorously. Following 2 min centrifugation at 13,000 rpm, 4
o
C, the upper aqueous layer was 
transferred to a new eppendorf tube and the above was repeated but with chloroform only. 
1/10
th
 volume of 3 M NaOAc pH 5.2 was added to the aqueous phase and mixed thoroughly. 
If the expected yield was less than 1 µg, 1 µl GlycoBlue ? (Ambion) was also added. Either 1 
volume of isopropanol or 2.5 volumes of ethanol was added, mixed thoroughly and left to 
precipitate for a minimum of 30 min at -20
o
C.  
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DNA was pelleted by centrifugation at 13,000 rpm, 4
o
C, for 20 min. The pellet was washed 
with 75 % ethanol, pelleted, and the supernatant carefully removed. Following a brief (5-
10min) air dry the pellet was resuspended in nuclease free water and, where necessary, 
quantified on a Nanodrop2000. 
2.5.b Reverse transcription 
 ?ʅŐŽĨƚŽƚĂůZE ?ĞǆƚƌĂĐƚĞĚĂƐĚĞƐĐƌŝďĞĚŝŶ2.6.b ǁĂƐďƌŽƵŐŚƚƚŽ ? ?ʅůǁŝƚŚŶƵĐůĞĂƐĞĨƌĞĞ
ǁĂƚĞƌ ? ?ʅůŽĨ ? ? ?ŶŐ ?ʅůƌĂŶĚŽŵƉƌŝŵĞƌƐ ?/ŶǀŝƚƌŽŐĞŶ ? ? ?ʅůŽĨ ?Pg/Pl oligodT20 ĂŶĚ ?ʅů ? ?ŵD
dNTPs (Invitrogen) were added. The mixture was incubated at 65
o
C for 5 min then on ice. 
 ?ʅů ?y&ŝƌƐƚƐƚƌĂŶĚďƵĨĨĞƌ ? ?ʅů ? ? ?Ddd ? ?ʅů^ƵƉĞƌĂƐĞ/Ŷ ?ŵďŝŽŶ ?ĂŶĚ ?ʅů^ƵƉĞƌƐĐƌŝƉƚ///
(Invitrogen) were added, mixed and incubated at 50
o
C for 30 min. Reactions were inactivated 
at 70
o
C for 15 min. RNA was degraded either by using 2 units of RNaseH and incubating at 
37
o
C for 20 min; or 0.1M NaOH, 0.05M EDTA and incubating at 90
o
C for 15 min, followed by 
neutralisation with 1M HEPES pH 7.5. 
2.5.c Polymerase chain reaction (PCR) 
Reactions were prepared as described in the table below. To reduce pipetting error and 
allow for optimisation of annealing temperatures, reactions were typically prepared as a 100 
ʅůŵĂƐƚĞƌŵŝǆ ?ƐƉůŝƚďĞƚǁĞĞŶ ?Žƌ ?ƚƵďĞƐĂŶĚƌƵŶŽŶĂŐƌĂĚŝĞŶƚƚŚĞƌŵŽĐǇĐůĞƌ ? 
Component  ? ?ʅůƌĞĂĐƚŝŽŶ  ? ? ?ʅůŵŝǆ 
10X PCR buffer with Mg
2+ 
(Roche) 2 10.0 
10mM dNTPs 0.4 2.0 
10mM Forward primer 0.4 2.0 
10mM Reverse primer 0.4 2.0 
RT reaction mix 0.4 2.0 
Nuclease free water 16.2 81.2 
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Taq DNA polymerase 0.2 0.8  
  
For fragments that were difficult to amplify, 5M betaine was added to a final concentration 
of 1M with the water adjusted accordingly to maintain the same final volume. 
2.5.d Agarose gel separation and extraction 
Agarose was dissolved in 1X TAE, with heating, to give an appropriate percentage solution to 
resolve DNA fragments of the size of interest (typically 1 % w/v). After allowing to cool a 
little, SybrSafe (Invitrogen) was added to 1X (10,000X stock). The molten agarose was poured 
into taped trays, combs inserted and left to set. 
4 volumes of sample were mixed with 1 volume of 5X DNA gel loading dye (30 % glycerol, 0.1 
% xylene cyanol, 0.1 % bromophenol blue). Tape was removed from the trays and the gel 
submerged in 1X TAE. The samples were loaded and the gel run at 120 V for 1-2 hrs, or until 
sufficient separation had been achieved. 
Gels were visualised on a SafeImager and the gel fragment corresponding to the correct size 
excised. DNA was recovered either using the QIAquick gel extraction kit (Qiagen) following 
ƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐŽƌƵƐŝŶŐƚŚĞŐůĂƐƐǁŽŽůŵĞƚŚŽĚĚĞƚĂŝůĞĚďĞůŽǁ ? 
A large gauge needle was used to pierce a 0.5 ml eppendorf. A small quantity of glass wool 
was placed in the bottom of the tube and this was placed in a 1.5 ml eppendorf. The gel slice 
was placed in the smaller tube and centrifuged 13000 rpm for 10min (for larger gel slices it 
was necessary to centrifuge for longer and/or split the slice between multiple tubes). The 
eluate was phenol chloroform extracted as described in 2.5.a. 
2.5.e Restriction endonuclease digestion of plasmid DNA 
Plasmid DNA was digested by 10-20 units of restriction endonucleases from NEB in the 
appropriate buffer from the supplier. Reactions were typically in 20- ? ?ʅůǁŝƚŚŶŽƚŵŽƌĞƚŚĂŶ
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5 % glycerol (the enzymes are stored in 50 % glycerol). Reactions were incubated at 37
o
C for 
1-2 h and heat inactivated 65
o
C for 10 min.  
2.5.f DNA cloning 
i) DNA ligation 
For ligation into pGEM-T Easy vector (Promega), PCR products were used without further 
modification as Taq EƉŽůǇŵĞƌĂƐĞůĞĂǀĞƐ ? ?ŽǀĞƌŚĂŶŐƐ ?&ŽƌůŝŐĂƚŝŽŶŽĨƚZEiMet 
fragments into pPur vector, fragments were digested with EcoRI. The linearised pPur vector 
was dephosphorylated with 1U calf intestinal phosphatase (Roche) at 37
o
C for 1 hr prior to 
ligation.  
For ligation into pGEM-T Easy vector, a 3:1 molar ratio of insert to vector was used. Typically 
50 ng of vector was used in a 10 Pl volume containing 1X Rapid ligation buffer (Promega) and 
3U T4 DNA polymerase (Promega). Reactions were incubated at room temperature for 1 hr 
or 4
o
C overnight. 
For ligation of tRNAi
Met
 fragments the ratio was 10:1 to encourage multiple inserts per 
vector. 
ii) Transformation of competent E.Coli 
 ?ʅůŽĨůŝŐĂƚŝŽŶŵŝǆǁĂƐĂĚĚĞĚƚŽ ? ?ʅůŽĨĐŽŵƉĞƚĞŶƚE.Coli suitable for blue white screening 
(DH5ɲ or TOP10) and kept on ice for 10-15 min. The mix was heat shocked at 43oC for exactly 
1 min then placed immediately on ice for 10 min. 
1 ml of warm LB was added to each mix and incubated at 37
o
C, 1 hr, with shaking. Cells were 
then pelleted, resuspended in 50 Pl warm media and spread on LB-Agar plates with 100 
Pg/ml ampicillin and left to grow at 37oC overnight. For blue-white selection of T-Easy 
transformants the agar plates also contained 100 PM /ƐŽƉƌŽƉǇůɴ-D-1-thiogalactopyranoside 
and 40 Pg/ml X-Gal. 
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Colonies were picked with a sterile pipette tip and placed in 5-10 ml LB with 100 Pg/ml 
ampicillin and incubated at 37
o
C with shaking, overnight. 
iii) Miniprep extraction of plasmid DNA 
Cultures were pelleted at 4000 rpm for 10 min, and the DNA extracted with the Miniprep SV 
Wizard Kit (Promega) according to maŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐ ? 
2.6 RNA methods 
2.6.a Acid phenol RNA extraction 
An equal volume of acid-phenol pH 4.5 was added to RNA-containing solution and shaken 
vigorously. Following 2 min centrifugation at 13,000 rpm, 4
o
C, the upper aqueous layer was 
transferred to a new eppendorf tube and the above was repeated but with chloroform in 
place of acid-phenol. 1/10
th
 volume of 3 M NaOAc pH 5.2 was added to the aqueous phase 
and mixed thoroughly. If the expected yield was less than 1 µg, 1 µl GlycoBlue ? was also 
added. 1 volume of isopropanol was added, mixed thoroughly and left to precipitate for a 
minimum of 30 min at -20
o
C.  
RNA was pelleted by centrifugation at 13,000 rpm, 4
o
C, for 20 min. The pellet was washed 
with 75 % ethanol, pelleted, and the supernatant carefully removed. Following a brief (5-
10min) air dry the pellet was resuspended in nuclease free water.  
2.6.b Trizol RNA extraction 
1ml of Trizol Reagent (Sigma) was added to each well of a 6-well plate of PBS washed cells. 
RNA was extracted following the manufacturĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐ ?WĞůůĞƚƐǁĞƌĞƚǇƉŝĐĂůůǇ
resuspended in 10-20 Pl nuclease free water and quantified on a nanodrop2000. 
2.6.c Denaturing agarose gel electrophoresis  
1 % RNA gels were made by heating 1 g of agarose in 72.5 ml RNase free water and once 
dissolved, adding 10 ml of 10X MOPS (200 mM MOPS, 50 mM NaOAc, 10 mM EDTA, pH 7.0) 
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and 17.5 ml of formaldehyde. Gel plates and combs were cleaned with RNase ZAP (Sigma) 
prior to use. 
hƉƚŽ ?ʅůƐĂŵƉůĞǁĂƐŵŝǆĞĚǁŝƚŚ ?ʅůŽĨ ? ?yDKW^ ? ? ? ?ʅůŽĨĨŽƌŵĂůĚĞŚǇĚĞ ? ? ?ʅůŽĨ 
ĚĞŝŽŶŝƐĞĚĨŽƌŵĂŵŝĚĞ ?ĂŶĚ ?ʅůŽĨĨŽƌŵĂŵŝĚĞůŽĂĚŝŶŐĚǇĞ ?ŚĞĂƚĞĚƚŽ ? ? ?ĨŽƌ ? ?ŵŝŶƵƚĞƐ ?
then snap cooled on ice.  Samples were loaded into the gel and run at 100 V for 
approximately 1 hour in 1X MOPS. 
2.6.d Passive transfer northern blotting for agarose gels 
Prior to transfer, RNA gels were incubated for 20 min at room temperature in 1X denaturing 
buffer (150 mM NaCl, 50 mM NaOH) followed by a further 20min in 1X neutralising buffer 
(150 mM NaCl, 100 mM Tris-HCl, pH 7.4). 
RNA was transferred to Zeta-Probe nucleic acid blotting membrane (Bio-Rad) from the gel by 
capillary transfer for at least 16 hours. Briefly, a salt-bridge was created by making a wick 
from 3MM blotting paper soaked in 20X SSC as a transfer buffer. The gel was placed on top 
followed by the membrane, which had been washed first in nuclease-free water then in 20X 
SSC. 3 pieces of blotting paper were soaked in nuclease-free water and placed on top of the 
membrane. The stack was completed by covering with absorbent tissues and compressed 
with a 1 kg weight. RNA was fixed to the membrane by UV cross-linking. The cross-linked 
RNA was stained for 30 sec with methylene blue stain (0.02 % methylene blue, 0.3 M NaOAc 
pH 5.2), followed by repeated washing in water, to visualise the ribosomal RNA bands which 
were marked with a pencil. The stain was removed by agitating the blot in 1 % SDS/1X SSC 
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2.6.e Denaturing Polyacrylamide gel electrophoresis (PAGE) 
i) Acid Urea PAGE 
A 6.5 % Polyacrylamide 8 M Urea 0.1 M NaAc pH 5 gel mix was prepared as in the table 
below, with rotation but without heating. 
Component Final concentration 20cm gel 30cm gel 
Urea (99 % purity; Sigma aldrich) 8 M 14.4 g 24 g 
Accugel 40 % polyacrylamide 
(19:1 acrylamide/bisacrylamide; BioRad) 
6.5 % 4.875 ml 8.125 ml 
1 M NaOAc, filtered  0.1 M 3 ml 5 ml 
TEMED -  ? ?ʅů  ? ?ʅů 
Nuclease-free water - 10 ml 15 ml 
 
DŝǆĞƐǁĞƌĞďƌŽƵŐŚƚƚŽƉ, ?ǁŝƚŚ'ůĂĐŝĂůĂĐĞƚŝĐĂĐŝĚ ? ?ĂƉƉƌŽǆ ? ? ?ʅůĨŽƌ ? ?ŵů ? ?ŵůĨŽƌ ? ?ŵů ?
and adjusted to 29 ml (20 cm gel) or 48.5 ml (30 cm gel) with nuclease free water. 
Prior to assembly, gel plates were treated with RNase ZAP (Sigma) and coated with 
dimethyldichlorosilane. Plates were clamped between 0.75 mm spacers. 1 ml (20 cm gel) or 
1.5 ml (30 cm gel) of 25 % APS was added to the gel mix and immediately cast and left to 
polymerise for 90 min. 
 ?ʅŐƚŽƚĂůZE ?AM ?ʅů ?ǁĂƐĐŽŵďŝŶĞĚǁŝƚŚĂŶĞƋƵĂůǀŽůƵŵĞŽĨĂĐŝĚ-urea loading buffer (8 M 
Urea, 0.1 M NaOAc pH 5, 0.05 % Xylene Cyanol, 0.05 % Bromophenol Blue) and kept on ice. 
Deacylated controls were obtained by combining 2 µg total RNA with an equal volume of 0.4 
M Tris-HCl pH 9.5 and incubating at 37
o
C for 30 min then combining with an equal volume of 
loading buffer. 
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Electrophoresis was performed at 4
o
C, at 120 V/cm in 0.1 M NaOAc pH 5. Following a 30 min 
pre-electrophoresis step each well was flushed with running buffer to remove residual urea. 
Samples were immediately loaded and run until the bromophenol blue had reached the end 
of the gel (typically 18 hr for 30 cm gel). 
ii) TBE-Urea PAGE 
TBE-Urea gel mixes were prepared as in the table below, with rotation but without heating. 
Component Final concentration 20cm gel 
Urea (99 % purity; Sigma aldrich) 7 M 12.6 g 
Accugel 40 % polyacrylamide 
(19:1 acrylamide/bisacrylamide; BioRad) 
15 % 11.25 ml 
10 % 7.5 ml 
10X TBE, filtered  0.1 M 3 ml 
TEMED -  ? ?ʅů 
Nuclease-free water - 5.5 ml 
Mixes were adjusted to 30 ml with nuclease  Wfree water and 150 ʅl 25 % APS added. The mix 
was cast into 20cm long plates prepared as described in 2.6.ei) and left to polymerise for 
approximately 1 hr. 
ZEƐĂŵƉůĞƐ ?AM ?ʅů ?ǁĞƌĞĐŽŵďŝŶĞĚǁŝƚŚĂŶĞƋƵĂůǀŽůƵŵĞŽĨd-Urea loading buffer (7 M 
Urea, 1x TBE, 12 % Ficoll 400, 0.05 % Xylene Cyanol, 0.05 % Bromophenol Blue) and kept on 
ice. Just before loading to the gel, samples were incubated at 75
o
C for 2 min then placed on 
ice for at least 2 min. 
Electrophoresis was performed at room temperature, at 21W in 1X TBE. Following a 30 min 
pre-electrophoresis step each well was flushed with running buffer to remove residual urea. 
Samples were loaded immediately and run until the bromophenol blue had reached the end 
of the gel (typically 60-90 min for 20 cm gel). 
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2.6.f Northern blotting of PAGE gels 
i) Wet Electrophoretic transfer northern blotting for Acid Urea PAGE gels 
The region of gel between the two dyes was cut and placed on chromatography paper, 
wetted in 1X TAE. N+ Hybond Membrane (Amersham) was washed first in nuclease free 
water, then 1X TAE and placed over the gel. The membrane was covered with a final sheet of 
chromatography paper to complete the sandwich and air bubbles removed with a serological 
pipette. The sandwich was loaded into TransBlot® Cell (BioRad) containing 1X TAE. 
Electrophoresis was performed at 25 V for 90 min at 4
o
C. RNA was fixed to the membrane by 
baking for 1-2 hr at 80
o
C. 
ii) Semi-dry transfer northern blotting for TBE Urea PAGE gels 
Transfer was performed as described in 2.6.fi) but with 1X TBE in place of 1X TAE, Trans-
Blot® SD Semi-Dry Transfer Cell (BioRad) in place of the wet transfer apparatus and 
electrophoresis performed at 300 mA for 90 min at 4
o
C. 
2.6.g Probing northern blots with radiolabelled probes 
i) Probing northern blots with [
32
P]-ɲ-dCTP radiolabelled DNA 
~60 ŶŐŽĨƚĞŵƉůĂƚĞEŝŶ ? ?ʅůŽĨŶƵĐůĞĂƐĞ-free water was denatured by heating to 95°C for 
 ?ŵŝŶĂŶĚƚŚĞŶƐŶĂƉĐŽŽůĞĚŽŶŝĐĞ ? ?ʅůŽĨ ?yůĂďĞůůŝŶŐďƵĨĨĞƌ ?WƌŽŵĞŐĂ ? ? ?ʅů ? ?ŵŐ ?ŵů
ďŽǀŝŶĞƐĞƌƵŵĂůďƵŵŝŶ ?^ ? ? ? ? ?ʅů ? ?ŵDĚEdW ?ĐŽŶƚĂŝŶŝŶŐŽŶůǇĚdW ?ĚddWĂŶĚĚ'dW ? ? ?ʅů
<ůĞŶŽǁƉŽůǇŵĞƌĂƐĞĂŶĚ ? ? ?ʅůŽĨ[32P]-ɲ-dCTP (400 Ci/mol, 10 mCi/ml; Hartmann Analytic) 
were added to the template DNA and the mixture was incubated at 37°C for 1 hr. The 
product was then filtered through a Sephadex G-50 size exclusion column (GE life Sciences) 
and the flow-through, containing the purified probe was denatured at 95°C for 3 min and 
then snap cooled on ice.  
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Northern blots were pre-hybridised by rotation in a rotisserie oven at 65°C in 10 ml of Church 
Gilbert solution for at least 30 min. The cooled denatured probe was then added directly to 
the Church Gilbert solution (140 mM Na2HPO4, 70 mM NaH2PO4, 7 % SDS) and the blots were 
hybridised by overnight rotation at 65°C. Northern blots were then washed by rotation for 15 
min at room temperature, twice in each of the 3 wash solutions (northern wash 1: 0.1 % SDS, 
2X SSC; northern wash 2: 0.1 % SDS, 0.5X SSC; northern wash 3: 0.1 % SDS, 0.1X SSC). Blots 
were wrapped in cling film and exposed to an imaging plate (Fujifilm) overnight before being 
visualised on a molecular imager (Bio-Rad).  
ii) Probing northern blots with [
32
P]-ɶ-ATP radiolabelled oligonucleotides 
Probe target Sequence  
tRNAi
Met
  ? ? W cgcgtcagtctcataatctgaag  W  ? ?
tRNAe
Met
  ? ? W cccataacccagaggtcgatgg  W  ? ?
eEF1a1  ? ? W agtctctgtgtcctggggcatc  W  ? ?
50-100 pmol oligonucleotide was incubated at 37
o
C for 30 min in a 10 ʅl reaction containing 
1 µl 10X PNK buffer, 2.5 µl [
32
P]-ɶ-ATP (400 Ci/mol, 10 mCi/ml; Hartmann Analytic), 1 ʅl PNK 
(NEB). Excess radiolabel was removed using Sephadex G-25 size exclusion column (GE life 
Sciences). 
Membranes were incubated at 42
o
C for a minimum of 3 hours in prehybridisation solution 
 ? ?y^^ ? ? ?yĞŶŚĂƌĚƚ ?Ɛ^ŽůƵƚŝŽŶ ? ? ? ? % SDS). Prehybridisation solution was replaced with 
15ml hybridisation solution (6X SSC, 0.1 % SDS), probe added and incubated overnight at 
42
o
C. 
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Blots were washed sequentially 6X SSC, 4X SSC and 2X SSC. Each wash was performed twice 
for 10 min, rotating at room temperature. Washed membranes were wrapped in cling film 
and exposed to an imaging plate (Fujifilm) overnight. 
2.6.h Polysome profiling 
i) Preparation of sucrose gradients 
Sucrose solutions were made by dissolving the following concentrations of sucrose  W 50 %, 
40 %, 30 %, 20 %, 10 %  W in 1X sucrose gradient buffer (300 mM NaCl, 15 mM MgCl2, 15 mM 
Tris-Cl pH 7.5, 100 µg/ml cycloheximide, 1 mg/ml heparin). 2ml of each concentration was 
carefully pipetted into 12ml Sorvall polyallomer centrifuge tubes, with the gradients frozen 
at -80
o
C between the addition of each layer. Completed gradients were stored at -20
o
C and 
equilibrated at 4
o
C for at least 8 hrs prior to use.  
ii) Preparation of adherent cells for polysome profiling, scrape method 
Cells were seeded as outlined in 2.2.a. The growth medium was replenished 90 min prior to 
harvest ? ?ŵŝŶƉƌŝŽƌƚŽŚĂƌǀĞƐƚĐĞůůƐǁĞƌĞŝŶĐƵďĂƚĞĚǁŝƚŚ ? ? ?ʅŐ ?ŵůĐǇĐůŽŚĞǆŝŵŝĚĞ ?,y ? ?
Cells were placed immediately on ice, washed with ice-cold PBS-CHX, then scraped into 10 ml 
of PBS-CHX. Cell suspensions were gently pelleted (1400 rpm, 5 min, 4
o
C) and resuspended in 
1 ml PBS-,yĨŽƌƚƌĂŶƐĨĞƌƚŽ ? ? ?ŵůĞƉƉĞŶĚŽƌĨƚƵďĞƐ ? ? ? ?ʅůǁĂƐƚƌĂŶƐĨĞƌƌĞĚƚŽƐĞƉĂƌĂƚĞ
tubes. All tubes were centrifuged at 3000 rpm for 5 min at 4
o
C, and the supernatant 
ƌĞŵŽǀĞĚ ?dƵďĞƐĐŽŶƚĂŝŶŝŶŐƚŚĞƐŵĂůů ? ? ? ?ʅů ?ƉĞůůĞƚǁĞƌĞƐƚŽƌĞĚĂƚ-20oC for subsequent 
western blot analysis, the larger pellets were lysed in 1 ml 1X polysome lysis buffer (1X 
sucrose gradient buffer, 1 % Triton X100) and centrifuged at 13,000 rpm, 4
o
C, for 1 min. The 
supernatants were carefully layered onto pre-prepared sucrose density gradients. 
Centrifugation was at 38,000 rpm for 2 hr at 4
o
C in a Beckman Coulter ultracentrifuge. 
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iii) Harringtonine run-off treatment 
A stock of 1000X harringtonine (2 mg/ml in DMSO) was added to cells or matrigel cultures to 
a 1X concentration and the plates returned to the incubator. At set time periods after 
addition of harringtonine (typically, 60 s, 120 s, 180 s etc.) cycloheximide was added to a 1X 
concentration and the cells were prepared as described in 2.6.hii). Crypt cultures were 
scraped into ice cold PBS-CHX and dispersed by 30 pipette strokes using a P200 tip. Cells 
were pelleted at 600 rpm ĂŶĚƚŚĞƐƵƉĞƌŶĂƚĂŶƚĂŶĚŵĂƚƌŝŐĞů “ƉůƵŐ ?ĐĂƌĞĨƵůůǇƌĞŵŽǀĞĚ ?dŚŝƐ
process was repeated twice to obtain a matrigel-free cell pellet. This was lysed in the 
standard polysome lysis buffer. 
iv) Preparation of adherent cells for polysome profiling, direct lysis method 
Cells were cultured as described above, but residual liquid was vacuum aspirated after PBS-
CHX wash and cells scraped into an appropriate volume of ice cold 1X lysis buffer (1 ml for 15 
ĐŵĚŝƐŚ ? ? ? ?ʅůĨŽƌ ? ?ĐŵĚŝƐŚ ? ? ? ?ʅůĨŽƌ ?ĐŵĚŝƐŚ ? ?>ǇƐĂƚĞƐǁĞƌĞĐůĞĂƌĞĚďy centrifugation 
at 13,000 rpm at 4
o
C for 3 min and centrifuged through sucrose gradient as described above. 
v) Lysis of pelleted colonic crypt epithelia 
1ml ice cold lysis buffer was added to crypt cell pellets obtained as described in 2.3.g. The 
pellets were disrupted by gentle pipetting and the lysate cleared by centrifugation at 13,000 
rpm at 4
o
C for 3 min. In later experiments using the rapid extraction method, the lysis buffer 
was supplemented with 500U/ml RNasin (Promega).  
vi) Fractionation and RNA extraction from sucrose gradients  
The centrifuged sucrose density gradients were analysed by continuous flow through a type 
12 optical unit, which read the OD at 254 nm. 65 % blue sucrose solution was used to force 
the gradient through the reader and the absorbance spectrum was detected and recorded by 
an UA-6 UV/VIS detector (Presearch Ltd., Hitchin, Herts).  1 ml gradient fractions were 
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collected and dispensed directly into 3 ml of 7.7 M guanidine hydrochloride. 4 ml of absolute 
ethanol was added to each fraction, mixed by inversion and precipitated overnight at -20°C. 
The gradient fractions were centrifuged at 4,000 rpm for 45 min at 4°C. The supernatant was 
aspirated and the RNA pellets re-ƐƵƐƉĞŶĚĞĚŝŶ ? ? ?ʅůŽĨZEĂƐĞĨƌĞĞǁĂƚĞƌ ? ? ?ʅůŽĨ ?D
NaOAc, pH 5.0 and 1 ml of absolute ethanol were added to the re-suspended RNA. This was 
incubated at -20°C for at least 2 hr and centrifuged at 13,000 rpm for 30 minutes at 4°C. The 
supernatant was removed and the RNA pellets were washed in 75 % ethanol by vortexing 
followed by 5 min on a shaker. The samples were then centrifuged for 10 min at maximum 
speed at 4°C. Ethanol was removed and the pellets were air dried before being re-suspended 
in either 25 or  ? ?ʅůŶƵĐůĞĂƐĞ-free water and stored at -80°C. 
2.6.i Ribosome profiling 
i) Preparation of sucrose gradients 
Sucrose solutions were made as described in 2.6.hi) with 1X sucrose gradient buffer replaced 
with 1X RPF buffer (300mM NaCl, 15 mM MgCl2, 15mM Tris-Cl pH 7.5, 100 µg/ml 
cycloheximide, 2 mM DTT). 
ii) Preparation of cultured cells for ribosome profiling 
Cells were prepared as described in 2.6.hii) and 2.6.hiv) with 1X lysis buffer replaced with 1X 
RPF lysis buffer (1X RPF buffer, 1 % TritonX 100, 500 U/ml RNasin). RNaseI (Ambion) was 
added to the lysates at a final concentration of 1 U/µl and incubated at room temperature, 
with rotation for 30 min. Lysates were placed briefly on ice then loaded onto prepared 
sucrose gradients and centrifuged as described in 2.6.hii). 
iii) Fractionation and RNA extraction from sucrose gradients  
The centrifuged sucrose density gradients were analysed by continuous flow through a type 
12 optical unit, which read the OD at 254 nm as previously described (2.6.hvi). 500 µl 
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gradient fractions were collected in 2 ml DNA/RNA LoBind tubes (Eppendorf) and stored on 
ice until all gradients were fractionated. 1.4 ml Trizol LS (Sigma) was added to each gradient 
fraction, mixed and left at room temperature for 5 min to dissociate ribosomes from mRNA 
and any other nucleoprotein complexes. 200 µl BCP was added to each sample and mixed by 
vigorous shaking for 15 sec. Samples were left to stand for 5-10 min at room temperature 
before being centrifuged at 13,000 rpm at 4
o
C for 15 min. The upper, aqueous, layer was 
carefully removed, mixed with 1 µl GlycoBlue and 1 ml isopropanol and left at room 
temperature for 15min. Precipitated RNA was pelleted by centrifugation at 13,000 rpm at 
4
o
C for 20 min. Pellets were washed with 75 % ethanol and centrifuged at 13,000 rpm at 4
o
C 
for 10 min. Following careful removal of the supernatant, pellets were air dried and 
resuspended in 10 µl nuclease free water. 
iv) RPF sequencing library generation 
 The fractions corresponding to the monosome peak were size selected using either a 10 % 
or 15 % precast Novex® TBE-Urea gel (Invitrogen) gel. 5 µl of each fraction were mixed with 
5 µl TBE-Urea loading dye and incubated at 75
o
C for 3 min then placed on ice and loaded 
within 10 min of denaturing. 5 µl of marker mix (either 27mer and 33mer or 28mer and 
34mer, 500 nM) was prepared in the same way.   
Marker name Sequence 
27mer AAGCGUGUACUCCGAAGAGGAUCCAAA 
33mer AGGCAUUAACGCGAACUCGGCCUACAAUAGUGA 
28mer AGCGUGUACUCCGAAGAGGAUCCAACGU 
34mer GGCAUUAACGCGAACUCGGCCUACAAUAGUGACGU 
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Wells were flushed with loading buffer, samples loaded and electrophoresis performed at 
room temperature, 180 V, until the bromophenol blue marker ran off the bottom of the gel 
(typically 45-60 min dependent on gel percentage).  
The gel was incubated at room temperature for 5-10 min in 1X TBE 1X SybrGold (Invitrogen) 
then visualised using the SafeImager (Invitrogen). A smear was observed in the lanes 
corresponding to fractions extracted from the gradient as not all RNA is digested to ~30nt 
fragments. The region between the markers was excised and eluted from the gel slices by 
incubating in 400 µl 300 mM NaCl, 0.1 % SDS, 1 mM EDTA overnight at 4
o
C, with rotation. 
The eluate was transferred to a new tube, 1 µl GlycoBlue added and the RNA was 
precipitated by addition of 1 ml of ethanol and incubation for at least 2 hr at -20
o
C. RNA was 
pelleted, washed with 75 % ethanol and resuspended in 10 µl nuclease-free water. 
To modify the ends of the rpf fragments PNK was used in two separate buffers: the first to 
dephospŚŽƌǇůĂƚĞƚŚĞ ? ?ĞŶĚ ?ƚŚĞƐĞĐŽŶĚƚŽƉŚŽƐƉŚŽƌǇůĂƚĞƚŚĞ ? ?ĞŶĚ ?ƌŝĞĨůy, 9 µl sample was 
mixed with 10 µl 2X MES buffer (200 mM MES-NaOH pH 5.5, 600 mM NaCl, 20 mM E-
mercaptoethanol, 20 mM MgCl2), 1 µl PNK and incubated at 37
o
C for 6 hr. RNA was 
ƌĞĐŽǀĞƌĞĚƵƐŝŶŐWƵƌĞůŝŶŬZEŵŝĐƌŽŬŝƚ ?/ŶǀŝƚƌŽŐĞŶ ?ĨŽůůŽǁŝŶŐƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐ
with elution with 12 µl nuclease-free water. 1 µl eluate was stored for analysis with the 
remaining  10- ? ?A?ů ? ?-phosphorylated by addition of 1.5 µl 10X PNK buffer, 1.5 µl 10mM 
ATP, 1 µl PNK and incubation at 37
o
C for 30 min. RNA was recovered using Purelink RNA 
micro kit and eluted with 10 µl nuclease-free water. 
hŶŵŽĚŝĨŝĞĚ ? ? ?-modified and fully modified RNA was analysed on 2100 Bioanalyzer (Agilent) 
using a small RNA chip to confirm fragments had not been partially degraded during the 
phosphorylation process and to provide an estimate of concentration. 
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 ? ?ŶŐƌƉĨĨƌĂŐŵĞŶƚƐǁĞƌĞƐƵďũĞĐƚĞĚƚŽ^K>ŝ ?^ŵĂůůZEůŝďƌĂƌǇ ?ƉƉůŝĞĚŝŽƐǇƐƚĞŵƐ ?
construction according to mĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐ ?ǁŝƚŚƚŚĞŵĂǆŝŵƵŵƌĞĐŽŵŵĞŶĚĞĚ ? ?
cycles of in-gel PCR. 
v) Whole transcriptome sequencing library generation 
Total RNA was extracted from pelleted cells as described in 2.6.b. 50 µg total RNA was 
subjected to two rounds of polyA+ selection using Dynabeads (Invitrogen) according to 
ŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐ ? ? ? ?ŶŐƉŽůǇA?ZEǁĂƐƐƵďũĞĐƚĞĚƚŽ^K>ŝ ?ǁŚŽůĞ
transcriptome library (Applied BiosysƚĞŵƐ ?ĐŽŶƐƚƌƵĐƚŝŽŶĂĐĐŽƌĚŝŶŐƚŽŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ
instructions. 
2.6.j Bioinformatic analysis of ribosome profiling data 
Analysis was performed by Dr Ruth V. Spriggs, using pipelines supplied by Applied Biosystems 
and custom scripts as described below. 
i) Mappings 
Colour space reads were mapped using BioScope (Applied Biosystems) with default 
parameters to the mouse reference genome (mm9, NCBI Build 37) or human reference 
genome (hg19 GRCh37) as appropriate. Reads were also mapped to a filter reference file 
supplied by Applied Biosystems for human and created using rRNA sequences from the NCBI 
Nucleotide database and tRNA sequences from the genomic tRNA database 
(http://gtrnadb.ucsc.edu/) for mouse and human genomes. Where reads mapped to multiple 
genomic locations, ƚŚĞůŽĐĂƚŝŽŶĚĞƚĞƌŵŝŶĞĚ “ďĞƐƚ ?ďǇƚŚĞŝŽ^ĐŽƉĞƐŽĨƚǁĂƌĞǁĂƐƵƐĞĚ ? 
ii) Alignment of fragments relative to CDS 
The nucleotide mappings were converted into SAM format using SAMtools 
(samtools.sourceforge.net) and mapped to refGene annotations to determine the position of 
ƚŚĞ ? ?ĞŶĚŽĨĞĂĐŚŵĂƉƉĞĚƌĞĂĚǁŝƚŚƌĞůĂƚŝŽŶƚŽƚŚĞƐƚĂƌƚŽĨƚŚĞĐŽĚŝŶŐƐĞƋƵĞŶĐĞ ?dŚĞƐĂŵĞ
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was performed relative to the end of the coding sequence codon. The number of counts at 
each position was obtained and expressed as a ratio relative to the total number of aligned 
reads (reads per million, rpm). 
iii) Determination of minimum read thresholds for inclusion of gene in hypothesis testing 
Genes were ranked based on the total number of reads mapping to that gene across both 
replicates of a given library type. This list was divided into bins of 1000 genes. For each gene 
the fraction of reads that came from replicate1 (ie rep1/total) was calculated and the 
standard deviation of these fractions within each bin calculated. The threshold was the start 
of the bin at which the standard deviation began to plateau. 
iv) Calculation of translational efficiency 
For each gene that passed the minimum reads threshold in all 4 conditions (whole 
transcriptome and RPF libraries for both conditions), the translational efficiency value (TE) 
was calculated as follows: rpm in translatome library/rpm in transcriptome library       
2.6.k Generating RNA dimers 
300 ƉŵŽůĞƐŽĨ ? ?ŵĞƌĂŶĚ ? ?ŵĞƌZEŽůŝŐŽŶƵĐůĞŽƚŝĚĞƐǁĞƌĞ ? ?ƉŚŽƐƉŚŽƌǇůĂƚĞĚǁŝƚŚ ? ? U 
PNK in a 50 Pl reaction containing 1X PNK buffer and 1 mM ATP incubated at 37oC for 30 
min. RNA was recovered as described in 2.6.a ?dŽŵŝŶŝŵŝƐĞƚŚĞĐŝƌĐƵůĂƌŝƐĂƚŝŽŶŽĨƚŚĞ ? ?
phosphorylated RNA by the ligase, ĂƐŽůƵƚŝŽŶǁŝƚŚĂ ? ? P ?ƌĂƚŝŽŽĨ ? ?hydroxǇůĂƚĞĚ P ? ?
phosphorylated forms of each oligonucleotides was made. This was subjected to ligation 
with 5U T4 RNA ligase 1 in 1X T4 Ligase buffer (NEB), 1 mM ATP, in a final reaction volume of 
10 Pl. After incubation at 37oC for 15 min, 10 Pl RNA loading dye was added and the RNA 
denatured at 80
o
C for 3 min. The RNA was separated on a 15 % TBE Urea gel and the dimer 
fragment recovered as described in 2.6.iiv). 
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2.6.l Generation of capped, radiolabelled, E-actin mRNA 
i) Template preparation 
Full length E-actin cDNA was amplified as described in 2.5.b and 2.5.c using the following 
primers and cycling conditions: 
 &ŽƌǁĂƌĚƉƌŝŵĞƌ P ? ? W accgccgagaccgcgt  W  ? ?
ZĞǀĞƌƐĞƉƌŝŵĞƌ P ? ? W tttattcaactggtctcaagtcagtgtac  W  ? ? 
98
o
C 
2min
 + 30*(98
o
C
20sec
 + 54.7
o
C 
20sec
 + 70
o
C 
30sec
) +70
o
C
10min
 
The PCR product was ligated into T-Easy vector, transformed and 7 white colonies selected 
to be grown on. Each colony was digested with XmaI and XmnI to determine the orientation 
of the fragment relative to the T7 promoter. A plasmid with the insert in the sense 
orientation relative to T7 was transformed and grown in 100 ml LB with the plasmid 
extracted using the Pure Link Maxiprep kit (Invitrogen). 
20 Pg plasmid was digested with SpeI (i.e. ũƵƐƚĚŽǁŶƐƚƌĞĂŵŽĨƚŚĞĞŶĚŽĨƚŚĞ ? ?hdZ ? ?ƐŵĂůů
aliquot was removed and separated on an agarose gel as described in 2.5.d to confirm 
digestion was complete. The digested sample was treated with 100 Pg/ml Proteinase K and 
0.1 % SDS at 50
o
C for 30 min to digest SpeI and residual RNase A from the maxiprep. The 
sample was then phenol-chloroform extracted, ethanol precipitated (2.5.a) and resuspended 
in 10 Pl nuclease free water.      
ii) in vitro transcription of moderate specific activity capped RNA  
The following reaction was assembled at room temperature in the following order: 4 Pl 5X 
transcription buffer (Fermentas), 2 Pl mix of NTPs each at 5 mM, 8 Pl [33P]-ɲ-UTP (3000 
Ci/mmol, 30 mCi/ml; Hartmann Analytic), 1 Pl 40 mM Anti-reverse cap analogue (Ambion), 
0.5 Pl 0.1U/Pl Inorganic pyrophosphatase (Fermentas) and 1Pl Superasin. 1 Pl of linearised 
plasmid (1 Pg/Pl) and 1.5 Pl of T7 RNA polymerase were added and the reaction incubated at 
69 
 
37
o
C for 2 hr.  Template was degraded with DNaseI at 37
o
C, 15 min.  
To this reaction was added 43 Pl nuclease free water, 25 Pl 4X PAP buffer (200mM Tris pH 
7.9, 1M NaCl, 40mM MgCl2) and 10 Pl 10mM ATP. 2.5 Pl was removed to a new eppendorf to 
serve as a no enzyme control, 4 Pl E-PAP (Ambion) was added to the main reaction and 
incubated at 37
o
C for 45min. 2.5 Pl was removed and the two 2.5Pl aliquots were denatured 
with 7.5 Pl formaldehyde loading dye (Ambion) at 75oC for 10 min and separated on a 
denaturing agarose gel as described in 2.6.c. RNA was visualised by soaking the gel in 1X 
MOPS 1X SybrGold for 15 min in the dark. 
The remainder of the polyadenylated message was recovered by acid phenol chloroform 
extraction and isopropanol precipitation.  
2.6.m RNase protection assay 
i) Generation of high specific activity probe 
&ƌĂŐŵĞŶƚƐĐŽƌƌĞƐƉŽŶĚŝŶŐƚŽƚŚĞ^ĂŶĚ ? ?hdZŽĨŚŽŵŽƐĂƉŝĞŶƐgapdh were generated by 
PCR amplification of cDNA from HEK293 cells using Taq polymerase as outlined in 2.5.c, using 
primers and cycling conditions detailed below. 
Target &ŽƌǁĂƌĚWƌŝŵĞƌ ? ?- ? ? ZĞǀĞƌƐĞWƌŝŵĞƌ ? ?- ? ? Product size bp 
Gapdh CDS gtcaaggctgagaacgggaa tgatgacccttttggctccc 184 
Cycling conditions : 98
o
C 
2min
 + 25*(98
o
C
20sec
 + 55.3
o
C 
30sec
 + 70
o
C 
30sec
) +70
o
C
10min
 
'ĂƉĚŚ ? ?hdZ Ccccagcaagagcacaaga tggttgagcacagggtacttt 184 
Cycling conditions : 98
o
C 
2min
 + 25*(98
o
C
20sec
 + 55.3
o
C 
30sec
 + 70
o
C 
30sec
) +70
o
C
10min
 
Fragments were gel purified as described in 2.5.d and ligated in to pGEM-T Easy vector 
(Promega) as described in 2.5.f.  
The vector was linearised as described in 2.6.li) with SpeI and recovered by phenol 
chloroform extraction and ethanol precipitation.  
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 The linearised plasmid was used as a template for in vitro transcription. The following 
reaction was assembled at room temperature in the following order: 4 Pl 5X transcription 
buffer (Fermentas), 2 Pl mix of ATP GTP UTP each at 5mM, 2.4 Pl 100PM CTP, 2.5 Pl [32P]-ɲ-
CTP (400 Ci/mmol, 10 mCi/ml; Hartmann Analytic), 1Pl RNasin and 6.1 Pl nuclease free 
water. 1 Pl of linearised plasmid (1 Pg/Pl) and 1 Pl of T7 RNA polymerase were added and 
the reaction incubated at 37
o
C for 2 hr.  Template was degraded with DNaseI at 37
o
C for 15 
min and the probe recovered by acid phenol chloroform extraction and isopropanol 
precipitation.  
The probe was resuspended in 5 Pl nuclease free water, 5 Pl RNA loading dye added and the 
sample denatured at 80
o
C for 3 min before being run on a 6 % TBE-Urea gel at 180 V until the 
bromophenol blue dye front ran off the bottom. The gel was wrapped in saran wrap and 
exposed to X-Ray film for approximately 10 min. The film was developed and then overlaid 
onto the saran wrap to guide the excision of the correct sized band from the gel, thus 
excluding undersized transcription products.  The probe was recovered from the gel slice as 
described in 2.6.iiv) and resuspended in 20 Pl nuclease free water. 1 Pl was added to 2ml 
EcoScint to quantify the specific activity of the probe.   
ii) Generation of radiolabelled RNA markers 
The small RNA fragments (28mer, 34mer and their respective dimers) were labelled with 
[
32
P]-ɶ-ATP as described in 2.6.gii).  To label the 0.1-2kb RNA ladder, 4 Pg of ladder was 
dephosphorylated with 2U Calf Intestinal Phosophatase (Roche) in a 20 Pl volume containing 
1X dephosphorylation buffer (ThermoScientific) at 37
o
C for 1 hr. RNA was recovered by acid 
phenol extraction and isopropanol precipitation (2.6.a). The pellet was resupended in 8 Pl 
nuclease free water and labelled with [
32
P]-ɶ-ATP.    
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iii) RNase protection 
5 Pl of RNA containing solutions (typically ½ of the RNA content of a fraction from an rpf 
gradient or 2 Pg yeast tRNA to act as a negative and positive controls) were added to a 15 Pl 
mixture containing 10 Pl formamide, 2 Pl 10X hybridisation salts (4 M NaCl, 400 mM PIPES 
pH 6.8, 20 mM EDTA) and 2.5x10
4
 dpm of probe. To ensure consistency the mixture was 
made up as a master mix, with 5 % excess to account for pipetting error.  
The 20 Pl reactions were incubated in a thermocycler at 98oC for 3min then 42oC, overnight 
to permit annealing of the probe.  
200 Pl RNase digestion buffer (10 mM Tris, 300 mM NaCl, 5 mM EDTA, pH 7.5) and 4.4 Pl of 
50X RNaseA/T1 stock (250 Pg/ml RNase A, 5000U/Pl RNase T1 in storage buffer of 50 mM 
Tris pH 7.5 50 % glycerol) were added to all samples other than the undigested control, and 
incubated 37
o
C, 45 min. 
RNA was precipitated by addition of 1 Pl glycoblue and 660 Pl precipitation buffer (2M 
Guanidine-HCl [in later experiments this was replaced with 1M Guanidium isothiocyanate], 
66.6 % isopropanol, 0.134 % SDS, 13.4 mM DTT), mixed thoroughly and incubated for at least 
45 min at -20
o
C. RNA was recovered by centrifugation (13,000 rpm at 4
o
C for 30 min) washed 
twice with 75 % ethanol and resuspended in 5 Pl nuclease free water and 5Pl RNA loading 
dye. 
iv) Visualisation 
Samples were denatured at 80
o
C for 3 min, placed on ice, then separated on a 10 % TBE Urea 
gel as described in 2.6.eii). Only 1/20
th
 of the volume of the undigested probe samples were 
loaded. 1x10
4
 dpm of 34 and 28mer markers and 0.1-2kb ladders were used to determine 
the sizes of bands.. The gels were fixed in 40 % v/v Methanol 5 % v/v Glacial acetic acid for 
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20 min then vacuum dried, 65
o
C for 1 hr then 80
o
C for 3 hr. Dried gels were exposed to a 
phosphorimager screen for 24 hr and visualised on a phosphorimager. 
2.6.n Alternate ligation methods for deep sequencing 
i) Selection of partially degenerate 20 nt RNA pool 
A random number generator (http://www.random.org) was programmed to output values 
between 1 and 4 inclusive. Each base was assigned a number: 1 = A, 2 = C, 3 = G, 4 = U. The 
program was run 10 times and the output converted giving the following sequence: 
GCAGUUGCCA. An RNA pool with this sequence followed by 1 ?ĚĞŐĞŶĞƌĂƚĞŶƵĐůĞŽƚŝĚĞƐ ? ? ? W 
GCAGUUGCCANNNNNNNNNN  W  ? ? ?ǁĂƐƐǇŶƚŚĞƐŝƐĞĚ ?dŚĞƌŵŽ^ĐŝĞŶƚŝĨŝĐDŽůĞĐƵůĂƌŝŽůŽŐǇ ? ?
dŚŝƐZEƉŽŽůŚĂƐďŽƚŚ ? ?ƉŚŽƐƉŚĂƚĞĂŶĚ ? ?K,ŵŽŝĞƚŝĞƐŶĞĐĞƐƐĂƌǇĨŽƌůŝŐĂƚŝŽŶ ? 
ii) Ligation of Universal Cloning linker 
40 ng RNA pool (~6 picomoles) was added to 1µl of 100 ng/µl Universal Cloning Linker (~18 
picomoles; NEB) and brought to 10 µl with nuclease-free water. RNA was denatured at 80
o
C 
for 2 min then placed immediately on ice. For ligation with T4 RNA Ligase 2 truncated K227Q 
mutant (Rnl2tr K227Q) the following were added: 2 µl RNA ligase buffer (NEB), 1 µl 
SuperaseIn, 6 µl 50 % PEG8000 (NEB) and 1 µl Rnl2tr K227Q (NEB), mixed thoroughly and 
incubated at 25
o
C for 3 hr. 
For ligation with Methanobacterium thermoautotrophicum RNA ligase K97A mutant (Mth 
K97A) the following were added: 2 µl NEB1 buffer, 1µl SuperaseIn, 6µl nuclease free water 
and 1 µl Mth K97A (NEB), mixed thoroughly and incubated at 65
o
C for 1 hr. 
Reactions were terminated by heat inactivation at 90
o
C for 2 min, then placed on ice. RNA 
was precipitated by adding 205 µl nuclease free water, 25µl 3M NaOAc pH 5.2, 1 µl 
GlycoBlue and 250µl isopropanol, mixing thoroughly and incubating at -20
o
C for at least 30 
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min. RNA was pelleted at 13,000 rpm 30min, 4
o
C, washed twice with 75 % ethanol and left to 
air dry before being resuspended in 5 µl of nuclease free water.  
5 µl of formamide loading dye was added to each sample, denatured at 80
o
C for 3 min then 
snap cooled on ice. 250 ng small RNA marker (Abnova) was prepared in the same way. 
Samples were run on a precast 15 % TBE-Urea gel (Invitrogen) in 1X TBE, at 180 V until the 
bromophenol blue dye front was at the bottom of the gel. 
RNA was visualised with SybrGold and a band corresponding to 37 nt was excised and 
recovered as described in 2.6.iiv).  
iii) Reverse transcription with Ion Torrent compatible primer 
2 µl of 1.25 µM Ion Torrent compatible primer  
  ? ? ?
CGCCTTGGCC/Sp/CACTCA/Sp/CCTCTCTATGGGCAGTCGGTGATATCTATTGATGGTGCCTACAG  W 
 ? ?ǁŚĞƌĞ^ƉŝƐĂn 18-atom hexa-ethyleneglycol spacer) was added to each sample, denatured 
at 80
o
C for 3min then snap cooled on ice. To this was added: 4 µl 5X First strand buffer, 1 µl 
0.1M DTT, 1 µl SuperaseIn, 1 µl 10mM dNTPs and 1 µl Superscript III, mixed thoroughly and 
incubated at 48
o
C for 30 min, with heated lid. 2.5 µl each of 1N NaOH and 0.5 M EDTA were 
added, mixed thorough, and incubated at 98
o
C for 20 min to hydrolyse RNA. cDNA was 
precipitated as in 2.6.nii), denatured in formamide loading buffer at 98
o
C for 3 min, and run 
on a 6 % TBE-Urea gel, 180V, until the bromophenol blue had run off the bottom. Upon 
visualising with SybrGold, three bands were seen. The upper band (~80bp) was excised, 
being careful to avoid the lower two bands which were unincorporated RT primer and RT 
primer dimers. cDNA was recovered as described in 2.6.iiv) though without SDS in the elution 
buffer. cDNA was resuspended in 15 µl nuclease free water. 
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iv) Circularisation of cDNA 
2 µl Circligase buffer, 1 µl 50mM MnCl2, 1 µl 10mM ATP and 1 µl Circligase (Epicentre) were 
added to cDNA, mixed thoroughly and incubated at 60
o
C for 1 hr, with heated lid. Reactions 
were terminated by heat inactivation, 80
o
C, 10 min then precipitated as described in 2.6.nii), 
before being resupended in 12 Pl nuclease free water. 
2.6.o Sequencing using the Ion Torrent  
cDNA libraries were amplified and subject to emulsion PCR as described in the Ion Total RNA-
Seq Kit v2 (Life Technologies). Templated beads were deposited on the 318 Chips and 
sequenced. 
2.7 Protein methods 
2.7.a Immunoblotting 
i) Solutions 
Whole cell lysis Buffer: 10 mM Tris pH 7.5, 50 mM NaCl, 0.5 % NP40, 0.5 % Sodium 
Deoxycholate, 0.5 % SDS, 10 mM iodoacetamide.  
Phospho-preserving lysis buffer: 10 mM Tris pH 7.5, 50 mM NaCl, 0.5 % NP40, 0.5 % Sodium 
Deoxycholate, 0.5 % SDS, 10 mM iodoacetamide, 0.5M NaF 
2X SDS sample buffer: 100 mM Tris pH 6.8, 20 % glycerol, 8 % SDS, 0.2 % bromophenol blue, 
20 % ɴ-mercaptoethanol, 2 mM EDTA 
4X SDS-PAGE resolving buffer: 1.5 M Tris, 1 % SDS pH 8.8. 
4X SDS-PAGE stacking buffer: 0.25 M Tris, 0.2 % SDS pH 6.8. 
10X SDS running buffer: 250 mM Tris, 1.92 M glycine, 1 % SDS pH 8.3. 
Transfer buffer: 50 mM Tris, 192 mM glycine, 20 % methanol. 
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Ponceau Stain: 0.5 % w/v Ponceau S in 5 % w/v TCA. 
TBST (Tris buffered saline, Tween): 10 mM Tris pH 8.0, 0.9 % NaCl, 0.1 % Tween 
Luminol solution: 50mg Luminol (5-amino-2,3-dihydro-1,4-phyhalazinedione) in 0.1 M Tris-
HCl pH 8.6.  
Enhancer: 11 mg para-coumaric acid in 10 ml DMSO. 
ii) Lysate preparation 
Whole cell lysis buffer or phospho-preserving lysis buffer was added directly to cell pellets 
obtained from polysome profiling experiments. Buffers were supplemented with protease 
inhibitors (complete mini, EDTA free protease inhibitor cocktail, Roche). Lysates were 
homogenised by 30 passages through a 25G needle. Insoluble material was pelleted by 
centrifugation at 13,000rpm for 10min at 4
o
C. The cleared lysates were stored at -20
o
C. 
iii) SDS-Polyacrylamide gel electrophoresis 
SDS-PAGE gels were cast and run in a Bio-Rad Protean system. Depending on resolution 
required, the resolving gel mixtures were prepared as described below. 
 % Gel 4X Resolving Buffer (ml) 30 % Acrylamide (ml) Distilled water (ml) 
10 2.5 3.33 4.17 
12.5 2.5 4.17 3.33 
15 2.5 5 2.5 
 
Gel mixes were polymerised by addition of ammonium persulphate and TEMED (N,N,N ?,N ?-
Tetramethylethylenediamine) to concentrations of  0.125 %  w/v  and 0.001 %  v/v 
respectively. The stacking gel was prepared by mixing 1.8 ml of water, 2.5 ml of stacking 
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buffer, 0.67 ml of  30 % acrylamide/ 0.8 % bisacrylamide, 25 ʅůŽĨ ? ? % APS and 5 ʅůŽĨ
TEMED. An equal volume of 2X loading buffer was added to each lysate and denatured at 
95
o
C for 5 min prior to loading. Gels were run in 1X SDS running buffer at a constant voltage 
of 120 V for approximately 2 hr, until the bromophenol blue dye front reached the bottom of 
the gel. 
iv) Transfer of protein to PVDF membrane 
Separated proteins were transferred to a PVDF membrane (Biorad) by semi-dry blotting. The 
membrane, pre-soaked in methanol, and gel were washed in transfer buffer and then 
sandwiched between layers of 3MM paper, also soaked in transfer buffer. Transfer was 
carried out at 10 V for 90 min. To confirm the efficacy of transfer, membranes were 
incubated for 5min in ponceau stain then washed repeatedly with water to reveal the bands. 
The location of each lane was marked with pencil before further washes to remove the stain. 
Non-specific binding was blocked by incubation with 5 % non-fat dried milk in TBST for 1 hr 
at room temperature.  
v) Protein detection 
Membranes were incubated overnight at 4
o
C in a solution of 5 % milk-TBST containing an 
appropriate concentration of primary antibody. Excess antibody was removed by 3x 10 min 
washes with TBST. Membranes were then incubated for 1 hr at room temperature with a 
horseradish peroxidise conjugated secondary antibody raised against mouse or rabbit 
immunoglobulins, diluted 1:5,000 in 5 % milk-TBST. Excess antibody was removed with 3 
TBST washes, 5-10 min each. 1 ml luminol ? ? ?ʅůĞŶŚĂŶĐĞƌĂŶĚ ? ? ?ʅů ? % (v/v) hydrogen 
peroxide were mixed to create an enhanced chemiluminescent (ECL) mix. The ECL mix was 
applied to the membrane for 5 min and the luminescence visualised by exposure to X-ray 
film.   
Antibodies 
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Target Supplier (Clone) Dilution Source 
ɴ-Actin Sigma 1:5000 Mouse 
Cyclin D1 Santa Cruz 1:1000 Rabbit 
Cyclin D1 Cell Signalling 1:1000 Mouse 
c-Myc  Cell Signalling (D84C12) 1:1000 Rabbit 
eIF4E Willis Lab 1:1000 Rabbit 
Ğ/& ?ɲ Abcam  1:500 Mouse 
Ğ/& ?ɲ-phospho Cell Signalling 1:1000 Rabbit 
eIF2B-ɸ Cell Signalling 1:1000 Rabbit 
2.7.b Immunohistochemistry 
All immunohistochemical methods were performed by Dr Liam Faller at the Beatson 
Institute, Glasgow. 
i) Slide preparation 
Slides were deparifinised using standard methods, incubated in citrate buffer (10mM Sodium 
Citrate pH 6.0) for 30 min at 95
o
C, then left to cool. After washing with distilled water slides 
were incubated in 3 % H2O2 for 10 min then washed for 5 min in TBST. Slides were blocked in 
5 % normal goat serum-TBST (TBST-5 % NGS) for 30 min at RT then and incubated at 4
o
C 
overnight with primary antibodies diluted in TBST-5 % NGS as follows: 
Target Supplier (Clone) Dilution Source 
Phospho S6K Abcam (#ab32359) 1:200 Rabbit 
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Phospho rps6 Cell signalling (D57.2.2E) 1:400 Rabbit 
Phospho 4E-BP1 Cell Signalling (#2855) 1:500 Rabbit 
 
Slides were washed twice for 5 min each with TBST, then incubated with biotinylated anti-
Rabbit 2q antibody (ABC kit; Vector Laboratories) for 30min at RT. The slides were then 
washed again twice for 5 min each with TBST then incubated with pre-mixed ABC complex 
for 30 min at RT. Excess ABC was removed in the same manner as the antibodies and the 
slide ǀŝƐƵĂůŝƐĞĚǁŝƚŚƌĞĂŐĞŶƚĂĐĐŽƌĚŝŶŐƚŽƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐ ? 
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Chapter 3. The contribution of tRNAi
Met
 to oncogenic transformation 
3.1 Introduction  
As described in the introduction, many components of the translational machinery may be 
dysregulated in oncogenesis. Much work has focussed on the role of initiation factors and 
microRNAs, however another class of non-coding RNAs  W tRNAs  W may also play a role in the 
formation of some tumours. 
Microarray studies have revealed that the total expression levels of tRNAs are higher in cell 
lines derived from breast cancers compared to non-transformed breast epithelial cell lines 
(Pavon-Eternod et al., 2009) and in samples from lymphoma patients (A. Lund, unpublished 
observations). This is perhaps not surprising, as the activity of RNA Polymerase III, the 
polymerase responsible for transcription of tRNA, is regulated by well characterised 
oncoproteins and tumour suppressors such as c-myc and p53 respectively (White, 2004). 
Notably, this upregulation is not uniform; tRNA transcripts encoding the same amino acid are 
differentially upregulated within each cancer cell line (Pavon-Eternod et al., 2009). However, 
some phenomena are correlative but not causative (Payne et al., 2008). The extent to which 
changes in tRNA abundance affect the translational efficiency of specific transcripts and thus 
are causative of transformation is an unresolved question. 
There are two strands of evidence in support of a causative role, even if the exact 
mechanism underlying this is contested (Qian et al., 2012, Stadler and Fire, 2011). First, in 
cases of degeneracy (i.e. where an amino acid is encoded by multiple codons), the 
abundance of each anticodon is correlated with the abundance of the codon within the 
transcriptome of budding yeast (Ikemura, 1985) and mammalian reticulocytes (Hatfield and 
Rice, 1986). That these correlations differ between organisms, suggests that selective 
pressure operates to determine codon bias  W i.e. codon bias can provide a selective 
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advantage for an organism/tumour. Furthermore the translational efficiency of endogenous 
proteins can be increased by mutating rarer codons to synonymous commoner ones, as has 
been shown for nPTB (Robinson et al., 2008) and EPO (Kim et al., 1997). Second, elevated 
expression of tRNAi
Met
 in mouse embryo fibroblasts has been associated with increased 
proliferation and oncogenic capacity (Marshall et al., 2008). Significantly, overexpression 
caused an increase in both the global translation rate and the translational efficiency of two 
transcripts, c-myc and cyclin D1.  
We planned to use a recently described deep sequencing technique, ribosome profiling, to 
identify other transcripts differentially translated under high tRNAi
Met
 conditions. 
3.2 Establishment of new high tRNAi
Met
 MEF cell lines 
Initial work using the MEF cell lines 2D and 4C described in Marshall et al., (kindly donated by 
Professor Robert J White) proved unproductive because over multiple (>10) passages the 
overexpression of tRNAi
Met
 was lost. These cell lines were constructed by co-transfection of a 
hygromycin resistance plasmid and a T-Easy based vector with or without the tRNAi
Met
 gene. 
It is possible that genomic integration had not occurred such that over time hygromycin 
selection permitted growth of cells without the tRNAi
Met
 plasmid. To avoid this issue, the 
fragment containing the tRNAi
Met
 gene was cloned into a puromycin resistance vector (pPur) 
using the EcoRI site. There are estimated to be 9 copies of the tRNAi
Met
 gene within the 
mouse genome (full details available from http://gtrnadb.ucsc.edu/Mmusc10/mm10-
tRNAs.fa; sequences starting AGCAGAT) so a vector with only one copy of the gene would be 
unlikely to result in a significant increase in expression. Thus, a vast excess of insert:vector 
was used to encourage ligation of multiple copies of the gene within a single vector. To 
identify if any clones did indeed contain multiple copies of the fragment, an equal mass of 
each vector clone was digested with either BamHI to linearise, or EcoRI to yield the original 
inserts. All linearised clones were larger than pPur vector alone, with the F clone (iMetF) 
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being larger than all others (Figure 3.1 B, upper gel). Upon digestion with EcoRI, iMetF also 
yielded a much more intense band at ~350 bp suggesting the increased size was due to extra 
copies of the tRNAi
Met
 gene. Subsequent cloning yielded a vector larger than iMetF, 
estimated to contain 3 copies of the gene (named 3Met). 
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Figure 3-1 Construction of a selectable tRNAi
Met
 expression vector 
A A genomic fragment containing the mammalian tRNAi
Met
 sequence (red text) was excised 
from a T-Easy vector backbone and ligated into puromycin resistance vector, pPur, using the 
EcoRI site. A 10:1 insert:vector ratio was used to encourage the ligation of multiple 
fragments within the same vector. 
B Upon linearization, clone F was shown to be larger than other ligated vectors. Digestion 
with EcoRI revealed this clone contained at least two copies of the tRNAi
Met
 gene. 
tRNA fragment sequence 
ATCCTTCGGAGCTCATTTTGctatatgtaaatc
accaattaaatcagctaatcactacacattggaaaaa
gctgtcagaagacagtgttcacatcgaactatacaag
tgtgatttcaaagaacacctaggcagctctagcagag
tggcgcagcggaagcgtgctgggcccataacccaga
ggtcgatggatcgaaaccatcctctgctaaggtgcag
cttttttttttcctcgtcacacaaaaccaaagttttattc
actttctatttgcttgcagaaaccgaaagtaataacta
attaaagcatgctgcgcacaatatttcttcgagatgaa
GATGAAAACATCTCGAAGCGC 
 
 
 
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NIH 3T3 MEFs were transfected with either pPur, iMetF or 3Met vectors and selected using 
puromycin as described in Materials and Methods. Interestingly, total RNA from iMetF and 
3Met transfected cells showed equally increased expression of tRNAi
Met
 compared to the 
pPur containing controls (Figure 3.2 A). This is somewhat surprising as the 3Met vector has 
more copies of the tRNA gene. That expression levels are similar may be due to an increased 
transfection efficiency of iMetF such that there are multiple copies of the vector within some 
cells creating a mixed population, or alternatively that there is a limit to Pol III activity upon a 
single vector. Importantly, by separating RNA under acidic conditions it was possible to 
confirm that the increased tRNA levels were of the aminoacylated form. Given that each 
amino acid has its own aminoacyl-tRNA-synthetase that specifically recognises tRNAs with 
the correct anticodon, it is most likely the upper band in the northern blots are methionyl-
tRNA, capable of forming ternary complex and able to participate in translation initiation.  
As was observed by (Marshall et al., 2008), overexpression of tRNAi
Met
 was associated with 
modest increases in protein synthesis (Figure 3.2 B) and cell proliferation (Figure 3.2 C) 
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Figure 3-2 Elevated tRNAi
Met
 is associated with increased protein synthesis and cell 
proliferation. 
A Representative northern blot of total RNA separated by acid-urea PAGE. NIH 3T3 MEFs 
were stably transfected with the vector listed above the lane.    
B Representative methionine incorporation assay data. Values are the mean of 3 
independent experiments, each from 3 wells. In each experiment values were normalised to 
pPur, thus the standard deviation is only calculated for iMet.  
C Representative methylene blue proliferation assay. Values are the mean of 6 wells +/- SD 
A 
B 
C 
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3.3 tRNAi
Met
 and translational control  
To investigate the change in polysomal association of mRNAs, cycloheximide treated post-
nuclear lysates were subject to sucrose gradient ultracentrifugation. An increase in 
polysomal association of RNA was observed in both high tRNAi
Met
 cell lines (a representative 
trace of iMetF is shown in Figure 3.3, 3Met was very similar). When taken with the increased 
rate of protein synthesis, the data suggest that translation initiation is the predominant stage 
of regulation within these cells (a reduction in polysomal association with an increase in 
protein synthesis rate would suggest elongation as a primary stage of regulation, a topic that 
shall be explored in later chapters).
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Figure 3-3 Elevated tRNAi
Met
 expression is associated with increased polysomal association 
Total cytoplasmic extracts were separated by sucrose gradient ultracentrifugation, represented in the image (left). Gradients were separated by upward 
displacement giving the representative absorbance trace shown (right).
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As described in the Introduction, global translation initiation is typically limited either by the 
availability of the eIF4F complex or of ternary complex. Given the change in translation 
initiation in response to increased tRNAi
Met
 it was assumed that the level of ternary complex 
was limiting in the cell line used. There was no dramatic decrease in the phosphorylation of 
eIF2 or an increase in eIF2B in iMet cells compared to the control (Figure 3-4 A), suggesting 
that tRNAi
Met
 alone is limiting for ternary complex formation in these cells. There was no 
difference in eIF4E expression, however a definitive answer on the phosphorylation status of 
the 4E binding proteins could not be obtained. In the absence of these data, the possibility 
that increased tRNAi
Met
 levels also increase eIF4F availability cannot be excluded, though the 
application of OcĐĂŵ ?ƐƌĂǌŽƌǁŽƵůĚƐƵŐŐĞƐƚƚŚĂƚƚŚŝƐŝƐƵŶůŝŬĞly. 
Consistent with the earlier report of Marshall et al., increased expression of c-myc and cyclin 
D1 in response to increased tRNAi
Met
 was observed (Figure 3-4 B). It was presumed that this 
was due to increased translational efficiency, but on reflection an assessment of mRNA 
abundance should have been performed to confirm this. Notably, the c-myc isoform (myc1) 
that is initiated from an alternate start codon (CUG) was expressed at higher levels in the 
iMet cells. Whilst it has been reported that CUG start codons can be translated by their 
cognate tRNA
Leu
 in immune cells (Starck et al., 2012), it was also the case that such CUG start 
codons nonetheless have higher occupancy of tRNAi
Met
 than tRNA
Leu
, consistent with the 
classical scanning model of translation initiation. The increased expression of the CUG 
initiated myc isoform led us to speculate that increased ternary complex availability may 
increase translation from less favoured start codons more generally and that this might 
partially explain the phenotypic changes observed. 
To investigate this, and other potential mechanisms, attempts were made to identify other 
mRNAs that were also differentially translated in response to increased tRNAi
Met
 and whether 
there were common features or motifs that contributed to this.     
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Figure 3-4 Expression and phosphorylation status of eIFs and oncogenic proteins in 
response to increased tRNAi
Met 
A) Representative western blots for the initiation factors listed. ɴ-actin was used as a loading  
control in addition to ponceau staining (not shown).  
B) Representative western blots for c-myc and cyclin D1. By running a PAGE gel so that the 
50kDa marker is about to run off the bottom it is possible to resolve two myc isoforms, one 
of which is initiated from a non-AUG start codon. 
B 
A 
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3.4 Using ribosome profiling to identify differentially translated mRNAs 
The previous approach of the Willis lab to identifying changes in translational efficiency 
between different conditions was to use translational profiling (Bushell et al., 2006, Powley 
et al., 2009). In this technique, RNA from the subpolysomal fractions of the sucrose density 
gradient are pooled, reverse transcribed and labelled with a fluorescent Cy dye. The 
remaining, polysomal, fractions are treated in the same way but with a different dye. These 
cDNA pools are then hybridised to microarrays containing probes to known mRNAs and the 
ratio of each dye intensity used as a measure of translational efficiency. 
However, this approach has three key limitations. First, it only identifies changes in the 
distribution of mRNA across a single point in the density gradient. For example, an mRNA 
that is associated with >8 ribosomes (fractions 9-11 in Figure 3-3) in condition A and 4-5 
ribosomes (fraction 7 in Figure 3-3) in condition B would not be identified as differentially 
translated by this method despite at least a 2 fold difference in translational efficiency. 
Second, expression data from a cDNA microarray is limited to the subset of complementary 
probes on its surface; there may be tissue specific genes that show differential regulation but 
cannot be detected as there are no complementary probes present on the array.  Third, the 
technical biases that plague microarrays are well characterised (Smyth and Speed, 2003), but 
the normalisation methods used to correct these make assumptions that are not necessarily 
applicable to translational profiling data (e.g. that the ratio of each dye should be 1:1). 
Subsequent work within the Willis lab has sought to develop new normalisation approaches, 
the details of which are beyond the scope of this thesis.  
For the above reasons it was decided to use the recently developed next-generation 
sequencing technique ribosome profiling (Ingolia et al., 2009) to identify differentially 
translated mRNAs.  
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Ribosome profiling involves the sequencing of two pools of RNA collected simultaneously  W 
one derived from all polyadenylated RNAs (the polyA+ transcriptome), the other from 
fragments created by digesting ribosome bound mRNA (the translatome). The former will 
give a value proportional
1
 to the abundance of an mRNA, the latter the degree of ribosomal 
association. By dividing one by the other it is possible to estimate the translational efficiency 
of an mRNA. Hypothesis testing can then be performed to identify mRNAs that show 
significant differences in translational efficiency between conditions. 
The process of fragment generation for ribosome profiling is represented (Figure 3-5) and 
will be described below. To assess the whole transcriptome, polyA+ RNA was selected from 
total RNA extracts from an aliquot of cells pelleted prior to lysis. PolyA+ RNA was fragmented 
with RNase III and used to generate a sequencing library compatible with the SOLiD 
sequencing platform. On reflection, it would have been more appropriate to extract the RNA 
from the post nuclear lysate as there may be mRNAs that show differential 
nuclear:cytoplasmic localisation between conditions. In addition, fragmentation with RNase 
III results in patchy coverage, an issue which will be addressed in a later chapter. 
The isolation of ribosome protected mRNA fragments exploits the fact that mammalian 
ribosomes arrested on mRNAs protect a region of approximately 30 nt within the ribosomal 
cleft  from digestion by RNases (Wolin and Walter, 1988). When a post nuclear lysate is 
digested with RNaseI and separated by sucrose gradient ultracentrifugation these fragments 
are present within the 80S peak. RNA can be extracted from this region of the gradient using 
the acid phenol method and size selected on a denaturing acrylamide gel. However, 
digestion with RNaseI ůĞĂǀĞƐĨƌĂŐŵĞŶƚƐǁŝƚŚ ? ?ŚǇĚƌŽǆǇůĂŶĚ ? ?ƉŚŽƐƉŚĂƚĞŐƌŽƵƉƐǁŚŝĐŚ 
cannot be successfully ligated to adaptors to form the templates for cDNA sequencing 
libraries. These ends are therefore modified with polynucleotide kinase. 
                                                          
1
 A full explanation as to why these values are proportional rather than absolute is described in a later 
section. 
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Figure 3-5 Ribosome profiling schematic 
Ribosome protected and RNase III digested fragments are generated in parallel and 
subjected to next generation sequencing. See Materials and Methods for full details 
B 
A 
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3.5 RNA sequencing using SOLiD technology 
Fragments were ligated to proprietary duplexed DNA adaptors with 6n degenerate 
overhangs. The degenerate overhangs should permit hybridisation of all RNA fragments, with 
the common adaptor sequences acting as primer binding sites for subsequent reverse 
transcription and PCR amplification. These cDNA libraries were then amplified onto magnetic 
beads by PCR within an oil emulsion. The result was a mix of beads with no DNA (where 
either no cDNA read or polymerase was present within the emulsion vesicle), monoclonal 
beads (only one cDNA read was within the vesicle) and polyclonal beads (multiple cDNA 
reads within the vesicle).  Successfully amplified beads were isolated. A fixed number of 
beads were deposited onto the surface of the slide, left to adhere and any unbound beads 
washed off. The slide was loaded into the sequencer and processed using either a 50bp run 
(whole transcriptome) or 35 bp run (translatome) using SOLiD technology. The details of this 
technology are available on the Life Technologies website
2
 but it is also described briefly 
below with a view to helping the reader understand the sources of variance within 
sequencing data. Polyclonal beads were excluded from downstream analysis. 
3.5.a SOLiD sequencing reaction overview 
In each cycle of the sequencing reaction, degenerate 8mer oligonucleotides are annealed to 
the bead bound reads. To align the 8mers to the start of the read, a primer antisense to the 
common RNA adapter is first annealed to the reads. Each oligonucleotide is  ? ?conjugated to 
one of 4 fluorophores dependent on the two  ? ?ŵŽƐƚ nucleotides (e.g. blue = AA, CC, GG or 
TT; green = AC, CA, TG or GT). Following ligation, the oligonucleotide is cleaved after the 5
th
 
nucleotide, releasing the fluorophore. An image of the slide is captured at this point such 
that a colour is associated with each bead. This ligation-cleavage-imaging cycle is repeated 
such that the 1
st
 and 2
nd
, 6
th
 and 7
th
, 11
th
 and 12
th
, etc. nucleotides of the read are 
                                                          
2
 E.g.: 
http://www3.appliedbiosystems.com/cms/groups/mcb_marketing/documents/generaldocuments/cm
s_057810.pdf 
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interrogated. The oligonucleotides are then denatured and removed from the slide and the 
process is repeated with a primer that is offset by one nucleotide such that the 2
nd
 and 3
rd
, 
7
th
 and 8
th
, 12
th
 and 13
th
 nucleotides are interrogated. This continues until all positions have 
been interrogated twice.  
The result is a series of colour calls for each position of each bead/read. For example, 
assuming the adaptor ends with a T, then the read TGGGGTG Q would have the colour call: 
blue (TT)-green(GT) and green(TG) and green (TG) when the primer with a +1 offset is used.  
3.5.b Conversion of colour calls to nucleotide reads 
Colour calls are then mapped to both a reference genome and to a filter set containing 
tRNAs and rRNAs. The use of the reference genome resolves situations where two colour 
calls overlapping the same nucleotide are discordant (eg calling yellow-green for +1 offset 
string in the above example). This can occur if an oligonucleotide hybridised with a sequence 
that is not 100 % complementary such that the colour called does not correspond to the true 
dinucleotide sequence. In some cases the image cannot be correctly read (because the 
reaction was unsuccessful and/or the reads were too close together) so no genomic mapping 
can be made. By merging the reads that successfully map to a genomic location and are not 
filtered a list of (predominantly) mRNA reads and their nucleotide sequence is obtained.  
3.6 Analysis of ribosome profiling read data 
Due to differences in the number of adherent beads and the quality values from the 
sequencing reactions the total number of reads differs between libraries (see Figure 3-6). In 
order to make comparisons between libraries, expression values are normalised relative to 
the total number of reads  W expressing the abundance of a sequence/mRNA in reads per 
million (rpm). To illustrate why this is necessary, imagine a scenario where the same library 
was sequenced twice, the first run yielding twice as many reads as the second (this would be 
described as having twice the read depth). For gene x there may be 100 reads in run one but 
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only 50 in run two. Looking at the raw values alone would suggest there was differential 
expression, which is not the case (the libraries were identical).  
Differences in read depth, along with the fact that libraries are amplified prior to sequencing, 
explains why sequencing data are only ever proportional to the abundance or ribosomal 
association of an mRNA.  
When comparing the mapping statistics of translatome and transcriptome libraries two 
differences are striking. First, the number of reads that map uniquely to genomic location is 
much higher in the transcriptome libraries (Figure 3-6, bottom row). The likely cause is the 
whole transcriptome libraries contained longer fragments of which 50 bp were sequenced, 
whereas ribosome protected fragments are ~ 30 nt. The second difference is that the whole 
transcriptome libraries are less contaminated by tRNA and rRNA sequences. rRNA 
contamination of the translatome libraries occurs because RNaseI will also digest the rRNA 
components of the ribosome itself as well as mRNA that is not protected by the ribosome. So 
long as a partially digested ribosome retains an 80S structure these rRNA fragments, some of 
which are ~30 nt in length, will be found within the monosome peak and ultimately will be 
incorporated within the sequencing library. Ultimately this means that even for similar 
numbers of total reads there are considerably fewer useful reads generated by sequencing 
translatome libraries  W the effective read depth is lower. How this affects attempts to 
accurately identify differentially translated mRNAs genome-wide will be discussed later in 
this section. 
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Figure 3-6 Mapping statistics for SOLiD sequencing runs  
Mapping statistics for all 8 libraries. Reads were mapped to the mouse reference genome mm9 and, independently, to a filter reference set containing rRNA 
and tRNA sequences. Percentages in the first four rows are expressed relative to the total. Unfiltered mapped reads are further divided based on the 
number of genomic locations they map to (bottom three rows) with percentages relative to the total unfiltered mapped reads in italics 
Total reads 73,284,040 100% 92,688,211 100% 55,039,740 100% 95,795,673 100% 41,004,828 100% 84,806,960 100% 70,707,146 100% 105,952,909 100%
Reads mapped 
to genome 50,944,225 70% 67,907,508 73% 21,060,761 38% 41,303,251 43% 13,833,758 34% 60,815,214 72% 36,234,043 51% 50,438,232 48%
Reads mapped 
to filter set 395,576 1% 762,920 1% 14,833,841 27% 42,412,968 44% 403,038 1% 763,316 1% 34,008,741 48% 44,134,842 42%
Reads mapped, 
not filtered
50,612,362 69% 67,284,384 73% 10,060,845 18% 9,621,477 10% 13,446,462 33% 60,193,065 71% 10,312,738 15% 18,160,457 17%
Reads with too 
many mappings 
(N >= 10) 4,271,846 8% 4,759,162 7% 3,487,836 35% 2,415,710 25% 1,434,928 11% 4,428,550 7% 1,941,379 19% 5,037,955 28%
Reads with 
number of 
mappings in 
proper range (N 
< 10) 46,340,516 92% 62,525,222 93% 6,573,009 65% 7,205,767 75% 12,011,534 89% 55,764,515 93% 8,371,359 81% 13,122,502 72%
Reads uniquely 
aligned 36,322,456 72% 49,468,003 74% 1,658,788 16% 2,513,242 26% 7,566,758 56% 44,300,874 74% 4,429,271 43% 5,049,273 28%
Replicate 1
Ppur Whole transcriptome
Replicate 2 Replicate 1 Replicate 2
Ppur RPF
iMetF
iMet Whole transcriptome
3Met iMetF 3Met
iMet RPF
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Before testing for differential translation of mRNAs it was necessary to confirm that the 
unfiltered reads from the translatome libraries mapped to positions consistent with 
ribosome protection. Using a custom Perl script (written and executed by Dr Ruth V. Spriggs), 
ƚŚĞ ? ?ĞŶĚŽĨĞĂĐŚƌĞĂĚǁĂƐĂůŝŐŶĞĚƌĞůĂƚŝǀĞƚŽboth the start and the end of the coding 
sequence of the RefSeq that the read best mapped to. The number of reads aligning at each 
nucleotide position was determined, summed for all RefSeqs and expressed as a read density 
(rpm). ZĞĂƐƐƵƌŝŶŐůǇ ?ƚŚĞƚƌĂŶƐůĂƚŽŵĞƌĞĂĚƐŵĂƉƉĞĚĂůŵŽƐƚĞǆĐůƵƐŝǀĞůǇƚŽƚŚĞ ? ?hdZĂŶĚS 
of transcripts (Figure 3-7). There is a striking 3n periodicity within the CDS-aligned reads, 
consistent with capture of ribosomes on in frame codons. That there are reads at +1 and +2 
positions relative to the start of the codon is unlikely to be due to the capture of ribosomes 
during translocation because the treatment with cycloheximide, which blocks the E site 
preventing further translocation of the ribosome (Pestova and Hellen, 2003, Schneider-
Poetsch et al., 2010), is for considerably longer than the time required for translocation. A 
more likely explanation is that the RNase I digestion does not generate ribosome protected 
fragments of identical length, perhaps due to slight conformational differences in the 
ribosome at different codons, so ƚŚĞ ? ?ŵŽƐƚĞŶĚŽĨƚŚĞƌĞĂĚƐĂƌĞŽĨĨƐĞƚďǇ ?Žƌ ?
nucleotides. dŚĞƌĞĂĚĚĞŶƐŝƚǇŽŶƚŚĞ ? ?hdZŝƐůŽǁĞƌƚŚĂŶŝŶƚŚĞ^ĂŶĚůĂĐŬƐƉĞƌŝŽĚŝĐŝƚǇ ?
This is consistent with the fact that only ~40 % of messages are reported to have uORFs and 
that these may be in a different frame to the CDS. Finally, the highest read density is 
clustered around the start site. This may, in part, be because the initiation of the full 
competent 80S ribosome at the start site involves multiple biochemical changes which may 
be comparatively slow compared to elongation. However it is also likely that part of this 
density is artefactual: because cycloheximide will only inhibit elongating ribosomes; newly 
initiated ribosomes can form during the treatment period on start sites unoccupied at the 
start of treatment. 
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Reads from the transcriptome libraries mapped to all regions of mRNAs, as would be 
expected. However, the density was not even across all positions as would be expected if the 
RNA was randomly fragmented and sequenced without bias. The source and potential 
remediation of biases in the sequencing protocols are addressed in a later chapter, although 
it is worth noting at this stage that RNase III does have a preference for double stranded RNA 
and was subsequently reported by Applied Biosystems to give more uneven coverage than 
chemical fragmentation, but that any biases should broadly apply equally between libraries 
unless there are substantial changes in the transcriptome. 
 
 
98 
 
 
Figure 3-7 Ribosome profiling gives sub-codon resolution of ribosome density 
dŚĞ ? ?ĞŶĚŽĨĞĂĐŚŵĂƉƉĂďůĞƌĞĂĚǁĂƐĂůŝŐŶĞĚƌĞůĂƚŝǀĞƚŽƚŚĞ^ƐƚĂƌƚ ?ƚŽƉ ?ĂŶĚ^ƐƚŽƉ ?ďŽƚƚŽŵ ?ŽĨƚŚĞZĞĨ^ĞƋŝƚŵĂƉƉĞĚƚŽ. The number of counts at 
each position across all RefSeqs was obtained and expressed as a ratio relative to the total number of aligned reads  W reads per Million.  
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The next step was to identify differentially translated mRNAs. A naïve (and ultimately 
inappropriate approach) would be to generate translational efficiency values (TE; 
translatome rpm/ transcriptome rpm) for each transcript in each replicate and do hypothesis 
testing (say with ĂĨĂŵŝůŝĂƌƉĂƌĂŵĞƚƌŝĐƚĞƐƚƐƵĐŚĂƐƚŚĞƐƚƵĚĞŶƚ ?ƐƚƚĞƐƚ ? ?ǁŝƚŚĂŵƵůƚŝƉůĞ
testing correction to account for the fact that when testing genome wide the number of 
comparisons being performed means there will necessarily be some false positives. 
To appreciate why such an approach would be incorrect it may be helpful to first outline a 
mathematical understanding of the problem. 
As with any quantitative property of interest, the expression (or ribosome occupancy) of any 
transcript (t) can be considered to be a random variable with two parameters: ŵĞĂŶ ?ʅt), and 
ǀĂƌŝĂŶĐĞ ?ʍ2t), and a probability distribution (e.g.: Gaussian/Normal). Experimental data are 
simply n samples of this random variable under different conditions resulting in a sample 
mean (ݔ ?) and sample variance (s2) for each condition.  Using a parametric test to identify 
genes differentially expressed in two conditions (A, B) involves making an assumption as to 
the distribution of this variable, using the sample means (ݔ ?, ݔ) and variances (s2tA, s2tB) to 
estimate probability that the two conditions share the same mean (ʅtA = ʅtB). 
The t-test assumes both that the data are continuous and normally distributed, neither of 
which are true for sequencing. Sequencing data are essentially the result of a counting 
process with discrete integer counts (reads), and random count based observations (e.g. 
radioactive decay) follow a Poisson distribution. However early RNA-seq data showed 
sequencing data has more variability than this and thus is not well modelled by such a 
distribution; a negative binomial distribution is felt to better approximate sequencing data 
(Anders and Huber, 2010, Robinson et al., 2010). This allows the variance to be modelled as 
two components  W random shot noise and raw variance. The raw variance (which would be 
expected to be predominantly biological variance as standardised protocols should minimise 
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technical biases) will differ between datasets; the shot noise is, by definition, a Poisson 
distributed component. Information is pooled across genes with similar total read counts 
because two data points are insufficient to accurately estimate the per-gene variances. 
Ultimately, it was not possible to use edgeR and DESeq to test for differential translation, 
because the hypothesis test for these packages is for the simple case comparing two 
transcriptome libraries. In that case there are two random variables (mRNA abundance in 
condition A, mRNA abundance in condition B) each negatively binomially distributed so the 
probability of the observed data occurring under the assumption of the null hypothesis can 
be estimated using an exact test. Translational efficiency is a compound variable: ʅribosome 
occupancy/ʅmRNA abundance. This will not be negatively binomially distributed nor is it safe to 
assume that they will have similar distributions under the null hypothesis. 
However, what the approaches of edgeR and DESeq highlight is that there are multiple 
components of variance. Importantly, because shot noise is Poisson distributed (i.e. it is 
equal to the mean) it has a greater effect on low count data than high count data. For 
example if ݔ ?   = 4 then stA. = ඥ ? ൅ ܾ݅݋݈݋݈݃݅ܿܽݒܽݎ݅ܽ݊ܿ  ݁ and if ݔ ?   = 400 then stB = ඥ ? ? ?൅ ܾ݅݋݈݋݈݃݅ܿܽݒܽݎ݅ܽ݊ܿ݁. The degree to which the sample mean is influenced by this 
shot noise can be compared by computing the signal to noise ratio (ݔ ?/s) for each condition. 
For simplicity, assume there is no biological variance (e.g. technical replicates where there 
should be no differential expression), then the signal to noise ratio is much smaller in A (2) 
than B (20). This means that, all other things being equal, translational efficiency values 
computed from low count data are less accurate than those from high count data. This 
partially explains the fanning out of the low count data when biological replicates are plotted 
against each other (Figure 3-8 A).
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Figure 3-8 Applying minimum read thresholds to sequencing data 
A Correlation of raw read counts for each RefSeq between iMet replicates 
B Scatter plot of a measure of inter replicate variance within equally sized bins. For equally 
sized libraries governed purely by random noise a binominal distribution would be expected. 
The start of the plateau (>260 reads, indicated with arrow) was chosen as the threshold.
B 
A 
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Being unable to use parametric hypothesis tests necessitated the use of non-parametric tests 
that use ranks derived from the raw means. However, if the signal to noise ratio is much 
lower for low count data, then using these methods would likely yield false positives of 
transcripts with very few counts because their rank would be more of a reflection of noise. 
To avoid this, Ingolia has suggested determining a threshold number of counts beyond which 
transcripts have broadly similar variances (Ingolia et al., 2009). To do this, genes are binned 
based on the total number of transcripts between two biological replicates and the standard 
deviation of the fraction of reads coming from a particular replicate computed within that 
bin. A plot of these per-bin variances is shown in Figure 3-8 B.  
If transcripts were distributed on a purely random basis between replicates of equal depth 
(i.e. pure shot noise, analogous to flipping a coin) the variances would follow a binominal 
distribution. That they are over dispersed suggests there are additional sources of variance 
within all bins  W biological and technical variance. Beyond 260 counts the variance plateaus. 
This is somewhat higher than the 128 counts in (Ingolia et al., 2009) and 200 in (Ingolia et al., 
2011), but the biological and technical variability will differ between experiments and must 
be estimated from the data rather than simply taking a numerical value as appropriate in all 
cases as appeared to be done in (Thoreen et al., 2012).
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Figure 3-9 Consequences of applying minimum read thresholds to sequencing data 
A Cumulative frequency plot of the % of total non-filtered reads that map to transcripts 
B Pie chart of genes that meet the chosen threshold (260 counts) in all four library types 
(pPur/iMet, transcriptome/translatome). 
C Scatter plot of translational efficiency values for the two iMet replicates with and without 
application of the threshold. 
C 
A 
B 
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This use of thresholds effectively limits identification of differentially expressed mRNAs to 
those that are highly expressed. This is because the abundance and translation of genes 
follow a Pareto-like distribution  W the 20 % most abundant/translated messages account for 
approximately 80 % of all sequencing reads (Figure 3-9 A). Consequently only 3258 genes 
crossed the threshold in all four library types (Figure 3-9 B). However, employing this cut off 
approach significantly improved the correlation of TE values between the replicates (Figure 
3-9 C). This validates the threshold approach, but also highlights that when using very few 
replicates the technique does not give an accurate genome-wide picture of the translational 
landscape.  For example, neither c-myc nor cyclin D1 met the threshold. 
To test for differential translation between these ~3000 genes the TE values for each 
replicate were calculated. These values were analysed with RankProd, a nonparametric test 
that has been successfully used on microarray DNA data where parametric testing would 
have been inappropriate (Breitling et al., 2004). No differentially translated genes were 
identified. This may have been because 2 replicates was too few for such a conservative test 
so another approach of Ingolia was used (Hsieh et al., 2012). The biological replicates were 
used ƚŽĞƐƚŝŵĂƚĞƚŚĞƌĂŶŐĞŽĨȴdǀĂůƵĞƐƚŚĂƚŽĐĐƵƌƐŝŵƉůǇƚŚƌŽƵŐŚďŝŽůogical variance and 
ĚĞƚĞƌŵŝŶĞƚŚĞȴdǀĂůƵĞƐďĞǇŽŶĚǁŚŝĐŚĂĐŽŵƉĂƌŝƐŽŶďĞƚǁĞĞŶĐŽŶĚŝƚŝŽŶƐŝƐƐŝŐŶŝĨŝĐĂŶƚůǇ
distinct from biological variance. Unfortunately ĂŐƌĞĂƚĞƌƌĂŶŐĞŽĨȴdǀĂůƵĞƐǁĂƐŽďƚĂŝŶĞĚ
when comparing biological replicates than when comparing different conditions isolated on 
the same day and sequenced on the same sequencing run (Figure 3-10, blue and green vs 
yellow and red lines).  Ultimately it was concluded the signal-to-noise ratio for the means 
was too low to identify differentially translated mRNAs from these two replicates.
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Figure 3-10 Inter-replicate variation confounds attempts to identify differentially 
translated messages. 
For the comparisons given in the figure legend, the logfold change difference in translational 
efficiency (TE; see materials and methods for more details) was determined for each RefSeq 
with over 260 reads in all libraries. This data is represented in a cumulative frequency plot, 
with the median fold change approximately 0. 
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3.7 Elevated tRNAi
Met
 is not always associated with the oncogenic phenotype. 
By generating more biological replicates of the ribosome profiling data it was hoped the 
signal-to-ŶŽŝƐĞƌĂƚŝŽŽĨƚŚĞȴd values could be improved. Unfortunately when working to 
generate these replicates it was noticed that pPur and iMet cells were showing similar 
translation rates, despite the high tRNAi
Met
 levels being maintained in the iMet cells. After 
some investigation, the cause of the adaptive response in these cells could not be 
determined and it was decided to pursue other projects.  Soon after, the paper from 
Marshall et al., was retracted due to evidence that elements of figures were duplicated.    
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Chapter 4. mTOR signalling in colorectal cancer 
4.1 Introduction 
The epithelia of both the small intestine and colon are organised into finger-like villi 
projecting from crypts anchored to the intestinal mucosa. The existence of villi massively 
increases the surface area of the intestine, aiding absorption from the lumen; loss of villi is 
associated with a number of pathologies. Intestinal stem cells (ISCs) are located at the base 
of the crypts and are the origin of all cell types within the crypt and villus (Schepers et al., 
2012). These stem cells can either self-renew or differentiate into one of five epithelial 
lineages (Gerbe et al., 2011). The first of these is the Paneth cell, that resides adjacent to ISCs 
and regulate their activity (Sato et al., 2009). The other four lineages are derived from 
intermediary cells termed  “ƚƌĂŶƐŝƚĂŵƉůŝĨǇŝŶŐ (TA) ĐĞůůƐ ? ?TA cells are initially found within the 
crypts but divide up to 6 times pushing older TA cells up toward the villi (Marshman et al., 
2002). Cells become more differentiated as they progress up the crypt-villi axis. 
Differentiated cells at the top of the villi undergo apoptosis and are lost into the lumen  W 
intestinal epithelial turnover time ranges from 2-5 days depending on the location in the 
intestine (Creamer et al., 1961).  
Colorectal cancer (CRC) is the third most common cancer in the world with 1,234,000 new 
cases in 2008 (Ferlay et al., 2010).  The disease has a characteristic sequelae, involving the 
accumulation of driver mutations leading to a gradually more aggressive phenotype (Fearon 
and Vogelstein, 1990). Mutations accumulate due to defects in chromosomal stability (CIN) 
or mismatch repair (MMR) pathways. In the latter case, loss of MMR proteins results in 
tumours with extensive microsatellite instability (MSI+) and mutation rates 10-100 fold 
higher than in CIN+ tumours (Cancer Genome Atlas, 2012). Approximately 3 % of CRC 
patients have Lynch Syndrome, autosomal dominant mutations in MMR proteins (Lynch et 
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al., 2009), and in total ~15 % tumours have a MSI+ hypermutated phenotype (Aaltonen et al., 
1998). 
Irrespective of mutational status, the initial event in colorectal tumourigenesis is typically 
dysregulated Wnt-signalling (Fearon and Vogelstein, 1990). Wnts are a class of extra-cellular 
ligand, which upon binding to cell membrane-bound Frizzled receptors trigger the 
disassembly of a degradation complex that restricts the activity of the pro-proliferative 
ƚƌĂŶƐĐƌŝƉƚŝŽŶĨĂĐƚŽƌɴ-catenin (Ilyas, 2005). Hyperactive Wnt signalling thus leads to 
formation of adenomas that contain both ISCs and Paneth cells (Schepers et al., 2012). 
Adenomatous polyposis coli (APC) is an essential component of the degradation complex. In 
70 % of sporadic tumours the activity of APC is lost due to mutation or deletion (Luchtenborg 
et al., 2004) increasing the availability of ɴ-catenin. Familial adenomatous polyposis (FAP), an 
autosomal dominant syndrome with an incidence of 1:10,000 (Jarvinen, 1992), is 
characterised by loss of function mutations in APC . Loss or mutation(s) in the second allele 
of APC result in the development of adenomas, and in the absence of colectomy, almost 100 
% progression to CRC by the age of 40 (Merg et al., 2005). 
Progression from adenomas to invasive adenocarcinomas (cancers) is associated with loss of 
function mutations in p53 (60 % of MSI-), and gain of function mutations in K-Ras (30 % of 
MSI- tumour) and PI3-K (18 % of MSI-) (all statistics are taken from (Cancer Genome Atlas, 
2012)).  
As highlighted in the Introduction, mTOR signalling is frequently upregulated in cancer and 
CRC is no exception. Evidence from cell lines and human biopsies suggested that mTORC1 
signalling was upregulated in CRC (Zhang et al., 2009). Initial work from Dr Owen Sansom ?Ɛ
group showed that treatment with rapamycin was sufficient to prevent hyperproliferation in 
APC null mice.  Whilst long term rapamycin inhibition has been reported to reduce mTORC2 
formation in some cell lines by sequestering free mTOR (Sarbassov et al., 2006), no decrease 
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in Akt1 phosphorylation was observed suggesting that mTORC1 but not mTORC2 signalling is 
crucial in the early stages of CRC development. However, the results of human clinical trials 
using analogues of rapamycin (rapalogs) have been disappointing (Markman et al., 2010), 
suggesting a more comprehensive understanding of the interplay between mTOR signalling 
and other common mutations acquired during CRC development is necessary to guide novel 
therapies. 
Using both mouse and Drosophila models of intestinal tumourigenesis we have attempted to 
characterise the mechanisms by which mTORC1 activity drives intestinal proliferation and to 
explain the poor performance of rapalogs in human trials. 
This work was performed in collaboration with Dr William (Liam) Faller and Dr Alessandro 
Scopelitti, both of Owen Sansom ?ƐŐƌŽƵƉĂƚthe Beatson Institute, Glasgow. Both have kindly 
given permission for their work to be presented within this thesis.    
4.2 Inhibition of mTORC1 signalling significantly reduces the oncogenic effects of APC 
deletion in mice. 
The Sansom group have an extensive range of mice strains with alleles either deleted 
systemically or under the control of a tamoxifen inducible Cre recombinase system. The 
inducible mice system allows specific knockdown of the gene in either the whole intestinal 
epithelia (villin) or lgr5+ cells (ISCs), full details of this can be found in the Materials and 
Methods (2.3.a).  The similarities in cell differentiation and proliferation between the small 
intestine and the colon make it an appropriate model for the study of intestinal tumours in 
general.  
Homozygous loss of function mutation of APC (APC
fl/fl
) was lethal to the mice with 100 % 
penetrance. When rapamycin treatment was administered 10 days after induction of APC 
loss, mice were protected against these lethal effects for the period of treatment (Figure 4-
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1A). Extending the treatment for 180 days resulted in comparable survival and phenotype to 
wild type mice (data not shown). Rapamycin also prolonged life in mice treated once they 
had developed clinical symptoms (Figure 4-1 B) suggesting that this approach may be 
clinically relevant.  Rapamycin treatment may not inhibit all mTORC1 activity (Thoreen et al., 
2009) so a genetic approach to studying the role of mTORC1 was also used. Intestine specific 
knockout of the mTORC1 essential component Raptor also prolonged life in both APC
fl/fl
 and 
APC
fl/fl
 PTEN
fl/fl
 genetic backgrounds (Figure 4-1C). That Raptor knockout was not fully 
protective for these mice (unlike rapamycin treatment) could be because recombination is 
not 100 % efficient so some residual mTORC1 signalling was present. Consistent with the 
survival data and the role of Raptor in mTORC1 signalling, crypt size and phosphorylation of 
mTORC1 targets 4E-BP1 and S6K was markedly reduced in APC
fl/fl 
Raptor
fl/fl
 mice compared to 
APC
fl/fl 
(Figure 4-2). 
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Figure 4-1 Inhibition of mTORC1 signalling prolongs life of APC deficient mice 
On day 0 mice were administered with tamoxifen to induce Cre recombination to flox out 
the alleles described. Recombination occurs within the small intestine.  
A Survival curve for mice with homozygous deletion of APC. 10 days after APC deletion, mice 
were treated for 30 days with rapamycin or a vehicle control (red region). N = 13 in 
treatment arm, 14 in vehicle control arm. 
B As per A, but rapamycin treatment commenced when animals showed signs of illness and 
continued for 60 days. N = 15 in treatment arm, 9 in vehicle control 
C Survival curves for mice with or without loss of mTORC1 by deletion of Raptor as described 
in the legends. N=10 in APC
fl/fl
 arm and 9 in APC
fl/fl
 Raptor
fl/fl
 arm (left). N = 4 in APC
fl/fl
 PTEN
fl/fl
 
arm and 12 in APC
fl/fl
 PTEN
fl/fl 
Raptor
fl/fl
 arm. All experiments in this Figure performed by Dr 
W. Faller (Beatson Institute, Glasgow). Differences in survival in response to mTORC1 
inhibition was statistically significant (p<0.001) in all cases. 
A B 
C 
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Figure 4-2 Reduction of mTORC1 signalling by Raptor deletion reverses the 
hyperproliferative phenotype of APC deficiency 
A Representative images of haematoxylin and eosin (H&E) stained slices from murine 
intestines. The black bars indicate the intestinal crypts. 
B Immunohistochemistry for targets phosphorylated by mTORC1: S6K and 4E-BP1 
All experiments in this Figure performed by Dr W. Faller (Beatson Institute, Glasgow) 
B 
A 
APC
fl/fl
 APC
fl/fl
 Raptor
fl/fl
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4.3 The effects of upregulated mTORC1 signalling in APC deficient mice are primarily due 
to changes in translation elongation  
To further investigate the mTORC1 driven changes in translational control in response to APC 
loss, the crypt epithelial cells were extracted from induced mice and subjected to sucrose 
gradient analysis. 4-5 mice of each genotype were profiled with a characteristic trace 
obtained for each (see Figure 4-3). Surprisingly crypt epithelia from APC
fl/fl
 mice showed 
decreased polysomal association relative to the WT mice. Cellular proliferation requires the 
accumulation of cell mass so an increase in proliferation typically requires an increase in 
protein synthesis rate (Zetterberg and Killander, 1965). A change in either the distribution of 
cell types within the crypts or of cell size could uncouple protein synthesis rates from 
proliferation (e.g. an increase in secretory cells that have lower proliferation rate relative to 
protein synthesis rates or the replication of smaller cells); neither was observed. In the vast 
majority of studied cases of translational control, an increase in protein synthesis is due to an 
increase in initiation and thus causes an increase in polysomal association. The most 
plausible explanation consistent with a decrease in polysomal association and an increase in 
protein synthesis is a reduction in ribosome transit time: i.e. APC deficiency is associated 
with an increase in translation elongation rate. Relative to the WT, there is a marked 
increase in polysomal association in the APC
fl/fl
 Raptor
fl/fl
 crypts but not Raptor
fl/fl
 suggesting 
that translation elongation is the locus point of regulation for mTORC1 signalling in the 
context of APC loss but not in general. 
In support of the hypothesis that upregulation of translation elongation is central to Wnt 
driven proliferation, treatment with low doses of cycloheximide (to lower translation 
elongation rates) reduces crypt proliferation to the same extent as rapamycin treatment in 
the APC
fl/fl
 mice (Figure 4-4). 
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Figure 4-3 APC
fl/fl
 and APC
fl/fl
 Raptor
fl/fl
 intestinal epithelia have altered polysomal 
association compared to WT 
Representative polysome traces from epithelial extracts from mice with the genotypes listed. 
Due to differences in the mass of material obtained from different mice the traces have been 
scaled to be comparable to each other. 
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Figure 4-4 Low dose cycloheximide mimics the effect of rapamycin treatment in APC
fl/fl
 
intestines 
H&E stained intestinal sections from APC
fl/fl
 mice treated with either rapamycin or low doses 
of cycloheximide as described in the Materials and Methods.  
All experiments in this Figure performed by Dr W. Faller (Beatson Institute, Glasgow) 
  APC
fl/fl
 + Cycloheximide APC
fl/fl
 + Rapamycin 
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However, the effect of cycloheximide treatment on crypt proliferation may simply be due to 
a decrease in protein synthesis rather than directly implicating translation elongation, 
therefore it was necessary to determine the translation elongation rates within the intestine. 
Performing such investigations within an in vivo model was too technically challenging and 
costly, so an in vitro Matrigel culture model was used. A full description of this system can be 
found within the Materials and Methods (2.2.b) but essentially crypt epithelia (WT) were 
extracted from mice and dispersed within a layer of Matrigel. When cultured in media 
containing a range of growth factors crypt stem cells differentiate to form organoids  W 
proliferating crypts that invade upwards into the Matrigel to form crypts with the same 
morphology as is seen in vivo. Cre recombinase was induced in some WT cultures to give 
matched APC
fl/fl
 crypts. Unfortunately cells derived from the APC
fl/fl
 Raptor
fl/fl
 mice did not 
culture under these conditions, but this system did allow investigation of the changes in 
response to APC deficiency. 
Protein synthesis rates are higher in the APC
fl/fl
 crypts compared to wild type (Figure 4-5A), 
consistent with the assumption that increased protein synthesis facilitates cell proliferation.  
Assessment of elongation rates is somewhat more challenging, in part because ribosome 
transit times are so short (half ribosome transit times are typically in region of 2 min 
(Ruvinsky et al., 2005)). The classical radioincorporation based assay requires large numbers 
of replicates and time points to generate accurate regression lines of the rate of 
incorporation into the total and released pools of protein (Fan and Penman, 1970). Slight 
differences in gradients of these lines have dramatic impacts on the x-axis intercept and 
subsequent transmit time estimates. Instead we chose to perform a harringtonine run-off 
assay. This exploits the ability of harringtonine to inhibit the elongation of newly initiated 
ribosomes but not those already elongating (Fresno et al., 1977). Treatment with 
cycloheximide (which inhibits all elongating ribosomes) at fixed time points after 
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harringtonine is added gives an indication of the rate of ribosomal transit (see Figure 4-5B for 
illustration). The mass of material obtained from crypt cultures was considerably smaller 
than from the whole mouse so a well resolved polysome profile could not be obtained, but 
the RNA extracted from each fraction of the gradient could be reliably quantified. Similar to 
the in vivo observations, RNA was more polysomally associated in WT crypts than the APC
fl/fl
 
ones (Figure 4-5C). Furthermore the reduction in polysomal association during the 
harringtonine run-off was much greater in the APC
fl/fl
 crypts implying the translation 
elongation rate is higher in these crypts.
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Figure 4-5 Protein synthesis and translation elongation rates are elevated in cultured 
APC
fl/fl 
crypts 
A [
35
S]-Met label incorporation from WT, APC
fl/fl
 and APC
fl/fl
 KRas
G12D/+
 crypts. 30min pulse. 
Data are mean of 2 independent wells +/- SD.  
B A schematic representing the ribosome association of a theoretical mRNA after treatment 
with harringtonine and then cycloheximide at set time points afterwards. The AUG start site 
is indicated with a diamond. 
C Polysomal association of RNA represented as the % of the total RNA isolated from each 
fraction of the sucrose density gradient. H0 traces were from crypts treated with 
harringtonine and cycloheximide simultaneously; H90: 90s between addition of 
harringtonine and cycloheximide; H180: 180s gap.
 
A 
 
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Having obtained evidence suggesting APC deficiency drives proliferation due to an increase 
in translation elongation it was important to confirm that this was mediated through the well 
described mTORC1 signalling pathways, using the in vivo models of the Sansom laboratory. 
Survival studies are exceptionally time and resource intensive so an alternative was used: 
intestinal regeneration after IR irradiation. Regeneration under these conditions is driven by 
Wnt signalling and thus analogous to APC deficiency (Ashton et al., 2010).  
Treatment of WT mice with rapamycin caused a significant reduction in intestinal 
regeneration compared to the vehicle treated controls (Figure 4-6 A). A similar result was 
obtained in Raptor
fl/fl
 mice, suggesting that mTORC1 is required for intestinal regeneration. 
As described previously mTORC1 has two well characterised targets, 4E-BPs and S6K, each 
with their own downstream targets (Figure 4-6B). Mice with systemic homozygous deletion 
of both 4E-BP1 and 4E-BP2 (4E-BP3 is reported to not be expressed in MEFs (Dowling et al., 
2010a) and we assume the same is true in the murine intestine) showed no difference in the 
capacity to regenerate compared with WT mice.  4E-BP DKO mice retain the same degree of 
sensitivity to rapamycin as WT. This suggests rapamycin inhibition of Wnt-dependent 
proliferation is mediated by activation of S6K and not inhibition of 4E-BPs. Consistent with 
this, mice with systemic homozygous deletion of both S6K isoforms have significant reduced 
intestinal regeneration, comparable to that observed with rapamycin treatment. Rapamycin 
treatment does not reduce regeneration as much as Raptor
fl/fl
, so it is possible that 
rapamycin does not fully inhibit mTORC1 signalling to 4E-BPs. However, the comparative 
difference between Raptor
fl/fl
 and rapamycin treated mice suggested that proliferation is 
more dependent on the S6K arm of the mTORC1 signalling pathway than the 4EBP arm.
120 
 
 
Figure 4-6 Intestinal regeneration is sensitive to mTORC1 inhibition and requires the inhibition of eEF2k 
A Box and whisker blots of number of regenerating crypts in a murine intestine 72 hours after IR irradiation. Numbers are derived from 10 fields of view , n= 
16, 4, 6, 3, 4,5,4,11,3 (left to right) with the box representing the interquartile range and the whiskers the full range of the data. All groups (other than WT) 
describe floxed gene(s) in the mouse as detailed in the Materials and Methods. All experiments in this Figure performed by Dr W. Faller (Beatson Institute, 
Glasgow) 
B Representation of some of the downstream effectors of mTORC1 signalling and how they mediate their effects on translation
A 
B 
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S6K has numerous downstream targets, which affect different cellular processes. Mice 
expressing a mutant form of RPS6 that cannot be activated by S6K-mediated 
phosphorylation were able to regenerate as efficiently as WT. Despite being used as a 
marker of mTORC1 activation, it would appear that RPS6 does not mediate intestinal 
regeneration. Interestingly a whole mouse knockout of eEF2k did show a slight reduction in 
regeneration. It is unclear why this is occurs; mTORC1 negatively regulates eEF2k so loss of 
eEF2k might be expected to give a similar result to the WT (where mTORC1 signalling is 
active). Irrespective, the intestinal regeneration of eEF2k
-/-
 mice is not reduced by inhibition 
of mTORC1 by rapamycin. Other targets of S6K were not investigated so may play some role. 
However the complete rapamycin insensitivity of the eEF2k
-/-
 mice in addition to the 
observations from the Matrigel crypt culture system strongly suggests that Wnt-dependent 
proliferation requires increased translational elongation mediated through mTORC1. 
To further confirm this, similar experiments were performed by Dr Alessandro Scopelitti in a 
Drosophila system. The crypt morphology and signalling pathways in the Drosophila intestine 
are very similar to those in mammals (Apidianakis and Rahme, 2011). Furthermore, the 
Sansom group have shown that intestinal damage with dextran sodium sulphate (DSS) 
results in the activation of Wingless (Wg), the drosophila Wnt homolog (Cordero et al., 
2012). The results observed in Drosophila are fully consistent with those seen in the mouse 
(Figure 4-7). Expression of a dominant negative form of dTOR prevents intestinal 
regeneration, suggesting that TOR signalling is required for Wnt/Wg mediated proliferation. 
Unlike mammals, Drosophila have only one 4E-BP. If repression of 4E-BP by dTORC1 is 
required to mediate intestinal regeneration then overexpression of 4E-BP should significantly 
reduce proliferation, but this was not observed. By contrast, RNAi knockdown of either of 
the S6Ks prevented intestinal regeneration. Finally, and crucially, RNAi knockdown of the 
downstream target of eEF2k, eEF2, prevented intestinal regeneration. Collectively the data 
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presented in this section strongly suggest that mTORC1 mediates Wnt-driven proliferation in 
the intestine via the upregulation of translation elongation.  
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Figure 4-7 Intestinal regeneration in Drosophila also requires mTORC1 to increase the activity of downstream eEF2 
Box and whisker plot of the number of phospho-histone3+ cells in a drosophila intestine after damage with DSS. pHH3 is a marker of regeneration. 
dTOR = overexpression of dominant negative dTOR; 4EBP = over expression of 4EBP; S6K2 = RNAi to S6K2; S6K1 = RNAi to S6K1 eEF2 = RNAi to eEF2. n=  20, 
14, 9, 9, 9, 8, 13, 15, 9, 10, 9, 6 (left to right). Experiments performed by Dr A. Scopeletti (Beatson Institute) 
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4.4 Improvements in intestinal crypt isolation 
To further investigate the role of mTORC1 in APC deficiency it would have been informative 
to identify if any mRNAs were differentially translated under these conditions using RNA 
from the polysome profiles of the murine intestinal epithelia. However, northern blotting 
with a probe complementary to a region of ƚŚĞŚŝŐŚůǇĂďƵŶĚĂŶƚƚƌĂŶƐĐƌŝƉƚɴ-actin showed 
evidence of RNA degradation within these samples (Figure 4-8A). The probe hybridised to 
RNA of the correct size in heavy polysomes fractions, but progressively shorter species in 
lighter fractions. This suggests that there was degradation of mRNA between adjacent 
ribosomes (somewhat analogous to the process for generating ribosome protected 
fragments). This was observed in samples from all mice genotypes strongly suggesting the 
source was the method of crypt isolation and/or lysis conditions. 
The original protocol involved approximately 15 minutes of incubation in warmed media to 
detach epithelial cells after the intestines were flushed with PBS-CHX. Endogenous RNases 
will function optimally under these conditions so are a plausible cause of the degradation. To 
address this, the extractions were repeated with a method that involved brief treatment in 
warmed media containing cycloheximide to facilitate uptake of the drug and rapid 
translational inhibition, with subsequent epithelial extraction performed by brief, but 
vigorous, shaking in ice cold PBS-CHX as described in 2.3.gii). Cell pellets were lysed in a 
buffer containing additional RNase inhibitors to supplement the action of heparin in the 
standard buffer.  The polysome profiles obtained under these conditions differ from those 
from the original method, showing a greater degree of polysomal association (Figure 4-8B). 
Importantly, the RNA of WT and APC
fl/fl
 Raptor
fl/fl
 epithelia were associated with heavier 
polysomes than in a APC
fl/fl
 background, consistent with the initial observations. 
Reassuringly, nŽƌƚŚĞƌŶďůŽƚƐĨŽƌɴ-actin showed no signs of the degradation seen in the 
original samples (Figure 4-8C). 
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Figure 4-8 Improved method of intestinal epithelial extraction  
A Northern blot for ɴ-actin on gradient fractions taken from colonic epithelia of a WT mouse. Similar blots were obtained for all other genotypes 
B Polysome profiles of epithelial cells obtained using a method that minimises the potential for RNase mediated degradation 
C Northern blots for ɴ-actin on the gradient fractions corresponding to the traces above.  
A 
C 
 
B 
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4.5 K-Ras mutation results in adenomas dependent on mTORC2 signalling rather than 
mTORC1 
As mentioned in the introduction to this chapter, in spite of the promising data from in vivo 
mouse models the use of rapalogs in the treatment of colorectal cancers has been 
disappointing. It has been suggested the loss of the inhibitory feedback loop of S6K on PI3K 
signalling may be the cause of this (Carracedo and Pandolfi, 2008). However, mice which 
have homozygous PTEN deletion are also responsive to rapamycin therapy (Figure 4-1B) 
despite PTEN being a negative regulator of Akt1 (a key affector of PI3K signalling). An 
alternative hypothesis is that other genetic changes acquired during tumourigenesis may be 
responsible for resistance to mTORC1 inhibition. This is also a plausible explanation of the 
poor performance of clinical trials as the patients recruited are often those resistant to 
existing therapies. 
A common change associated with the progression of early adenomas to more proliferative 
late adenomas and adenocarcinomas is mutation of K-Ras (Fearon and Vogelstein, 1990). 
Mutation results in constitutive activation which may explain why therapeutic inhibition of 
upstream EGF signalling lacks efficacy in patients with Ras Wmutant tumours (Prenen et al., 
2010). In addition K-Ras activates PI3K, driving signalling independent of the S6K feedback 
loop.  
Rapamycin treatment of mice with the heterozygous G12D mutation of K-Ras in addition to 
APC deficiency does not prolong survival (Figure 4-9A). These mice have enlarged crypts 
relative to APC
fl/fl
 mice which were not decreased by rapamycin treatment (Figure 4-9C). 
Finally, no difference in polysomal association between APC
fl/fl
 KRas
G12D/+
 and APC
fl/fl
 
KRas
G12D/+ 
Raptor
fl/fl
 mice was observed (Figure 4-9B)
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Figure 4-9 Addition of K-Ras mutation to APC deficiency removes sensitivity to mTORC1 inhibition 
A Survival curve for mice with APC
fl/fl
 K-Ras
G12D/+
 intestines with or without rapamycin treatment. Dr W. Faller (Beatson Institute, Glasgow) 
B Polysome profiles of intestinal epithelia with indicated genotypes 
C H&E stained intestinal slices from the indicated genotypes, right panel shows a mouse treated with rapamycin. Dr W. Faller (Beatson Institute, Glasgow) 
A B 
C 
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Treatment of K-Ras mutant mice with pp242, to inhibit both mTORC1 and mTORC2, did 
result in a modest reduction in crypt size but not even to APC
fl/fl
 levels (data not shown). This 
suggests that the combination of APC loss and K-Ras mutation makes the tumour dependent 
on mTORC2 signalling, but that either the pp242 dose was not sufficient to fully reverse the 
phenotype or that targeting both mTORC1 and mTORC2 simultaneously is 
counterproductive. Intriguingly, treatment of APC
fl/fl
 or APC
fl/fl
 PTEN
fl/fl
 mice with pp242 did 
not improve survival and is under investigation within the Sansom group.  
To investigate the importance of mTORC2 signalling alone, rather than both complexes as 
occurs when using pp242, mice with inducible homozygous deletion of Rictor were bred. 
The percentage of proliferating cells with crypts of APC
fl/fl
 mice was unaffected by Rictor 
deletion (Figure 4-10). As expected, there was increased proliferative activity in the crypts of 
APC
fl/fl
 KRas
G12D/+
 mice compared to the APC
fl/fl 
mice.  APC
fl/fl
 KRas
G12D/+
 Rictor
fl/fl
 mice showed 
significant reduction in proliferative activity to levels comparable to WT crypts. The 
morphology of crypts from these mice was exceptionally similar to those from WT mice 
suggesting that normal intestinal function was present. Survival studies for these mice are 
on-going, but it appears that whilst mTORC1 signalling is required in early adenoma 
formation, K Ras mutation results in late adenomas that are dependent almost exclusively on 
Rictor. Rictor has been described to act outside of mTORC2, most notably in complex with 
integrin-linked kinase (ILK) that can phosphorylate Akt1 on S473 (i.e. the same site as 
mTORC2) (McDonald et al., 2008). However, increased expression of ILK is an event observed 
in benign polys from FAP patients (Marotta et al., 2001) as well as carcinomas (Marotta et al., 
2003). That Rictor deletion does not reduce proliferation in the APC
fl/fl
 mice suggests it 
unlikely that Rictor is predominantly acting via ILK in the intestine. In the absence of 
confounding data, it was presumed that Rictor-mediated affects in KRas mutant tumours 
were via mTORC2. 
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Figure 4-10 K-Ras mutation creates tumours that are dependent on mTORC2 signalling. 
A Immunohistochemistry for BrdU incorporation over 2 hr within the intestines of the 
genotypes indicated. 
B 10 fields of view were quantified to give the % of BrdU positive cells in each of the 
indicated genotypes. Values are mean +/- SD n =3, except for APC
fl/fl
 KRAS
G12D/+ 
where n=5. All 
experiments in this Figure by Dr W. Faller (Beatson Institute, Glasgow) 
A 
B 
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4.6  Discussion 
In this chapter it was shown the mTORC1 signalling is necessary for the hyperproliferative 
phenotype associated with APC deficiency. 
Given that many recent reviews highlight the role of 4E-BPs and translational initiation in 
mTORC1 signalling (Dowling et al., 2010b, Laplante and Sabatini, 2012, Populo et al., 2012) a 
primary role for translation elongation in APC deficiency may appear rather surprising. 
Perhaps it should not be. In addition to eEF2k being a target of S6K, two recent papers that 
have used ribosome profiling in cultured cells find the eEF2 is in the top 3 most differentially 
translated mRNAs in response to modulations of mTORC1 activity (Hsieh et al., 2012, 
Thoreen et al., 2012). That Thoreen et al., report that inhibition of mTOR signalling with Torin 
has no effect on the translation rate of 4E-BP DKO MEFs suggests that the contribution of the 
4E-BP and S6K arms of mTORC1 signalling may differ between cellular contexts.  
Work in cultured cell lines suggests that resistance to active-site mTOR inhibitors (asTORi) 
can be acquired through downregulation of 4E-BP expression thus increasing eIF4E 
availability (Alain et al., 2012). Similarly it is possible that treatment with rapamycin could 
drive selection of tumour cells with upregulation of eEF2, but APC
fl/fl
 mice given long term 
rapamycin maintenance therapy are phenotypically normal so this seems unlikely. 
Furthermore, when mice with heterozygous mutation of APC (APC
Min/+
: analogous to the 
genetic status of FAP patients) were bred until they acquired the second-hit mutation and 
became sick, rapamycin treatment caused regression of these adenomas (W. Faller, 
unpublished observations). These observations may offer a potential therapy for FAP 
kindreds. Given that the existing management of people with FAP is regular (invasive) 
colonoscopies and eventual bowel resection, a pharmacological therapy would dramatically 
improve the quality of life for these families.  
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However, when patients present with sporadic CRC their tumour will typically have acquired 
more genetic changes than just APC mutation. In the in vivo mouse model, the combination 
of APC deficiency and K-Ras mutation conferred resistance to mTORC1 inhibition consistent 
with similar findings in human colorectal cancer cell lines (Di Nicolantonio et al., 2010). K-Ras 
mutated tumours are resistant to other standard chemotherapeutics (Prenen et al., 2010) 
and genetic testing for K-Ras mutation has recently been approved for the management of 
colorectal cancer
3
 so these patients can be advised to take part in trials of novel therapies 
tailored to their molecular phenotype. Combination therapies targeting both MEK (a 
downstream target of Ras) and the PI3K/mTOR pathway have resulted in partial responses 
for a subset of Ras-mutated human advanced cancers (Shimizu et al., 2012). A larger trial 
treating patients with K-Ras mutated tumours with drugs targeting these pathways is on-
going
4
. 
However another centre found that matching colorectal cancer patients resistant to 
conventional therapies to clinical trials on the basis of their molecular profile provided no 
benefit (Dienstmann et al., 2012). There are three non-mutually exclusive explanations for 
this. The first is that the doses used in these trials were not biologically effective (this in part 
may be due to overlapping toxicity profiles limiting the use of full doses of combination 
therapies). The second is that patients were incorrectly matched due to deficiencies in the 
methods used to characterise the molecular phenotype. Third, patients were incorrectly 
matched because of an insufficient understanding of how different mutations affect 
interactions between different signalling pathways.  
Our data address the third of these concerns. That inhibition of mTORC1 does not protect 
mice with K-Ras mutated tumours and that treatment with dual mTORC1/2 inhibitors is less 
effective than genetic deletion of an mTORC2 specific component suggest selective inhibition 
                                                          
3
 http://www.accessdata.fda.gov/cdrh_docs/pdf11/p110030a.pdf  
4
 http://clinicaltrials.gov/ct2/show/NCT01347866?term=mTOR+K-ras&rank=2 
132 
 
of mTORC2 may be a more effective approach. Additionally, a monotherapy may reduce the 
toxicity profile of the treatment thus increasing efficacy. To date no selective 
pharmacological inhibitor of mTORC2 has been developed, but delivery of a siRNA to Rictor, 
targeted to CRC cells may have promise (see (Kong et al., 2012) for a review of this 
approach). 
Finally, determining whether other genetic changes found in some K-Ras mutated colorectal 
tumours (eg loss of p53 or PTEN) modulate the dependency on mTOR signalling would be 
invaluable in determining the scope for inhibition of mTORC2 as a treatment strategy.
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Chapter 5. Translation elongation as a component of the cold shock 
response 
5.1 Introduction 
Culturing cells at hypothermic temperatures has appeal for the industrial production of 
recombinant proteins. Superficially, lower temperatures are cheaper to maintain, but more 
significantly the yield of some recombinant proteins is increased in cells cultured in mild 
hypothermic conditions (~30
o
C), despite a reduction of total protein synthesis rates (Al-
Fageeh et al., 2006).  This increased yield is not observed for all recombinant proteins. The 
characterisation of the mechanisms associated with cold stress (the cold shock response), 
would therefore be helpful in designing protein expression platforms that will maximise the 
yield of any given protein. 
The term  “cŽůĚƐŚŽĐŬƌĞƐƉŽŶƐĞ ?ŚĂƐďĞĞŶƵƐĞĚƚŽĚĞĨŝŶĞĂƌĂŶŐĞŽĨƚĞŵƉĞƌĂƚƵƌĞƚƌĞĂƚŵĞŶƚƐ
from near zero Celsius to moderate hypothermia. This is unfortunate as the responses differ 
between these conditions. Near zero conditions are associated with severe growth arrest (Al-
Fageeh et al., 2006) and a 95 % reduction in protein synthesis (Hofmann et al., 2012). 
Characterisation of these conditions may be of use to improving preservation of transplant 
organs but of little use to industry. The cold shock response described in this chapter is to 
that of mild hypothermia.   
Initial work by Dr Amandine Bastide (Willis group) showed that culturing the kidney epithelial 
cell line, HEK293, at 32
o
C for 24 hr resulted in a ~60 % reduction in protein synthesis (Figure 
5-1A) and an increase in fraction of eIF2 that is phosphorylated (Figure 5-1B). There were no 
significant changes in the abundance of eIF4G or eIF4E or the phosphorylation of 4E-BP1. A 
slight increase in phosphorylation of eIF4E was observed in the cold shocked cells. 
Phosphorylation of eIF4E may be associated with an increase in protein synthesis (Bianchini 
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et al., 2008), but given the reduction in global protein synthesis observed in response to cold 
shock this is either not the case in HEK293 cells or else the effect is masked by reductions via 
other mechanisms. The increase in eIF2 phosphorylation would be expected to reduce the 
translation initiation rate and thus reduce the polysomal association of mRNA. However 
there was little difference in polysomal association of cells treated at 37
o
C and 32
o
C (Figure 
5-1 C). An explanation consistent with this observation is that a reduction in translation 
elongation is also a component of the cold shock response. This change was not mediated by 
changes in phosphorylation of either of the canonical regulators of elongation: eEF2k and 
eEF2 (Figure 5-1 D). To further investigate the role of elongation in cold shock I collaborated 
with Dr Bastide and Dr John Knight (both of the Willis Group). 
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Figure 5-1 The cold shock response in cultured mammalian cells 
HEK293s were cultured for 24 hr at 37
o
C or 32
o
C, data presented are all from Dr A. Bastide. 
A [
35
S] Met-label incorporation over 30 min. Data are the mean of 8 independent 
experiments +/- SD. Experiments were the average of 3 wells normalised to the 37
o
C value 
B Representative western blots for the abundance and phosphorylation of initiation factors 
C Representative polysome traces  
D Representative western blots for the abundance and phosphorylation of key elongation 
factors. 
A 
B 
C 
D 
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5.2 Ribosome profiling of cold shock treated cells.  
To test the assumption that elongation rates were decreased in response to cold shock the 
harringtonine run-off approach was used (described in 2.6.hiii) and 4.3). The reduction in 
polysomal association occurred more rapidly in cells cultured at 37
o
C than those cultured at 
32
o
C (Figure 5-2). The possibility that harringtonine was less efficiently absorbed into the cell 
at 32
o
C, allowing for new cycles of initiation and elongation during the run-off period, cannot 
be excluded but the data from the harringtonine run-off assay are nonetheless consistent 
with a reduction in elongation rate being partially responsible for the reduction in protein 
synthesis rates in cold shock. 
The harringtonine run-off approach can be coupled with ribosome profiling to estimate 
global elongation rates and, for transcripts sequenced to sufficient depth, gene specific 
elongation rates. The report that the global elongation rate in cultured MEFs is 5 
codons/second (Ingolia et al., 2011)  created concern that using the same time intervals used 
for the initial run-off assays (Figure 5-2)  would result in ribosome occupancy estimates only 
for long transcripts. To attempt to estimate elongation rates across a range of transcript 
lengths, run-off times of 60, 90 and 120 seconds were used. Translatome libraries were 
obtained as described in 2.6.i and analysed as per 2.6.j. There was no time dependent 
reduction in read density downstream from the start site in the translatome libraries, so it 
was concluded that the harringtonine treatment had not been successful in this instance. 
Therefore, further work focussed on the H0 libraries, i.e. those from cells treated with 
cycloheximide alone.  
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Figure 5-2 Translation elongation is reduced during cold shock 
Representative sucrose gradient profiles from HEK 293 cells subject to harringtonine run-off 
after 24 hr at 37
o
C or 32
o
C. Harringtonine was added to the media, the cells returned to the 
incubator and cycloheximide added at the indicated time points.   
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The translatome library from cells cultured at 37
o
C showed a prominent start site peak, 
ƉĞƌŝŽĚŝĐŝƚǇǁŝƚŚŝŶƚŚĞ^ĂŶĚƚŚĞĂďƐĞŶĐĞŽĨƌĞĂĚƐŵĂƉƉŝŶŐƚŽƚŚĞ ? ?hdZ ?&ŝŐƵƌĞ ?-3A). The 
cold shock translatome library showed no prominent start site peak, a partial reduction of 
periodicity within the CDS and extensive read density on  ? ?hdZs (Figure 5-3B). The read 
ĚĞŶƐŝƚǇŽŶ ? ?hdZƐ, and Western blots that showed no difference in the size of proteins in 
response to cold shock, suggested there was no failure of translation termination, but a 
failure of ribosomal release. This was surprising as translation termination is normally tightly 
coupled with ribosome release (see 1.2). Whilst there have been reports of termination 
codon run-through in yeast in response to stress (Gerashchenko et al., 2012) this is typically 
ŽŶůǇƚŚĞĨŝƌƐƚĨĞǁŶƵĐůĞŽƚŝĚĞƐĚŽǁŶƐƚƌĞĂŵĂŶĚŶŽƚƚŚƌŽƵŐŚŽƵƚƚŚĞ ? ?hdZĂƐŽďƐĞƌǀĞĚ ?To 
ƌĞƐŽůǀĞǁŚĞƚŚĞƌƚŚĞŽďƐĞƌǀĞĚ ? ?hdZŽĐĐƵƉĂŶĐǇǁĂƐĂƌĞƐƵůƚŽĨa technical flaw in the 
ribosome profiling method or a genuine component of the cold shock response, an RNase 
protection assay was used to compare the monosome fragments obtained at 37
o
C and 32
o
C. 
This approach removed the need to size select fragments and generate sequencing libraries, 
two potential sources of technical error.
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Figure 5-3 Changes in ribosome profiling reads in response to cold shock. 
A Alignment of reads from translatome libraries derived from HEK293 cells cultured at 37
o
C, relative to start site (left) and stop site (right) 
B Same as A but for HEK293 cells cultured at 32
o
C for 24 hr. 
B 
A 
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5.3 InvesƚŝŐĂƚŝŶŐƚƌĂŶƐůĂƚŽŵĞƌĞĂĚƐŝŶƚŚĞ ? ?hdZ 
RNase protection assays involve the hybridisation of a radiolabelled probe complementary to 
a portion of the transcript of interest to an RNA pool. The hybridised region is protected from 
digestion by RNase A and RNase T1. If the hybridisation conditions used are correctly 
optimised, and assuming the probe is in excess of the target, the activity of the probe 
fragments that remain after RNase digestion will be proportional to the abundance of the 
specific target. Performing the assay in the presence of a total RNA sample will give a reading 
of the abundance of the targeted transcript; performing it on RNA extracted from the 
monosome peak of an RNaseI digested lysate from cycloheximide treated cells (i.e. the 
location of RPFs) will give a reading of ribosome density.  
Gapdh mRNA was well expressed at both temperatures and ƐŚŽǁĞĚĞǆƚĞŶƐŝǀĞ ? ?hdZƌĞĂĚƐ in 
the translatome library from 32
o
C but not 37
o
C. dŚĞ ? ?hdZŽĨgapdh is 184 nt, considerably 
shorter than the CDS of either short or long isoforms (881 nt and 1007 nt respectively). Using 
a longer probe for the CDS region might have required a higher hybridisation temperature 
and would give a stronger radioactive signal, so for convenience both probes contained 184 
nt complementary to their respective targets. Probes were larger than 184 nt as they also 
contained flanking regions of the vector.  
In the absence of RNase there was little degradation of the probe (Figure 5-4). Hybridisation 
with yeast tRNA did not protect the probe from digestion (no input control), however the 
total RNA sample resulted in protection of a ~184 nt band. A five-fold dilution of total RNA 
was adequately detected, demonstrating the assay is quantitative. It is possible that there 
was hybridisation to transcripts other than gapdh that share a similar sequence. This is 
unlikely; RNase A/T1 is able to cleave probes between as few as two adjacent mismatches 
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(Lau et al., 1993)
5
 and whilst there are bands smaller than 184 nt it is more likely that these 
are due to RNA degradation prior to loading as this is was also observed in the lanes 
containing the ladders.    
                                                          
5
 Because RNase A/T1 collectively cleave after C, G and U residues, if the region of mismatch on the 
probe  is 2 morĞ ?ƐĨůĂŶŬĞĚďǇĂŶŽŶĞŝƚŚĞƌƐŝĚĞƚŚĞŶƚŚŝƐǁŽŶ ?ƚďĞĐůĞĂǀĞĚ ?ďƵƚƚŚŝƐǁŝůůďĞ
comparatively rare.   
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Figure 5-4 RNase protection assay for gapdh CDS 
An autoradiograph from an RNase protection assay. The indicated masses of total RNA 
extracted from HEK293 cells were hybridised with a [
32
P] labelled probe to gapdh and 
digested as described in 2.6.m. A negative control with yeast tRNA and an undigested control 
were also performed. The resulting products were recovered, denatured and separated on a 
6 % denaturing acrylamide gel. The probe contains a 184 nt region antisense to gapdh CDS.     
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Ribosome protected fragments (RPFs) are ~ 30 nt; much shorter than the probes. All other 
things being equal, this means the predicted Tm for the probe:full length transcript  hybrid is 
higher than for the RPF:probe hybrid. An often quoted prediction formula (Bodkin and 
Knudson, 1985) is recommended for hybrids longer than 100 bp (Sambrook, 1989) so may 
not have been appropriate for RPFs. Nevertheless this formula for a 30 nt fragment with 25 
% GC under the conditions used for the total RNA gave a Tm of 52.9
o
C so it was decided to 
initially test to see if RPFs would hybridise under those conditions.  
In lanes from reactions containing the monosome fraction, a smear of 28-34 nt in length was 
observed, consistent with hybridisation to RPFs. As with the total RNA samples, a 5-fold 
dilution of the monosome sample could also be detected. Interestingly, when RNA from the 
fraction corresponding to two ribosomes was used for the assay bands were observed 
between 28 and 34 nt and between 56 and 68 nt (far right lane, Figure 5-4). The ~30 nt 
smear may be due to two individual ribosomes bound to each other after RNaseI digestion 
(ribosome dimers). The ~60 nt smear maybe due to due adjacent ribosomes being so close 
on an mRNA as to prevent RNase digestion between them (disomes). Further evidence for 
these phenomena and their implications for ribosome profiling are presented in the next 
chapter. 
In order to resolve the RPFs a higher percentage denaturing acrylamide gel was used than 
had been the case for the RPA on total RNA. This revealed some very short (<25 nt) bands in 
the yeast tRNA control lane, which were also present in all lanes from reactions that were 
treated with RNase. This result suggests that some of the probe must have hybridised to 
itself, to an adjacent probe or the yeast tRNA (in the no input lane). Given that the shorter 
the hybrid the higher the GC % necessary to retain the same Tm, at least one of two things 
are likely to be true: 1) There were very GC-rich sections of the probe, 2) the hybridisation 
temperature was lower than it needed to be to detect RPFs. Consistent with the latter, the 
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total RNA lanes contained a prominent band below 28 nt which could be microRNAs (~21 nt), 
however bands of the same size were observed in the no input lane suggesting self-
hybridisation was a more likely cause.
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Figure 5-5 RNase protection assay on fragments within the monosome peak 
An autoradiograph from an RNase protection assay performed with the gapdh CDS probe on 
the indicated masses of RNA obtained from the monosome peak of RNaseI digested HeLa 
lysate. The outermost lane is from the RNA obtained from the peak corresponding to two 
ribosomes. The undigested control is 1/10
th
 of total input.  
146 
 
If the temperature was too low then it is possible that ~30 nt fragments of rRNA or other 
mRNAs with 1 mismatch to the probe were detected in the monosome fractions. However if 
this was the case then it would be unlikely that none of the signal would be from the 
hybridisation of gapdh-derived RPFs. Therefore the absence of any smear at ~30 nt would be 
indicative of no ribosome occupancy within region complementary to the probe. When the 
monosome fractions from the samples that were ribosome profiled were assayed, a 30 nt 
ƐŵĞĂƌǁĂƐŽďƐĞƌǀĞĚǁŝƚŚƚŚĞ^ƉƌŽďĞďƵƚŶŽƚƚŚĞ ? ?hdZƉƌŽďĞ(Figure 5-6). From this it 
was concluded ƚŚĞƚƌĂŶƐůĂƚŽŵĞƌĞĂĚƐƚŚĂƚŵĂƉƉĞĚƚŽƚŚĞ ? ?hdZƐǁĞƌĞůŝŬĞůǇƚŚĞƌĞƐƵůƚŽĨĂ
technical problem when the ribosome profiling was performed.
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Figure 5-6 RNase protection assay does not show evidence of 3' UTR ribosome footprints 
An autoradiograph from an RNase protection assay performed with either gapdh CDS probe 
Žƌ ? ?hdZprobe on the H0 samples that were sequenced and represented in Figure 5-3. Both 
probes contain a 184 nt region ĂŶƚŝƐĞŶƐĞƚŽŐĂƉĚŚ ?^Žƌ ? ?hdZĂƐĂƉƉƌŽƉƌŝĂƚĞ ? 
148 
 
5.4 Discussion 
The cold shock response involves the modulation of multiple different cellular processes. 
That culturing HEK293s in hypothermic conditions does not reduce polysomal association 
despite a reduction in global protein synthesis rates suggests elongation rates are reduced. 
Consistent with this, ribosome run-off after harringtonine treatment is much slower at 32
o
C. 
This change in elongation rate is not mediated by eEF2 or eEF2k, so perhaps the cause is 
thermodynamic phenomenon (i.e. at lower energy levels recruitment of tRNAs and 
subsequent peptide bond catalysis occurs more slowly). The failure of the harringtonine 
treatment in the ribosome profiling experiment meant it was not possible to address 
whether some transcripts are differentially regulated at the level of elongation. 
That reads from translatome libƌĂƌŝĞƐŵĂƉƉĞĚĞǆƚĞŶƐŝǀĞůǇƚŽ ? ?hdZƐǁĂƐƐƵƌƉƌŝƐŝŶŐ ?ďƵƚ
subsequent RNase protection assays suggest this was due to a technical error. It is unclear 
precisely at what stage of the process this occurred. There were two important differences 
between the gel electrophoresis used to resolve RPFs in the ribosome profiling compared to 
the RPAs. First, the gels used for ribosome profiling were considerably shorter than for RPAs 
so the resolution would have been less crisp (i.e. under or oversized, non RPF fragments 
could have been selected). Second, the markers used in the RPA were 28 and 34 nt rather 
than the 27 and 33 nt used in the profiling work. The reason for the difference was that the 
first ribosome profiling paper used these shorter markers in a yeast system (Ingolia et al., 
2009) but a subsequent publication from the same group working in a mammalian system 
used the larger ones (Ingolia et al., 2011). dŚĞZEĂƐĞƉƌŽƚĞĐƚŝŽŶĂƐƐĂǇǁŝƚŚƚŚĞ ? ?hdZƉƌŽďĞ
does show bands just below the 28 nt marker so it is possible that these were extracted with 
the 27/33 nt markers. It should be noted that the 27/33 markers did give the expected 
distribution of RPFs in the iMet work and in the 37
o
C libraries, and a degree of periodicity at 
32
o
C so they can be used to capture RPFs, but there is a risk of contaminating fragments 
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might result in spurious conclusions.   
Ultimately these experiences served as a cautionary tale. In subsequent collaborative work, 
that is not the scope of this thesis, the 28/34 nt markers were used and gave sequencing 
data with the expected RPF periodicity.   
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Chapter 6. The identification and remediation of biases in next 
generation sequencing protocols. 
6.1 Introduction 
Next generation sequencing is a powerful tool. It allows analysis of the whole genome, 
transcriptome or translatome without any prior assumptions as to their composition.  
However, as with all techniques there are limitations.  As highlighted in Chapter 3, statistical 
approaches commonly applied to RNA-seq experiments are not applicable to ribosome 
profiling data such that differential translational efficiency can only be accurately tested for 
well translated, abundant transcripts. 
More fundamentally, the assumption of all next-generation sequencing work is that the read 
data obtained is a good estimate of the relative abundance of features within a biological 
system (e.g. microRNA/mRNA abundance, ribosome occupancy, RNA-Protein interactome). 
Biases in the technique will reduce the extent to which this assumption is true and thus the 
possible strength of conclusions that can be inferred from sequencing data.  
A simple reason why data may not fully reflect the biological complexity is if insufficient RNA 
is used to generate the sequencing library meaning fragments from lower abundance 
transcripts are excluded. In silico fragmentation of the human RefSeq library into 30 nt 
fragments yields 4.2x10
8
 fragments, 93 % of which are unique (Julian Wang, Willis lab). 
Assuming equal nucleotide content, the molecular weight of a 30 nt RNA will be 9759 g/mol. 
Typically no less than 10ng of RPF fragment pool is used in a ribosome profiling experiment: 
~6.1x10
11
 molecules. Even factoring in that 80 % of these fragments will come from 20 % of 
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transcripts it seems unlikely transcripts are under-sequenced because of a lack of input 
material
6
. 
However, there are significant differences in the data obtained when sequencing an identical 
pool of RNA or DNA on different platforms (Quail et al., 2012, Toedling et al., 2012). This 
implies there are at least two sources of bias in sequencing data: library preparation and 
sequencing reaction chemistry (both of which differ between platforms). There is also a third 
source of bias that may be particularly significant in ribosome profiling: fragment generation. 
Ribosome profiling assumes that the ratios of ribosome protected fragments (RPFs) in the 
fragment pool are proportional to the steady state ribosome density across a message. If this 
is not the case then making conclusions on changes in the location of ribosomes should be 
made with caution  W it could be that the ribosome occupancy is actually increased at a 
feature of interest but that biases in fragment generation result in a lower proportion of RPF 
fragments from that feature in the fragment pool. 
To briefly summarise, biases at any of the three stages identified will lead to results that are 
not representative of the biological system being studied. Identifying how significantly these 
biases skew data and potential remedies to them is thus important. This chapter will focus 
on biases in fragment isolation in the context of ribosome profiling and in library preparation 
on Life Technologies platforms.  
6.2 Ribosome protected fragments may not fully reflect ribosome occupancy 
Central to ribosome profiling is the nuclease digestion of lysates leaving fragments where 
ribosomes are bound: ribosome footprints. A single eukaryotic ribosome will protect ~30 nt 
from digestion, but protein-mRNA complexes may also do the same. For this reason 
                                                          
6
 Current sequencing platforms have a maximum yield of approximately 2x10
8
 reads per multiplexed 
library, not all of which are useable, so not every possible fragment is eventually sequenced 
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footprints are isolated from the monosome peak of a sucrose gradient (i.e. just one ribosome 
with associated with an RPF). 
It is then assumed that all ribosome occupancy is reflected in the relative distributions of 
these 30 nt RPFs. For instance, given two equally abundant mRNAs where the first has twice 
the ribosome occupancy, fragments from the first will appear twice as frequently in the 
translatome fragment pool.  
However, the sucrose gradient traces from RNase-digested lysates showed peaks 
corresponding to multiple ribosomes (Figure 6-1 A). Notably, this is also seen in all published 
papers that display sucrose gradient traces from ribosome profiling in eukaryotic systems 
(Ingolia et al., 2009, Stadler and Fire, 2011). The existence of these peaks could be due to 
insufficient RNase digestion (i.e. concentration, time or temperature not optimised) or due 
to adjacent ribosomes being so close as to prevent the region between them being accessed 
by RNase: ribosome stacking (Wolin and Walter, 1988). A hybrid of these two explanations is 
also theoretically possible  W the shorter the distance between adjacent ribosomes the 
smaller the region of mRNA that can act as an initial binding site for RNase I, leading to 
regions of high ribosome density being digested less efficiently than regions of low density. 
Northern blotting with a 20 nt fragment complementary to a region within the CDS of an 
abundant mRNA, revealed that whilst the monosome peak contains mRNA fragments of ~30 
nt, the bi-ribosome peak (i.e. 2 ribosomes present) contains a mixture of ~30 nt and ~60 nt 
fragments (Figure 6-1 B). A similar observation was made using an RNase protection assay 
with a probe spanning 184 nt of the CDS of gapdh mRNA (Figure 5-5). Protection of a ~60 nt 
fragment is consistent with ribosome stacking. If the hybrid explanation were true, then 
species slightly larger than the equivalent of two monosomal RPFs would be expected. This 
was not the case in the RNase protection assay. Whilst there are larger molecular weight 
bands in the northern blots, these are much larger than 60 nt, are found in all fractions and 
are reduced in intensity after washing at a higher temperature (not shown). It was therefore 
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presumed that they were the result of non-specific binding to non-mRNA species. An 
increase in RNase concentration significantly reduced the intensity of these non-specific 
bands but did not result in the loss of the ~60 nt band (Figure 6-1 C). 
The presence of a ~30 nt band in the bi-ribosome peak is somewhat perplexing; if they are 
RPFs then they are from monosomally associated mRNA. The 1 ml of lysate added atop the 
gradients represents ~10 % total volume so it is possible that the disomes at the top of the 
lysate sediment alongside monosomes at the bottom of the lysate. Another possibility, 
described in Chapter 5, is that the dimerisation of ribosomes after digestion results in the 
associated RPFs sedimenting in the bi-ribosome peak. 
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Figure 6-1 RNase I digestion does not reduce all ribosome footprints to monosomes 
A) Representative sucrose gradient trace of lysates from cycloheximide treated MEFs. 
Lysates were prepared as described in 2.6.iii) and 2.6.hii)  
B) Northern blot with a 20 nt DNA probe anti-sense to eEF1a. Each lane contains 1/5
th
 of the 
RNA extracted from the fraction listed above. An illustration of ribosome stacking (giving 
disomes) and post digestion ribosome dimerisation is shown on the right.  
C) Same as B but with digestion performed with twice the RNase I concentration
B 
C 
A 
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Ribosome dimers have been detected in undigested lysates from excised liver and cell lines 
of hamster and rat, but not from mice or human cell lines (Reader and Stanners, 1967). 
Dialysis against RSB lysis buffer, which has near physiological levels of K
+
 and Mg
2+
 (Romani, 
2007, Williams and Wacker, 1967), reduced, but did not abolish, dimerisation in that case. 
RNase digestion of the hamster and rat lysates did not remove the 115S (bi-ribosome) peak, 
but did result in the radioactivity from the 14C-Phe used to trace nascent protein synthesis 
being localised in the 80S peak and not the 115S peak. Therefore the authors concluded that 
the dimers were not associated with translating mRNA.  
By contrast, the ribosome profiling work presented in this thesis shows what may be ~30 nt 
mRNA fragments in the 115S peak of RNase digested lysates from human (Figure 5-5) and 
mouse cells lines (Figure 6-1). A possible explanation for the difference between these data 
and the previous observations (Reader and Stanners, 1967) is that under harsh RNaseI 
treatment there is extensive digestion of the ribosome itself (hence the contaminating rRNA 
fragments in translatome libraries) which may expose new sites on the partially digested 
ribosome that can hybridise to another. High cation concentrations and that lysates are 
placed on ice after digestion and centrifuged at 4
o
C may further favour dimerisation.  
To investigate the role of cation concentration in the presence of the 115S peak, HeLa cells 
were lysed in either a buffer used routinely within the Willis lab (HSB; see 2.6.iii)) or a lower 
salt and magnesium buffer used by (Guo et al., 2010) (LSB). The sucrose gradients used for 
fractionation contained the same ion concentrations as the buffer. The polysomal 
distribution was different in the undigested samples. High salt conditions dissociate 80S 
ribosomes not bound to mRNA (vacant couples) (Falvey and Staehelin, 1970), hence the 
prominent 80S peak in Figure 6-2 A is not seen in Figure 6-2 B. It is unclear whether the 
relative increase in heavy polysomes in HSB is because polysomes are not as stable in LSB or 
because HSB results in aggregation of lighter polysomes. Interestingly the RNase I 
concentration used in the HSB resulted in destruction o
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was somewhat surprising as when RNase I was first characterised it was reported to have 
optimal activity in NaCl or KCl concentration of ~200mM with an approximately 10 % 
decrease in activity at both 300mM and 100mM (Spahr and Hollingworth, 1961). Increasing 
Mg
2+
 was reported to reduce activity, but not as dramatically is seen in Figure 6-2 so there is 
presumably an additive effect of high salt and high magnesium.  Crucially, bi-ribosome peaks 
were present in both LSB and HSB, though less in the LSB. This could be because there were 
fewer heavy polysomes in the LSB and thus less ribosome stacking or because the ionic 
conditions affect dimer formation.  Comparison of the relative abundance of dimers and 
disome fragments would distinguish between these two possibilities, but this was not 
performed. When the Mg
2+
 concentration in the lysis buffer was reduced to 1.5mM no 
polysomes could be recovered, possibly because intracellular magnesium levels are higher 
than has been previously reported.
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Figure 6-2 The effect of buffer composition on the bi-ribosome peak 
Identical plates of HeLa cells were lysed directly and digested under conditions described in 
the legends.  
A Lysis and sucrose density ultracentrifugation in a low salt, low magnesium buffer (100mM 
KCl, 5mM MgCl2, 10mM Tris-HCl pH 7.4, 100 µg/ml cycloheximide, 2 mM DTT). The offset of 
the 80S peak in the digested samples compared with the undigested ssamples is likely due to 
pipetting error when the gradients were made. 
B As A but in a high salt, high magnesium buffer (300mM NaCl, 15 mM MgCl2, 15mM Tris-HCl 
pH 7.5, 100 µg/ml cycloheximide, 2 mM DTT) 
B 
A 
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To address concerns that the 115S peak may be due to insufficient RNaseI activity in the HSB 
a range of RNaseI concentrations were used on lysates from NIH 3T3 MEFs
7
 and HeLas. 
Surprisingly, in MEF lysates the 115S peak was increased when higher RNaseI concentrations 
were used (Figure 6-3 A). To gain comparable width peaks in sucrose gradient traces, it was 
necessary to maintain the same volume of lysate at each RNaseI condition so lysates with 
increased RNase concentration also had higher concentrations of glycerol (which inhibits 
RNase). The high RNase concentration condition had 2.5 % glycerol and there was no 
increase in the height of peaks larger than disomes so it seems unlikely the RNase activity 
was lower at the higher concentration.  A possible explanation is with more digestion there is 
more opportunity for dimerisation. In HeLa extracts, increasing RNase concentration had no 
effect on the size of the 115S peak and only a modest decrease in heavier polysomes (Figure 
6-3 B).  
                                                          
7
 The undigested lysates are more polysomal that was seen in Chapter 2 and Figure 6-1, this is due to 
the extraction method being altered to replace scraping of cells into PBS and subsequent pelleting 
with lysis of cells directly on the plate. The scrape-first method appears to reduce polysomal 
association by an unknown mechanism. 
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Figure 6-3 Increased RNase I digestion increases bi-ribosome peak in MEFs but not HeLa  
A Identical plates of MEFs were lysed in high salt buffer and digested with the indicated 
concentrations of RNase in the figure legends. 
B As A, but with HeLas and with a smaller volume of lysate loaded onto the gradient to give 
greater separation between peaks 
B 
A 
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Collectively the above experiments suggest that RNase I digestion is not sufficient to yield 30 
nt RPFs from all locations of ribosome occupancy. However both the RPA and northern blot 
can suffer the same limitation: non-specific hybridisation of the probe. A strategy to address 
this would be to specifically label mRNA and detect the location of labelled fragments in the 
sucrose gradient, thus removing any hybridisation steps. Labelling intracellularly will not 
result in specific labelling of mRNA as all RNAs use the same nucleotides. Treatment with 
300nM CX-5461 can reduce rRNA synthesis by up to 80 % with only modest reduction in the 
abundance of select mRNAs and translation (Drygin et al., 2011). However rRNA accounts for 
~70 % of total RNA so even an 80 % reduction in synthesis would likely result in more 
labelled rRNA than mRNA, and associated background fragments. Therefore transfection of 
in vitro transcribed mRNA is necessary for this strategy. Attempts to use 4-thiouridine as a 
labelling molecule were unsuccessful as conjugation to biotin and subsequent detection with 
streptavidin-HRP, which can be performed in solution, could not be achieved on labelled RNA 
immobilised on a nylon membrane (i.e. northern blotted). [
33
P] labelled mRNA was used 
instead as no secondary detection method was required. In order to maximise the specific 
activity within the RPF pool (aiding detection), increase the likelihood of observing ribosome 
stacking and reduce the possibility that overexpression of the transcript would substantially 
perturb ƚŚĞĐĞůůƐ ?ĂŶĂďƵŶĚĂŶƚŵZEƚŚĂƚŝƐĂƐƐŽĐŝĂƚĞĚǁŝƚŚŚĞĂǀǇƉŽůǇƐŽŵĞƐǁĂƐĐŚŽƐĞŶ Pɴ-
actin. 
 1-2 hr after lipofection of [
33
P]-actin mRNA into HeLa cells, the labelled mRNA was found in 
light polysomal fractions, unlike the native transcript that was in heavy polysomes (Figure 6-
4).  Lipid-based transfection has been reported to retain mRNAs in discrete, stabilised 
particles (Barreau et al., 2006). To investigate whether this accounted for the reduced 
polysomal association of the transfected mRNA, the experiment was repeated with 
nucleofection (i.e. electroporation) in place of lipofection. This did not address the issue of 
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polysomal association as lysates obtained 3 hr
8
 after nucleofection showed extensive 
degradation and radioactive bands corresponding to the 18S and 28S rRNA (data not shown).  
Degradation was also observed in the lipofected samples (see fractions 1 and 2 of Figure 6-4) 
and lysates taken 4 hr after lipofection had no full length [
33
P] transcript (data not shown). By 
contrast the half-ůŝĨĞŽĨĞŶĚŽŐĞŶŽƵƐɴ-actin mRNA in HeLa cells has been reported to be 6-12 
hr (Khalili and Weinmann, 1984). There are two possible explanations for the reduced 
polysomal association and rapid degradation of the [
33
P] labelled mRNA. First, during the 
transcription and processing of endogenous mRNAs, proteins are associated that protect the 
mRNA from degradation and aid translation  W ƚŚĞƐĞĂƌĞŶŽƚƉƌĞƐĞŶƚŝŶƚŚĞ “ŶĂŬĞĚ ?ZE
transfected into cells. Second, regions of the T-Easy vector that flank the cloning site were 
ƉƌĞƐĞŶƚŝŶƚŚĞĂĐƚŝŶŵZE ?ĞĨĨĞĐƚŝǀĞůǇĂůƚĞƌŝŶŐƚŚĞ ? ?hdZĂŶĚ ? ?hdZ ? The linearisation site 
(SpeI) for the template plasmid was only 4 nt downstream from the cloning site and created 
ŶŽĂĚĚŝƚŝŽŶĂůŵŝĐƌŽZEƐŝƚĞƐƐŽŝƚŝƐƵŶůŝŬĞůǇƚŚĂƚƚŚĞ ? ?hdZŵĞĚŝĂƚĞĚĂŶǇĂĨĨĞĐƚ ? However, 
after these experiments were performed it was noticed that the 50 nt between the cloning 
site and the T7 transcriptional start site of pGEM-T Easy does contain a start codon in good 
Kozak context:  GGCCGCCATGG (ggcRccAUGG). If translated, this would create a 42 amino 
acid uORF that overlaps the CDS of the actin transcript and so might explain the reduced 
polysomal association of the in vitro transcribed mRNA. Using SP6 polymerase to transcribe 
the mRNA from a vector with the actin sequence in the opposite orientation would have 
produced a transcript without an AUG in such good context but this was not performed. The 
lack of success in this approach means that it may be possible that the bi-ribosome peak is 
not particularly significant and the data presented thus far are simply a consequence of 
methodological artefacts.
                                                          
8
 Cells were left for 3 hr to allow attachment to the culture plates 
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Figure 6-4 Transfected in vitro transcribed actin mRNA does not share the same polysomal 
distribution as the native transcript 
A Polysomal association of [
33
P] labelled capped mRNA 1hr (top) and 2hr (bottom) after 
lipofection into HeLa cells. ¼ of RNA was from each fraction was northern blotted. The 
monosome peak was within fraction 5. 
B The membrane in A was probed with a [
32
P] labelled probe complementary to actin. The 
transfected mRNA had a longer polyA tail and so is visible above the native transcript.
B 
A 
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6.3 Ligation biases in deep sequencing libraries 
Even if no biases are introduced at the level of fragment generation, sequencing data may be 
skewed by biases in the library generation protocols. In order to sequence RNA fragments 
using current platforms, they must be ligated to adaptors that can be used to amplify all 
fragments onto beads (or in the case of Illumina directly and later versions of SOLiD 
technology directly onto the sequencing slide) to be sequenced. 
SOLiD transcriptome libraries are generated from RNase III fragmented polyA+ RNA. It was 
assumed that the fragmentation protocol had been optimised by Life Technologies to be 
essentially random and thus that sequenced reads obtained would map evenly across the 
transcript. This is not the case (Figure 6-5). This is at least in part because digestion by RNase 
III is not unbiased (it has preference for dsRNA), a fact acknowledged in later editions of the 
SOLiD Total RNA-Seq kit manual. Alkaline (i.e. chemical) fragmentation methods give much 
more even coverage than enzymatic ones (Danny Nedialkova, personal communication, 26
th
 
September 2012).  
Given that the uneven coverage in the transcriptome libraries is similar between the control 
and iMet cells (see Figure 6-5 and Chapter 3) it seems reasonable that comparison between 
conditions for a given transcript can be performed regardless of biases. However, if library 
generation biases are substantial they will prevent accurate quantification of the abundance 
of a fragment/transcript relative to the whole transcriptome. This would limit the ability to 
answer a question such as: what is the most abundant mRNA/microRNA in a particular cell? 
Furthermore it may limit attempts to make position specific inferences about ribosome 
profiling data  W e.g.: was there a lack of translatome reads mapping to a particular feature 
because there was genuinely no ribosomes there or because the fragments generated were 
selected against due to biased library preparation?   
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Figure 6-5 Uneven read distributions within transcriptome libraries 
The distribution of reads from transcriptome libraries prepared with fragmentation by RNase III that map to ɴ-actin mRNA. ɴ-actin is the most abundant 
mRNA in these two sequencing libraries. Treatment is over expression of tRNAi
Met 
(see Chapter 3 for details of cell lines).  
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There are three steps in library generation: ligation of adaptors, reverse transcription to 
generate cDNA and PCR of the resulting cDNA. The use of random hexamers to prime 
reverse transcription does bias sequencing data (Hansen et al., 2010), but the use of a 
universal RT primer that binds to a sequence on the adaptor circumvents this. PCR 
amplification results in under-representation of both AT rich and GC rich regions (Aird et al., 
2011, Dohm et al., 2008) but this can be minimised by the use of polymerases that have been 
generated through molecular evolution to reduce these biases (e.g. KAPA HiFi) or by using 
alternative protocols if the likely AT content of the library is known (Oyola et al., 2012). It 
may also be possible to correct for PCR biases using statistical methods (Benjamini and 
Speed, 2012), but it is unclear how appropriate these methods will be for translatome data 
where GC content may play role in ribosome occupancy under different conditions.  
The approaches for the ligation of fragments differ between Illumina and Life Technologies 
platforms. For completeness and to aid in understanding of referenced work that follows, 
both are briefly described below. 
In the Illumina approach, RNA adaptors are sequentially ligated to the  ? ?and the 5 ?ĞŶĚs of 
fragments using truncated T4 RNA ligase 2 (trRnl2) and T4 RNA ligase 1 (Rnl1) respectively. 
Rnl1 shows sequence specific biases (Jayaprakash et al., 2011) and the Illumina strategy gives 
libraries with very patchy coverage (Ingolia et al., 2009).  Life Technologies platforms (SOLiD 
and Ion Torrent) use duplexed adaptors with degenerate 6 nucleotide overhangs that can 
hybridise to the fragments and guide ligation with T4 RNA ligase 2 (Patent US 20/00279305 
A1 and Figure 6-6).  However, nucleotide composition is known to affect hybridisation 
efficiency (hence why random hexamer priming is biased) and in experiments ligating single 
fragments and overhang adaptors differential ligation efficiency has been observed (Zhuang 
et al., 2012). Furthermore the degree of predicted structure correlates with the 
representation of different variants of miR-1 in SOLiD libraries (Tian et al., 2010).
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Figure 6-6 Schematic of Life Technologies and alternate library generation methods 
The standard library construction for SOLiD and Ion Torrent libraries (left) involves the hybridisation of fragments to duplex adaptors with degenerate 6n 
ends, these can then act as primers for reverse transcription and PCR amplification (green and blue regions). The alternate method (right) uses ligation of an 
5 ?adenylated ? ? ?ďůŽĐŬĞĚ adaptor (yellow) ƚŽƚŚĞ ? ?ĞŶĚŽĨĞĂĐŚĨƌĂŐŵĞŶƚǁŚŝĐŚŝƐƵƐĞĚƚŽƉƌŝŵĞƌĞǀĞƌƐĞƚƌĂŶƐĐƌŝƉƚŝŽŶƵƐŝŶŐĂƉƌŝŵĞƌƐƵŝƚĂďůĞĨŽƌƉƌŝŵŝŶŐ
PCR when the fragment is circularised. Barcoding libraries allows multiplexing of sequencing reactions which improves yield and reduces hands on time.    
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6.4 Use of an alternate library preparation method reduces bias in Ion Torrent 
sequencing 
An alternative approach to the Illumina protocol (Ingolia et al., 2009) is represented in Figure 
6-6. In this method ?ĂŶĂĚĂƉƚŽƌŝƐůŝŐĂƚĞĚƚŽƚŚĞ ? ?ĞŶĚŽĨĨƌĂŐŵĞŶƚƐwith a K227Q mutant of 
ƚƌZŶů ?ƚŚĂƚƌĞĚƵĐĞƐ ? ?ĂĚĞŶǇůĂƚŝŽŶĂŶĚƚŚƵƐĐŝƌĐƵůĂƌŝƐĂƚŝŽŶŽĨƚŚĞZEĨƌĂŐŵĞŶƚƐ(Viollet et 
al., 2011). The adaptor is used to prime reverse transcription with a primer containing PCR 
sites to the Illumina specific sequencing primers. Different RT primers can be designed to 
allow amplification by PCR primer pairs used for other platforms. The use of this alternate 
approach does improve coverage relative to the standard Illumina protocol, but no published 
comparison has been made to the Life Technologies approach. 
TƌZŶů ?< ? ? ?YŝƐƌĞƉŽƌƚĞĚƚŽƐŚŽǁĂƉƌĞĨĞƌĞŶĐĞĨŽƌĨƌĂŐŵĞŶƚƐǁŝƚŚƵŶƐƚƌƵĐƚƵƌĞĚ ? ?ĞŶĚƐĂŶĚ
those predicted to co-fold with the adaptor (Zhuang et al., 2012).  RNA structure is reduced 
at high temperature so the use of a thermostable ligase may result in more even coverage. A 
recently characterised K97A point mutant of an RNA ligase from Methanobacterium 
thermoautotrophicum (Mth K97A) is able to ligate only pre-ĂĚĞŶǇůĂƚĞĚEƚŽƚŚĞ ? ?ĞŶĚŽĨ
ssDNA or RNA (Zhelkovsky and McReynolds, 2012) and so maybe expected to act like trRnl2 
but function at 65
o
C.    
To compare the biases of the standard Life Technologies approach against the alternative 
approach and to investigate the potential of Mth K97A to replace trRnl2, libraries from an 
RNA pool of known composition were generated using each method and sequenced on an 
Ion Torrent. The RNA pool used contained partially degenerate 20 nt RNAs: 
 ? ?- GCAGUUGCCANNNNNNNNNN  W  ? ?. Degeneracy at 10 positions yields 1,048,576 (410) 
unique sequences and as the synthesis of the degenerate section was requested to be 
performed with equimolar ratios of each NTP at each position it was assumed that all 
fragments were at an equimolar concentration within the pool. The typical yield from the 
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largest Ion Torrent chip is ~3 million usable reads. Having more reads than unique sequences 
increases the likelihood that each sequence will be represented at least once. This allows for 
characterisation of all biases, rather than just the most prominent ones and accounts for the 
fact that PCR and/or sequencing reaction biases would be expected to reduce the 
representation of some fragments even in the absence of ligation biases. Crucially, the PCR 
amplification, bead preparation and deposition of all 3 libraries (standard, alternate with 
trRnl2 K227Q, alternate with Mth K97A) were identical and performed by the same 
researcher (Carolyn Jones, Willis Lab). 
Rnl2tr K227Q was able to ligate almost all of the RNA pool to the adenylated linker giving 
fragments of 47 nt (Figure 6-7 A). By contrast Mth K97A did not ligate all of the RNA pool 
under the conditions recommended by (Zhelkovsky and McReynolds, 2012) and this was not 
significantly improved by increasing the reaction time. The enzyme was in excess of the RNA 
pool but not of the linker which may have been the cause of the incomplete ligation. An 
inability to ligate all fragments in the pool is not an issue per se unless the enzyme shows 
preference as to which fragments it does ligate. These ligated fragments were successfully 
reverse transcribed giving a product of ~80 nt as expected (Figure 6-7 B). It is worth noting 
that RT primer dimers form in the absence of ligated fragment (figure 6-7B) and that if the 
concentration of RT primer is too high no 80 nt product forms in the presence of ligated 
fragments (data not shown). The hydrolysis of the RNA following the RT reaction leaves 
single stranded ends which allow for the circularisation ǁŝƚŚƚŚĞƚŚĞƌŵŽƐƚĂďůĞŝƌĐ>ŝŐĂƐĞ/ ?.  
This results in a site complementary to the forward primer upstream of the fragment and a 
site identical to the reverse primer downstream of the linker, permitting amplification of the 
libraries. These sites are the 8 nt assumed, on the basis of the similarity to the SOLiD 
protocols, to be within the two proprietary Ion Torrent adaptors. Consistent with this 
assumption amplified libraries were of the expected size (data not shown).
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Figure 6-7 Alternative library preparation method compatible with Ion Torrent sequencing 
The partially degenerate RNA library shown on the top left was ligated with either truncated 
Rnl2 K227Q at 25
o
C or Mth K97A at 65
o
C.  
A The products, visualised after separation on a denaturing gel. The 37 nt band was 
extracted from the gel and reverse transcribed with a custom RT primer then subjected to 
alkaline hydrolysis to degrade the RNA. 
B The resulting RT reactions. The ligation products from 1hr Mth K97A treated were used. 
B 
A 
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Sequencing data having been obtained, bioinformatic analysis was performed to compare 
the degree of bias in each method and attempt to identify potential causes of this. These 
analyses were done with the support of Dr Nicholas Burgoyne (MRC Toxicology Unit).   
The standard Ion Torrent pipeline was used to trim the Ion Torrent adaptor sequences away 
from reads. This resulted in reads of ~20 nt from libraries generated with the standard 
protocol and ~42 nt for the alternate protocols (Figure 6-8, original reads). It might be 
expected the alternate libraries would have 41 nt reads: 20 nt fragments+17 nt linker +4 nt 
sequence between linker binding site and PCR site in the RT primer. A potential explanation 
for the oversized reads is tailing activity of the reverse transcriptase used, adding an extra 
ďĂƐĞďĞƚǁĞĞŶƚŚĞ ? ?end of the fragment and the beginning of the PCR primer site.  
To identify possible sequence specific-biases, non-Ion Torrent adaptors and the conserved 
(i.e. non-degenerate) regions were further trimmed (Figure 6-8, trimmed reads).  
There were a substantial number of 19 nt reads in the standard libraries. These truncated 
reads did not contain all 10 nt of the conserved sequence (Figure 6-8). The reported 
insertion/deletion rate on the IonTorrent is 1 %, but perhaps this particular sequence is more 
prone to being misread. However, the last few nucleotides of the conserved sequence were 
always present in the untrimmed reads, which allowed alignment to the conserved section to 
guide the trimming. This resulted in almost all trimmed reads being 10 nt therefore any 
sequence specific biases are unlikely to be due an artefact of trimming. 
Whilst all libraries showed higher than expected representation of guanines, no position 
specific biases were observed in the standard protocol or alternate protocol with trRnl2 
K277Q (Figure 6-9). However, the use of Mth97A resulted in a profound bias for adenine or 
cytosine at position 8 in the degenerate region. Notably, the reporter RNA used to initially 
characterise this enzyme contained an A in the equivalent position (i.e. 2 nt from the end of 
the read) (Zhelkovsky and McReynolds, 2012).  
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Figure 6-8 Trimming of sequencing reads 
A Frequency of each nucleotide for untrimmed reads from standard library. Top is 19 nt and 
bottom is 20 nt. The 10 nt conserved sequence in the partially degenerate RNA pool is 
GCAGUUGCCA  
B Results of trimming conserved sequence from  ? ?ĞŶĚĂŶĚƵŶŝǀĞƌƐĂůĂĚĂƉƚŽƌĨƌŽŵ ? ?ĞŶĚ ? 
A 
B 
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Figure 6-9 Sequence specific bias in library constructed with Mth K97A 
Frequency of each base at each position across the degenerate region of all reads. Position 1 is the first nucleotide after the conserved 10 nt. 
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To compare the level of uneven coverage between the three libraries, the 10 nt degenerate 
regions of the reads were analysed. In the absence of any biases, the theoretical read 
distribution or a pool of 4
10
 equimolar fragments should be binomially distributed with 
probability 1/4
10
 and the number of trials (n) equal to the total number of sequencing reads. 
Each of the libraries has roughly 3 million reads so the theoretical was modelled as 
X~Bin(1/4
10
, 3,000,000). Any over-dispersion relative to this implies bias  W this was observed 
for all 3 methods (Figure 6-10 A). However reads from trRnl2 K227Q alternate libraries show 
a distribution much closer to the theoretical than either of the other two libraries. This 
suggests that the alternate method will give more even (unbiased) coverage than the 
standard approach. Somewhat surprisingly, the use of Mth K97A did not reduce bias despite 
ligation occurring at temperatures less permissive for structure. Sequencing data from the 
standard and Mth libraries contained over 200 sequences at least 5X more abundant than 
would be expected without any biases. Initial examination suggested the most 
over-represented sequences in all libraries show a profound GC % biases, but strictly this is a 
purely G % bias (Figure 6-10 B). This G % preference may not be a reflection of ligation biases 
alone. It is possible that the Ion Torrent sequencer suffers from an A->G substitution bias 
that has not been previously reported, or alternatively that the oligo pool was not correctly 
formulated by the supplier.    
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Figure 6-10 Alternate library generation methods reduce, but do not eliminate, bias 
A Read density of 1000 most abundant fragments in each of the three libraries. The theoretical is X~Binomial (3x10
6
, 1/4
10
). 
B Percentage content for each nucleotide in last 10 nt of the fragments (ie the degenerate section) using a sliding window of 1000 across a ranked list of 
fragments. 
B 
A 
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Secondary structure of the fragment and cofolding with the adaptors have been suggested as 
possible causes of the ligation bias. It had been hoped that the use of a thermostable ligase 
to ligate the fragments at 65
o
C would therefore reduce bias. To understand why this was not 
the case, all 20 nt fragments that were represented in the sequencing libraries were folded in 
silico under the salt and temperature conditions used for library construction. Interestingly, 
some fragments were predicted to be structured even at 65
o
C and folding energy inversely 
correlated with over-representation in all three sequenced libraries (Figure 6-11).  
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Figure 6-11 Over-represented fragments are predicted to have lower folding energies 
The predicted folding energies of the 10 nt trimmed read plus associated conserved region 
(i.e. a full length of 20 nt) were computed by Nick Burgoyne using ViennaFold. The plot 
shows the mean folding energy across sliding window of 1000 across the reads ranked by 
abundance (high to low).   
177 
 
It should be noted that fragments were denatured at 80
o
C in the alternate method and 65
o
C 
in the standard method prior to ligation/hybridisation so it may be that some fragments that 
were predicted to be structured were not at the time of ligation. In the case of the standard 
protocol, fragments were left for 5 min at 16
o
C to hybridise to adaptors prior to ligation 
overnight so it is theoretically possible all fragments hybridised perfectly to the adaptors 
without refolding. The likelihood of this would be affected by the relative abundance of the 
adaptors (the more abundant the adaptors the increased probability of inter-molecular 
hybridisation vs intra-molecular hybridisation). If hybridisation is extensive in the standard 
protocol then the cofolding of the adaptors and the fragments may play a role in ligation 
efficiency.  It has been shown that Rnl2 can ligate fragments that create a 1-2 nt overhang 
when hybridised to a duplexed adaptor (Sorefan et al., 2012). If this occurs in Life 
Technologies protocols then the PCR products will contain mismatches as the upper strand 
(containing the fragment) will be longer than the lower one. Consistent with this, a 
considerable fraction of reads from the standard library were shorter than 20 nt and showed 
ĚĞůĞƚŝŽŶƐŝŶƚŚĞĐŽŶƐĞƌǀĞĚƌĞŐŝŽŶǁĞƌĞŽĐĐƵƌƌŝŶŐŝŶƚŚĞ ? ?ŵŽƐƚŶƵĐůĞŽƚŝĚĞƐ which hybridise 
with the adaptor overhangs (Figure 6-8 A). 
 A bioinformatics approach to assess how significant mishybridisation is in the biases 
observed in the standard library, could not be performed because the concentration of 
adaptors is a proprietary secret and existing folding programs cannot process duplexes.  
In silico analysis of cofolding in the alternate protocol is possible and would be worthy of 
further investigation.  
  
6.5 Discussion 
This chapter has focussed on the limitations of next generation sequencing. This is not to 
argue that the technique is without merit (nothing could be further from the truth!), but 
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rather to suggest where potential limitations may exist that could result in 
overinterpretation of sequencing data. 
As described in the introduction of this chapter there are essentially three potential areas 
that could be considered: fragment generation, library construction and sequencing.  Biases 
at any of these stages will lead to patchy/incomplete coverage of the 
transcriptome/translatome.  
A fragment generation method that results in an RNA pool that reflects the biological system 
being studied is crucial, particularly when trying to infer ribosome density with ribosome 
profiling. Whilst the majority of polysomes are reduced to monosomes by RNase digestion, a 
bi-ribosome peak was observed in two different, commonly used buffers and was not 
reduced by increased RNase concentration. The ~30 nt mRNA fragments found in this peak 
are likely the result of either overlap between peaks or the dimerisation of ribosomes after 
digestion. Assuming ribosomes are not specialised (i.e. structurally different) at different 
locations then the dimers are likely formed in an unbiased fashion so are a curiosity rather 
than a problem. 
The existence of ~60 nt fragments in this peak is more concerning as it suggests there might 
be disomes formed due to ribosome stacking at regions that are translated slowly/have 
pause sites.  
Attempts have been made to investigate pause sites using ribosome profiling (Ingolia et al., 
2011). In that report, a pause site was defined as a region with more than 25 times the 
median translatome density on the transcript. This was almost double the largest difference 
in regions assessed in the chemically fragmented transcriptome library so is unlikely to be 
purely a result of sequencing bias. They reported no secondary accumulation of ribosomes 
upstream of these sites, and so concluded that ribosomes do not stack in MEFs or if they do, 
upstream ribosomes displace downstream ones. Given that we find ~60 nt fragments in the 
bi-ribosome peak from MEFs digested with the same buffer used by (Ingolia et al., 2011) it at 
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least seems plausible that there is some stacking and that this results in fragments from 
these regions not sequenced. This would mean that regions of highest ribosome density 
within a transcript are paradoxically represented as areas of lower density! To investigate 
this further it will be necessary to sequence these disome fragments. 
It may well be that in many experiments there is no significant difference in stalling and thus 
the disome phenomenon is not significant. However, recent work suggests the prokaryotic 
homologue of eIF5A (EF-P) is responsible for ribosome stacking at polyproline stretches 
(Doerfel et al., 2013, Ude et al., 2013). eIF5A contains an unusual amino acid, hypusine, that 
is absolutely required for the protein to promote translation elongation (Saini et al., 2009).  
Hypusination involves the transfer of 4-aminobutyl moiety from spermidine, in a process 
involving both deoxyhypusine synthase and deoxyhypusine hydroxylase (Park, 2006). 
Ribosome profiling in conditions where any of these three factors may be down-regulated 
would thus be of interest. 
Furthermore, there are other circumstances in which a reduction in elongation rates may 
occur (e.g. cold shock). This reduction in elongation rates may result in an increase in 
stacking at codons that are translated more slowly. As described in Chapter 3, the presence 
of codons decoded by less abundant tRNA  W giving the transcripts a low tRNA adaption index 
(tAI) value (dos Reis et al., 2004)  W is associated with reduced translational efficiency. It is 
assumed this is because such codons are translated more slowly. However, ribosome 
profiling of MEFs with the harringtonine run-off protocol showed no difference in translation 
elongation rates of transcripts with a lower tAI (Ingolia et al., 2011). It is worth noting that 
these calculations could only be reliably performed on abundant, relatively well translated 
mRNAs. Given selective pressures it may be that all these well translated mRNAs have 
comparatively high tAI relative to the whole transcriptome and so show no differential 
elongation.    
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Recent work has shown that ribosome profiling can be used to detect stalled ribosomes in 
response to proteotoxic stress (Liu et al., 2013). However, it remains possible that this 
increase in occupancy is actually an under-representation of the extent of ribosome stalling 
as the bi-ribosome peak was not examined. Ultimately it remains unclear that RNase 
digestion fully captures all locations of ribosome density and that this may have important 
implications when interpreting ribosome profiling data. To limit the possibility of 
misinterpretation of data it might be wise to always perform full sucrose gradient analysis of 
RNase digested lysates to compare the bi-ribosome peak between conditions rather than 
simply pellet ribosomes as recommended in more recent protocols (Ingolia et al., 2012). 
The second area addressed by this chapter was library generation. This was initially 
motivated by the observation of patchy coverage in the transcriptome libraries. Whilst that 
was in part due to enzymatic fragmentation of the polyA+ RNA, library generation is still a 
potential source of bias.  
The use of an alternate library generation protocol reduced over-representation of 
fragments compared to the standard Life Technologies methods. Beyond a desire to identify 
which transcripts are genuinely highly expressed in a system, reducing over-representation 
may be important in the light of the current need to employ thresholds when detecting 
differential translation in ribosome profiling data (see Chapter 3).  If certain fragments are 
over-represented they necessarily reduce the reads that map to other transcripts. This may 
limit the ability to accurately determine TE values for these transcripts. In addition, the use 
of sequencing to identify binding motifs or to assess which microRNAs are most abundant 
within a given cell may be skewed by these biases.  
All libraries showed over-representation with some transcripts more than 10X abundant that 
theoretical. Libraries generated using the alternate method showed less over-representation 
than the standard IonTorrent library. Unfortunately the use of the thermostable ligase Mth 
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K97A did not improve upon the results obtained with trRnl2 K227Q. This is in part due to a 
ƉŽƐŝƚŝŽŶƐƉĞĐŝĨŝĐďŝĂƐĨŽƌĂĚĞŶŝŶĞŽƌŐƵĂŶŝĚŝŶĞ ?ŶƵĐůĞŽƚŝĚĞƐĨƌŽŵƚŚĞ ? ?ĞŶĚ ? In all libraries 
the most over-represented sequences were predicted to be structured under the conditions 
used for ligation. Both Rnl2 and Mth ligases are part of a conserved class of enzymes 
involved in repair of nicked dsRNA (Ho and Shuman, 2002) which may explain why the most 
over-represented fragments were those predicted to have secondary structure. Moreover, a 
role in repairing nicked dsRNA would favour those fragments that are able to co-fold more 
effectively with adaptor sequences and would make for an interesting further study using 
the sequencing data obtained, though this is much more challenging bioinfomatically.   
Replacing the ends of RNA linkers used in the standard Illumina protocol with degenerate 
sequences, so as to reduce the consistency of cofolding, reduces but does not eliminate 
over-dispersion (Sorefan et al., 2012). It may be of interest to see if the alternate library 
preparation method with trRnl2 can be improved by adopting this approach.  
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Chapter 7. Summary 
This thesis has described studies of translational control in a variety of different contexts. 
There were several challenges faced working on the original thesis proposal: the role of 
tRNAi
Met
 in oncogenic transformation.  In support of the data shown in the original paper 
(Marshall et al., 2008), the data in Chapter 3, show an increase in both global translation rate 
and of selected messages following the re-establishment of high tRNAi
Met
 levels in a NIH 3T3 
cell line. However this phenotype was not stable, so despite time-consuming efforts to retain 
a consistent phenotype we must conclude tRNAi
Met
 cannot drive oncogenic transformation in 
D&Ɛ ?&ŽůůŽǁŝŶŐĂŶŝŶǀĞƐƚŝŐĂƚŝŽŶŝŶƚŽƐĐŝĞŶƚŝĨŝĐŵŝƐĐŽŶĚƵĐƚǁŝƚŚŝŶWƌŽĨĞƐƐŽƌŽďtŚŝƚĞ ?Ɛ
group, the original paper that claimed to show increased tRNAi
Met
 levels could drive 
transformation was retracted. However, despite the lack of biological significance, this work 
allowed the development of the ribosome profiling method using the SOLiD sequencing 
platform. It was these experiences that motivated the final of three additional projects that 
were undertaken, all of which were productive. 
The first, perĨŽƌŵĞĚŝŶĐŽůůĂďŽƌĂƚŝŽŶǁŝƚŚƌKǁĞŶ^ĂŶƐŽŵ ?ƐŐƌŽƵƉ ?ƵƐĞĚŐĞŶĞƚŝĐ
manipulation localised to the intestinal epithelia of in vivo and in vitro mouse models to 
investigate mTOR signalling in colorectal cancer.  
Inhibition of mTORC1 with rapamycin prevented the onset of benign (but pathological) 
intestinal tumours when administered shortly after APC loss, and improved survival when 
treatment commenced upon development of a sick phenotype.  This suggests that 
rapamycin would be a promising therapy for FAP patients, which would be a significant 
improvement on the current recommended management: colon resection. 
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That deletion of Raptor provides little additional benefit beyond that conferred by rapamycin 
treatment suggests that proliferative mTORC1 signalling in the intestine is mediated 
predominantly via S6K and not 4E-BPs. S6K has multiple targets which affect different 
mechanistic processes; this thesis presented five distinct pieces of evidence to suggest that 
increased translational elongation is the key underlying mechanism by which Wnt-driven 
mTORC1 signalling leads to proliferation. First, the polysomal association in APC
fl/fl
 mice was 
reduced relative to wild type, which in the absence of an uncoupling of protein synthesis 
from proliferation would imply a reduced ribosome transit time. Second, treatment of APC
fl/fl
 
mice with the elongation inhibitor cycloheximide resulted in a reduction in crypt proliferation 
comparable to rapamycin treatment. Third, APC
fl/fl
 crypts cultured in vitro show an increase 
in protein synthesis rate and a decrease in ribosome run-off time when treated with 
harringtonine. Forth, systemic deletion of eEF2k, a negative regulator of elongation 
downstream of mTORC1, removes rapamycin induced inhibition of Wnt-driven proliferation. 
Finally, RNAi knockdown of eEF2, the downstream target of eEF2k, prevents intestinal 
regeneration in Drosophila. Collectively these data suggest that unlike in other organs, in the 
intestine, the increase in protein synthesis required to drive proliferation is due primarily to 
an increase in translation elongation and not initiation. 
Approximately 40 % of CRC patients present with a K-Ras mutant tumour and respond poorly 
to existing therapies. The common G12D gain of function mutation conferred resistance to 
inhibition of mTORC1 (by rapamycin or Raptor knockout) and to both mTORC1 and mTORC2 
(with pp242). Intriguingly, deletion of Rictor alone reduced proliferation to almost wild type 
levels in APC-null, K-Ras mutant epithelia, but not APC-null alone. In the absence of reports 
of other plausible Rictor targets that could mediate this effect, we hypothesise that selective 
inhibition of mTORC2 may be an effective therapy for Ras-mutant CRC. Investigating the 
effect of loss of other mTORC2 essential components, such as mSIN1, would be of value in 
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investigating this theory. Investigation using a selective inhibitor of mTORC2 would be ideal, 
but these have not been developed.  
The second collaboration was within the Willis group, supported the research carried out by 
Dr Amandine Bastide to characterise the cold shock response. It was shown that translation 
elongation is vastly reduced under these conditions, which explains the maintenance of 
heavy polysomes at 32
o
C despite a 60 % reduction in protein synthesis rates. Notably these 
changes in elongation rate were not mediated via eEF2k. To investigate the possibility of 
differential regulation at the level of elongation ribosome profiling was performed.  
Extensive read density was observeĚŝŶƚŚĞ ? ?hdZƐŽĨŵZEƐŝŶƌĞƐƉŽŶƐĞƚŽĐŽůĚƐŚŽĐŬ ?
although ultimately the use of RNase protection assays revealed that this was likely to be a 
technical artefact. 
In the final project it was decided to better characterise the potential limitations of the 
ribosome profiling technique and of sequencing more generally. The great advantage of 
ribosome profiling is the ability to compare the ribosome occupancy at multiple different 
features such as coding sequences, uORFs or start sites. However this is best achieved when 
biases are minimised so that sequencing data is an accurate representation of the true 
biological situation. 
A potentially troubling issue, consistently observed, was that, unlike in the schematics, 
RNase I digestion does not digest polysomes to monosomes. Through the use of northern 
blotting and RNase protection assays we have identified the formation of both ribosome 
dimers after digestion and digestion resistance disomes. Two pieces of additional work are 
necessary to confirm the significance of this. First, a more direct method of assessment of 
the dimer/disome RNA fragments as the data seen may be due to non-specific binding. 
Attempts to use transfection of radiolabelled RNA were unsuccessful both because of rapid 
RNA degradation and the possible presence of a functional uORF within the vector. However, 
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using a transcript with longer half-ůŝĨĞĂŶĚŝŶĂǀĞĐƚŽƌƚŚĂƚĚŽĞƐŶ ?ƚŚĂǀĞƚŚĞƵKZ&ŵĂǇ
address this issue. The second key experiment would be the sequencing of ~60 nt fragments 
within the bi-ribosome peak. If there is no difference in the representation of transcripts 
within this peak compared to the 30 nt fragments in the monosome peak then it would be 
safe to infer that no bias is introduced at the RNase digestion step. 
Given the initial aim to characterise and reduce biases, it was pleasing that the use of an 
alternate library preparation method showed substantially reduced bias relative to the 
standard Life Technologies protocol.  However, consistent with previous reports from other 
library protocols, reads with a high degree of secondary structure were over represented.  
Unfortunately the use of a thermostable enzyme (Mth K97A) did not rectify this problem. It 
is unclear whether this was due to additional biases of Mth K97A  W for example a sequence 
specific bias was observed  W or whether structure is correlative with, but not causative of 
bias. Irrespective, it would be would be interesting to use the dataset generated to 
investigate whether over represented fragments are also predicted to co-fold with adaptors, 
in agreement with the work of other groups. If this is the case then the use of partially 
degenerate adaptors would be expected to result in more representative libraries, though 
this may create difficulties in adaptor trimming. 
A final area that would be useful to investigate would be increasing the effective read depth 
that can be achieved with ribosome profiling. Two potential approaches would be to develop 
robust statistical methods to reliable analyse low count data and to develop subtractive 
hybridisation methods against contaminating rRNA fragments. The latter has been described 
by (Ingolia et al., 2012), but it is unclear by how much this improves read depth or its 
applicability to different organisms. 
In conclusion, my research has shown how global changes in post-transcriptional regulation 
of gene expression are associated with the development and progression of neoplasia, in 
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particular changes in elongation rates. Detailed analysis of ribosome profiling suggests that 
some further development of this technique is required, however this method is already 
beginning to revolutionise the analysis of the translatome and will only become more 
powerful and more accessible as next-generation sequencing technologies mature. 
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